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ABSTRACT 
 This work aimed to investigate the potential of medicinal halophytes as sources of 
bioactive compounds with health-promoting properties, while validating their traditional uses 
and searching for new bioactivities/applications. Halophytes are salt-tolerant plants that survive 
in extreme biotopes and, to cope with environmental stress, are equipped with powerful defence 
mechanisms, including highly bioactive compounds. Several medicinal halophytes are used in 
folk therapeutics but, despite their ethnopharmacological importance, are still underexplored. 
This study focused on five medicinal halophytes from southern Portugal, namely Artemisia 
campestris L. subsp. maritima Arcangeli (dune wormwood), Crithmum maritimum L. (sea 
fennel), Eryngium maritimum L. (sea holly), Helichrysum italicum (Roth) G.Don subsp. 
picardii (Boiss&Reuter) Franco (everlasting), and Plantago coronopus L. (buckshorn plantain). 
Water and organic extracts were prepared from different plant organs, assessed for in vitro 
antioxidant, anti-diabetic, anti-hyperpigmentation and anti-protozoan activities, and chemically 
characterized. 
 The large majority of the extracts have high polyphenolic content and are a potentially 
good source of these bioactive phytochemicals. They presented a wide diversity of phenolics, 
especially coumaric, ferulic, syringic, chlorogenic, and p-hydroxybenzoic acids. Minerals were 
also analysed, and some species may have a nutritional role as mineral supplementary source, 
particularly sea fennel for macronutrients and dune wormwood for microelements. A 
preliminary toxicological assessment showed that extracts had overall low toxicity. As for 
bioactivities, results confirm the strong in vitro antioxidant capacity of the extracts. Everlasting, 
dune wormwood and sea holly also showed anti-diabetic activity, while dune wormwood had 
additional anti-hyperpigmentation capacity, and sea fennel had activity against Trypanosoma 
cruzi. In conclusion, all halophytes can be useful sources of antioxidants to potentially help 
prevent oxidative-stress related diseases, while everlasting, dune wormwood and sea holly may 
additionally help control glucose levels. Dune wormwood is also a prospective source of 
compounds to prevent skin darkening and sea fennel may provide effective anti-T. cruzi 
molecule(s).  
 
Keywords: medicinal halophytes, phenolic compounds, minerals, antioxidant activity, anti-
diabetic activity, anti-hyperpigmentation activity 
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RESUMO 
 Este trabalho teve como objetivo principal explorar o potencial de plantas halófilas 
medicinais enquanto fontes de compostos bioativos com aplicação terapêutica, e ao mesmo 
tempo validar os seus usos na “medicina” popular e procurar novas bioatividades e / ou 
aplicações. As plantas halófilas possuem uma elevada tolerância ao sal e completam o seu ciclo 
de vida em biótopos extremos, tais como zonas costeiras de influência salina. Para resistirem 
ao stress ambiental, estão equipadas com poderosos mecanismos de defesa que incluem a 
produção de compostos altamente bioativos, cujas atividades biológicas poderão ajudar a 
explicar a utilização de algumas destas plantas como remédios populares e para alimentação 
humana (e animal). De facto, inúmeras plantas halófilas são utilizadas no tratamento de várias 
doenças e infeções, principalmente em áreas rurais onde as plantas medicinais ainda são uma 
importante fonte terapêutica. No entanto, estas plantas são pouco exploradas e são também 
poucas as descrições das suas bioatividades, apesar da sua importância etnofarmacológica. Na 
região do Algarve (sul de Portugal), poucas espécies têm sido estudadas apesar do seu potencial 
conteúdo em moléculas bioativas. Assim, com o intuito de expandir o nosso conhecimento 
acerca das possíveis propriedades terapêuticas e promotoras de saúde e bem-estar deste tipo de 
plantas, este trabalho estudou cinco plantas halófilas medicinais comuns no Algarve, escolhidas 
pelos seus usos medicinais e potenciais atividades biológicas, nomeadamente Artemisia 
campestris L. subsp. maritima Arcangeli (madorneira), Crithmum maritimum L. (funcho 
marítimo), Eryngium maritimum L. (cardo marítimo), Helichrysum italicum (Roth) G.Don 
subsp. picardii (Boiss&Reuter) Franco (perpétua das areias) e Plantago coronopus L. 
(diabelha). O objetivo foi desvendar o seu potencial enquanto fontes de compostos e / ou 
extratos bioativos com aplicações terapêuticas, cosméticas e / ou nutricionais. Para tal, à 
semelhança de preparações tradicionais, foram preparados extratos aquosos e / ou orgânicos de 
diferentes órgãos (raízes, caules, folhas e / ou flores), e avaliados quanto às suas atividades 
antioxidante, antidiabética, anti-hiperpigmentação e anti-protozoária in vitro. Adicionalmente, 
para o funcho marítimo, cardo marítimo e perpétua das areias, os extratos foram estudados na 
sua dose de ingestão tradicional, i.e., usando a medida “chávena-de-chá” (e também a medida 
“gotas”, no caso das tinturas do cardo), para analisar as plantas duma perspetiva de utilização 
medicinal típica. Os extratos foram ainda caracterizados quimicamente. 
 Os extratos foram caracterizados em relação aos compostos fitoquímicos presentes por 
métodos espectrofotométricos para determinar o seu conteúdo em fenólicos totais (TPC), para 
além do conteúdo em outros grupos fenólicos (flavonóides totais, taninos condensados, etc.). 
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Em geral, todos os extratos analisados têm um elevado conteúdo polifenólico e são, 
potencialmente, boas fontes destes compostos fitoquímicos bioativos. De um modo geral, os 
extratos da perpétua das areias tiveram o maior conteúdo em fenólicos totais, seguidos pelos 
extratos da madorneira, enquanto que o cardo marítimo teve o mais baixo TPC. De notar que, 
globalmente, os órgãos aéreos (folhas e flores) de todas as plantas mostraram ter conteúdos 
fenólicos mais elevados do que os restantes órgãos. Os extratos foram ainda caracterizados por 
Cromatografia Líquida de Alta Eficiência (HPLC) ou por Ultra-HPLC para determinar o seu 
perfil polifenólico e outros compostos tentativamente identificáveis. Foi encontrada uma grande 
diversidade de fenólicos nestas plantas halófilas, sendo os mais abundantes: verbascósido e 
luteolina-7-O-glucosídeo na diabelha, ácidos clorogénico, neo- e cripto-clorogénico no funcho 
marítimo, ácidos quínico e clorogénico na perpétua das areias e na madorneira, e carvacrol e 
naringenina no cardo marítimo. Os compostos fenólicos mais comuns foram os ácidos 
fenólicos, com uma ligeira prevalência dos ácidos hidroxicinâmicos. Os ácidos cumárico e 
ferúlico foram identificados nas cinco plantas, e os ácidos p-hidroxibenzoico, siríngico e 
clorogénico estavam presentes em pelo menos quatro das espécies. O conteúdo em minerais foi 
também analisado nos extratos das folhas da diabelha e dos órgãos do funcho marítimo, cardo 
marítimo e madorneira. O sódio foi o elemento mais abundante encontrado, e os outros minerais 
estavam presentes em valores representativos de uma pequena porção da ingestão diária 
recomendada para adultos. De um modo geral, os resultados salientaram um possível papel 
nutricional destas plantas enquanto fonte mineral suplementar, particularmente o funcho 
marítimo para os macronutrientes e a madorneira para os micronutrientes. Foi efetuada também 
uma avaliação toxicológica preliminar aos extratos do funcho marítimo, madorneira e perpétua 
das areias, através da sua capacidade para diminuir a viabilidade de diferentes linhas celulares. 
Os extratos apresentaram, de um modo geral, baixa toxicidade. 
 Os extratos foram também analisados quanto a propriedades antioxidante, antidiabética e 
anti-hiperpigmentação, através de uma bateria de ensaios para testar in vitro atividades de 
captação de radicais e de quelação de metais, capacidade de inibição de enzimas digestivas e 
de inibição da tirosinase, respetivamente. As decocções, tinturas e óleos essenciais da perpétua 
das areias e do funcho marítimo, foram também testados in vitro para a atividade anti-
protozoária contra Trypanosoma cruzi, o agente causativo da doença de Chagas. Os extratos da 
perpétua das areias e da madorneira detiveram a maior capacidade antioxidante, seguidas pelos 
do funcho marítimo; contudo, os extratos do cardo marítimo demonstraram a mais potente 
atividade quelante do ferro. Os extratos da perpétua, madorneira e cardo revelaram ainda 
atividade antidiabética, apesar de apenas os do cardo serem capazes de inibir todas as enzimas 
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hidrolisantes de hidratos de carbono; contudo, os extratos da madorneira foram os mais 
eficientes a inibir a α-glucosidase, mais ainda que o controlo positivo (acarbose). Apenas os 
extratos da madorneira apresentaram capacidade de inibir a tirosinase. O extrato aquoso do 
funcho marítimo foi o mais ativo e seletivo contra T. cruzi. De um modo geral, os resultados 
confirmaram a forte capacidade antioxidante in vitro dos extratos, evidenciando que todas as 
cinco plantas halófilas podem ser úteis como fontes de moléculas ou produtos antioxidantes e, 
como tal, poderão ajudar a prevenir doenças relacionadas com stress oxidativo. O potencial 
antidiabético dos extratos da perpétua das areias, da madorneira e do cardo marítimo podem 
ainda auxiliar no controlo dos níveis de glucose, ajudando pacientes com diabetes mellitus tipo 
2. Por outro lado, os extratos da madorneira são também possíveis fontes de compostos para 
prevenção / tratamento de hiperpigmentação da pele, enquanto que os do funcho marítimo 
poderão ser fontes de moléculas anti-T. cruzi.  
 No geral e em conclusão, o resultado deste trabalho demonstra que as cinco espécies de 
plantas halófilas estudadas são prospectivamente boas candidatas a serem utilizadas como 
alimento (as folhas da diabelha, por exemplo), em bebidas à base de plantas (como por exemplo 
tisanas de funcho e cardo marítimos e de perpétua das areias), como fontes de moléculas de 
relevo (ex.: compostos anti-T. cruzi do funcho marítimo), ou como matéria prima para as 
indústrias cosmética (como a madorneira para problemas de hiperpigmentação) e farmacêutica 
(ex.: a perpétua das areias, a madorneira e o cardo marítimo para o controlo da diabetes), e 
ainda para o segmento comercial de alimentos funcionais e / ou nutracêuticos (todas as cinco 
plantas halófilas enquanto antioxidantes potentes para prevenção de condições relacionadas 
com stress oxidativo). Adicionalmente, o perfil químico e atividades biológicas podem ajudar 
a explicar os usos tradicionais destas plantas.  
 
Palavras Chave: plantas halófilas medicinais, compostos fenólicos, minerais, atividade 
antioxidante, atividade antidiabética, atividade anti-hiperpigmentação 
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OUTLINE OF THE THESIS 
This thesis is divided in eight chapters. The first chapter corresponds to a general literature 
review of the main subjects of the thesis, chapters 2 to 7 describe the experimental work and 
obtained results in a publication format (research articles), and chapter 8 includes an overall 
discussion and conclusions of the main results along with future perspectives of this research. 
This thesis was designed to be based on research articles that have been published (chapters 2 
to 5), are in press (chapter 6) or in preparation (chapter 7) for publication, and that provide an 
account of the research that supports this thesis. All presented publications were written to stand 
alone and, therefore, some repetition may be found in parts of the manuscript. 
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GENERAL INTRODUCTION 
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1.1. Halophyte Plants 
 Representing approximately 1% of the world’s plant species, halophytes are salt-tolerant 
plants with particular morphological and physiological traits that make them well suited to 
survive and flourish in a multitude of saline biotopes. These environments, usually coastal 
ecosystems like beaches, rocky shores, estuaries, saltmarshes and lagoons, are exposed to 
highly fluctuating abiotic constraints namely salinity, light intensity, drought, temperature, 
among others (Grigore and Toma 2017; Hasanuzzaman et al. 2014; Ksouri et al. 2012). 
Halophytes are well adapted to these harsh conditions due to their high physiological plasticity 
comprised by various response mechanisms to handle abiotic stress, particularly salinity and 
drought, although species differ in the overall degree of stress tolerance. Most halophytes use 
selective ion accumulation and compartmentalization for internal osmotic adjustment, 
controlled ion uptake by roots and transport to leaves, synthesis and accumulation of compatible 
solutes to accommodate ionic balance, salt accumulation or secretion, and induction of 
antioxidant systems and other metabolites to maintain redox homeostasis; other adaptations 
may include succulence, salt glands, successive cambia or bulliform cells, found only in some 
halophytic species (Aslam et al. 2011; Flowers et al. 2010; Grigore and Toma 2017; 
Hasanuzzaman et al. 2014). The extreme environmental stress in which halophytes develop can 
particularly trigger the production and accumulation of reactive oxygen species (ROS) that, in 
turn, can lead to cellular and tissue damage, generating metabolic disorders and senescence 
processes. To cope with these excessive ROS, halophyte plants are equipped with powerful 
antioxidant defence systems, including antioxidant enzymatic mechanisms and enhanced 
synthesis of antioxidant secondary metabolites (phenolics, terpenoids, vitamins and other 
molecules) that counteract ROS production, inhibit oxidative chain-reactions and protect 
cellular structures from oxidative effects (Ksouri et al. 2008, 2012). Apart from antioxidant 
activity (e.g. radical-scavenging and redox metal-chelating), most of these metabolites display 
additional biological activities such as enzyme inhibition, antimicrobial, anti-inflammatory, 
antitumoral, among others, leading to beneficial therapeutic properties that help explain the use 
of some halophytes in traditional medicine and as dietary plants (Ksouri et al. 2012; Shahidi 
and Ambigaipalan 2015).  
 Halophyte plants have been studied from several different scientific perspectives 
(ecology, botany, plant physiology, biochemistry, molecular biology, biotechnology, etc.) 
rendering a plethora of classifications to define them based on different criteria such as salt 
requirements, adaptive mechanisms or biotope characteristics. Until today, due to their 
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taxonomical and ecological complexity, no consensus has been reached and it remains a matter 
of much debate (Grigore and Toma 2017; Hasanuzzaman et al. 2014; Ksouri et al. 2012). From 
an ecological perspective, it is logical to associate halophytes to the saline ecosystems they live 
in. Hence, plants that grow in saline environments can be considered halophytes given their 
close dependence on soil salinity, despite its varying degrees (Grigore and Toma 2017). In this 
sense, halophytes can be classified as obligate, facultative, or habitat-indifferent. Obligate 
halophytes (also called true halophytes) only grow in salty habitats, requiring saline conditions 
for optimum growth and development (e.g. members of the Amaranthaceae family). Facultative 
halophytes tolerate salt and grow in saline soils, although their optimum is in salt-free or low-
salt conditions (e.g. members of Poaceae, Cyperaceae, and Juncaceae families). Habitat-
indifferent plants (or supportive halophytes) are able to cope with salt, but usually grow on salt-
free conditions (e.g. some species of the Poaceae, Juncaceae, and Amaranthaceae families) 
(Aslam et al. 2011; Hasanuzzaman et al. 2014). Nevertheless, this classification is still 
controversial as some authors defend that only true halophytes should be considered halophyte 
plants due to the mandatory salt requirements, while others believe that facultative and 
supportive halophytes deserve their place in the halophyte category since they occupy niches 
in saline ecosystems (Grigore and Toma 2017). Usually, the parameter to separate a halophyte 
from a non-halophyte (glycophyte, a non-salt tolerating plant species, ‘sensitive’ to saline 
conditions) has been the tolerance to salt (NaCl) concentration, with a dividing line established 
at 0.5% NaCl (~86 mM). Additionally, a limit of 200 mM NaCl tolerance has also been 
suggested to separate true halophytes from salt-tolerant plants (Flowers et al. 2010; Santos et 
al. 2015). However, these limits can be quite reductive when considering the very broad 
spectrum of salt tolerance, from the least (e.g. chickpea dies in 25 mM NaCl) to the most salt-
tolerant species (e.g. Arthrocnemum macrostachyum (Moric.) Moris and Tecticornia spp. 
survive in up to 1000 mM NaCl) (Flowers et al. 2010; Grigore and Toma 2017; Hasanuzzaman 
et al. 2014; Santos et al. 2015). 
 More than 2500 plant species with some level of salinity tolerance are known worldwide; 
they are distributed through a large number of plant families and have a wide ecological 
spectrum (Flowers et al. 2010; Grigore and Toma 2017; Ksouri et al. 2012). Perhaps the most 
promising value of halophytes is their potential to grow and be produced in otherwise 
uncultivable saline soils and marine-influenced environments, being irrigated with salt water. 
Most of our crop species are ‘salt-sensitive’ glycophytes whose cultivable areas are diminishing 
due to soil salinization and desertification. In the present context of increasing world population 
and global climate change, this threat to agriculture and food production could be overcome 
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with alternative resources such as halophytes. In fact, several halophyte species can be suitable 
candidates to serve as alternative cash crops to be explored in diverse commercial segments, 
from human and animal nutrition to pharmaceutical and cosmetic industries, serving as an 
approach for the sustained management of saline areas, for revegetation, soil-remediation or 
even ecosystem-engineering purposes (Buhmann and Papenbrock 2013; Flowers et al. 2010; 
Grigore and Toma 2017; Hasanuzzaman et al. 2014; Ksouri et al. 2012; Santos et al. 2015; 
Ventura and Sagi 2013). In the scientific environment, halophyte plants are currently 
considered and increasingly proved to be an important promising (and almost untapped) 
reservoir of bioactive molecules with multiple possible biotechnological applications (Barreira 
et al. 2017; Custódio et al. 2012; Ksouri et al. 2012; Lopes et al. 2016; Oliveira et al. 2016, 
2018; Pereira et al. 2017a,b,c, 2018; Petropoulos et al. 2018a,b; Rocha et al. 2017; Rodrigues 
et al. 2014, 2015, 2016, 2017a,b,c, 2018a,b). Moreover, many halophytes have been and are 
still traditionally used all over the world as food and folk remedies, which stands to prove their 
great potential still largely unexplored (Ksouri et al. 2012). 
 
1.1.1. Ethnopharmacological uses of halophytes 
 Some halophytes are edible and consumed as vegetables or salad ingredients (e.g. 
Crithmum maritimum L., Daucus carota L., Eryngium maritimum L., Portulaca oleracea L., 
Atriplex, Chenopodium, Plantago, Polygonum, Salicornia, Salsola and Sarcocornia species, 
etc.) in countries such as Italy, France, Syria and in the Balcans (Al-Oudat and Qadir 2011; 
Guarrera and Savo 2016; Ksouri et al. 2012; Redzic 2006), or used for animal feeding (e.g. 
Arthrocnemum, Atriplex and Tamarix species) (Al-Oudat and Qadir 2011; Ksouri et al. 2012; 
El Shaer 2006). But more than being a food resource, several halophytes are used as traditional 
remedies to treat various diseases and infections particularly in rural areas where folk medicine 
remains a major therapeutic source. Yet, for most of those plants there is no scientific evidence 
supporting their therapeutic claim (Ksouri et al. 2012). Researchers have long been compiling 
and categorizing the ethnomedicinal uses of plants in different areas of the world, namely the 
Mediterranean region (González-Tejero et al. 2008), in Italy (Cornara et al. 2009), Portugal 
(Neves et al. 2009; Novais et al. 2004), Egypt (AbouZid and Mohamed 2011), or the North Sea 
(Liebezeit et al. 1999), but studies dedicated specifically to the ethnobotany of halophytes are 
uncommon (Al-Oudat and Qadir 2011; Ksouri et al. 2008, 2012; Qasim et al. 2011).  
 Ksouri et al. (2012) is, in the author’s opinion, the best comprehensive review committed 
to detail exclusively the folkloric medicinal uses of halophyte plants, grouped by plant families, 
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discussing their claimed beneficial health properties along with reported biological activities 
and phytoconstituents. Those authors describe up to 20 plant families (Aizoaceae, Apiaceae, 
Asteraceae, Brassicaceae, Amaranthaceae, Combretaceae, Elaeagnaceae, Fabaceae, 
Lamiaceae, Liliaceae, Malvaceae, Moraceae, Palmae, Plantaginaceae, Plumbaginaceae, 
Poaceae, Rubiaceae, Tamaricaceae, Verbenaceae, and Zygophyllaceae) containing more than 
70 species of medicinal halophytes used in the treatment of various human ailments. Qasim et 
al. (2011), in its compilation of coastal halophytic medicinal species along the Arabian Sea, 
reports 21 plant families (14 of which not mentioned by Ksouri et al. [2012]: Asclepiadaceae, 
Boraginaceae, Capparaceae, Convolvulaceae, Cucurbitaceae, Cyperaceae, Euphorbiaceae, 
Mimosaceae, Portulacaceae, Rhamnaceae, Rhizophoraceae, Salvadoraceae, Solanaceae, and 
Tiliaceae), with a total of 45 halophyte species with folk uses (13 of them recorded in Ksouri 
et al. [2012]). Al-Oudat and Qadir (2011) present an extensive list of Syria’s halophytic flora 
with more than 90 halophytes in 27 plant families having traditional uses (medicinal, food or 
fodder); 9 plant families (Amaryllidaceae, Caryopphyllaceae, Cistaceae, Frankeniaceae, 
Juncaceae, Papilionaceae, Polygonaceae, Thymelaeaceae, and Typhaceae) and around 80 
halophytes are not mentioned by Ksouri et al. (2012) nor Qasim et al. (2011). These three 
studies show the high diversity of halophytes used by local populations, attesting to the 
importance of this group of plants in folk medicine. The halophytes described are used to treat 
almost all types of conditions being the most common uses antimicrobial and antiparasitic, 
analgesic, antipyretic, anti-inflammatory, diuretic, to treat digestive and respiratory disorders, 
skin conditions (dermatitis, wounds, burns) or specific diseases (tuberculosis, scurvy, diabetes, 
cancer). When applied as therapeutics, the whole plant or plant organs (usually roots, leaves or 
flowers), fresh or dried, are typically eaten raw or cooked, applied as cataplasm (poultice), or 
more commonly ingested as infusions, decoctions, or alcoholic extracts (tinctures) (Al-Oudat 
and Qadir 2011; Ksouri et al. 2012; Qasim et al. 2011).  
 While the purpose of this work is not to compile a review of medicinal halophyte species 
recorded in literature, examples of halophytic folk remedies can be given in a general overview. 
In this sense, Table 1.1 is a compilation of halophyte plants and their traditional medicinal uses 
mostly in the Mediterranean region, found in some studies besides the ones mentioned above 
(Al-Oudat and Qadir 2011; Ksouri et al. 2012; Qasim et al. 2011). The eHALOPH database 
was used to identify halophyte species (eHALOPH 2018). Briefly, in the Mediterranean region, 
halophytes such as Ammi visnaga (L.) Lam., Centaurium spicatum (L.) Fritsch., Cynodon 
dactylon (L.) Pers., Dittrichia viscosa (L.) Greuter, E. maritimum, Plantago coronopus L., 
Polygonum aviculare L., or Spergularia rubra (L.) J.&C.Presl. are some of the plants 
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comprised in the populations’ collective knowledge to treat conditions related to several 
pathologies like respiratory, digestive or skin disorders, among others (González-Tejero et al. 
2008). In Italy, Asparagus officinalis L. and Lavatera arborea L. are used as diuretic, C. 
maritimum and Helichrysum italicum (Roth) G.Don as anti-inflammatory, and D. carota as 
laxative (Cornara et al. 2009). In Tunisia, Mesembryanthemum edule L. (syn. Carpobrotus 
edulis L.) and M. crystallinum L. are used for their antiseptic and antimicrobial properties 
(Ksouri et al. 2008); M. edule is also commonly used in South Africa for oropharyngeal 
infections and to treat wounds, stings and burns (Falleh et al. 2011; Springfield et al. 2003). 
Still in Tunisia, Limoniastrum monopetalum (L.) Boiss. is used against infectious diseases or 
parasites (Trabelsi et al. 2010) and Tamarix gallica L. is used as diuretic and laxative (Ksouri 
et al. 2008). In Egypt, P. olearacea is used for rheumatic pain (AbouZid and Mohamed 2011) 
while it also has recorded uses in Albania and Cyprus for cardiovascular and muscular 
conditions (González-Tejero et al. 2008). But perhaps the medicinal halophyte with most uses 
and in the higher number of Mediterranean countries, as well as in Iraq and Iran, is Pistacia 
lentiscus L.; from its numerous applications the more common ones are analgesic, antipyretic, 
anti-inflammatory, for skin and gastrointestinal disorders (Aflosul 2006; Ali-Shtayeh et al. 
1998; Bozorgi et al. 2013; González-Tejero et al. 2008; Novais et al. 2004). In other areas, like 
the North Sea region for example, some halophyte species with traditional uses are Artemisia 
maritima L., as anthelmintic, Limonium vulgare Mill. and Salsola kali L., both anti-diarrheic 
(Liebezeit et al. 1999). Artemisia maritima is also a diabetes treatment in North East India 
(Sheikh et al. 2015) and S. kali is known as hypotensive in Tunisia (Ksouri et al. 2008). 
 In Portugal, ethnobotanical surveys have referenced some halophytes as plants with 
medicinal uses (Table 1.1). Achillea millefolium L. and Raphanus raphanistrum L. are used as 
antipyretic, while Arundo donax L., D. carota, Eucalyptus camaldulensis Dehnh. and P. 
coronopus help treat colds and cough. Plants with described anti-inflammatory properties are 
A. millefolium and Plantago species; Plantago species are also reported as analgesic along with 
D. carota and P. lentiscus. The latter species is also employed to address rheumatic issues, just 
like C. dactylon and Artemisia campestris L. subsp. maritima Arcangeli. To handle digestive 
disorders, including diarrhoea, A. campestris subsp. maritima, Chenopodium ambrosioides L., 
C. dactylon, D. carota, Plantago major L., P. lentiscus, P. aviculare and Rumex crispus L. are 
described, and some of these plants (C. dactylon, C. ambrosioides, P. lentiscus and P. 
aviculare), along with A. millefolium, are also used as diuretic. For skin infections, wounds or 
with emollient properties, Chenopodium album L., E. camaldulensis, H. italicum, P. aviculare, 
P. lentiscus, Typha dominguensis Pers., Mesembryanthemum and Plantago species are the 
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species reported. Helichrysum italicum and A. campestris subsp. maritima also have 
anthelmintic uses. Additionally, Cotula coronopifolia L. is used for bladder issues, D. viscosa 
for sciatic pain, Salicornia ramosissima J.Woods and Sarcocornia fruticosa (L.) A.J.Scott to 
address obesity and Tamarix africana Poir. for tooth ache and abscesses (Aflosul 2006; 
Almargem 2018; Bozorgi et al. 2013; Carapeto 2006; Carvalho 2006; Neves et al. 2009; Novais 
et al. 2004; Viegas et al. 2014).  
 The length of Table 1.1, which aimed at giving only some examples of medicinal 
halophytes found in few studies, demonstrates the importance and extensive uses of halophyte 
plants in folk medicine, particularly in the Mediterranean region. Herbal medicine has always 
had a fundamental role in human welfare and it is still of utmost importance in many cultures 
today. In this sense, the ethnopharmacological knowledge of populations can serve as base to 
search for novel bioactive compounds. Considering this, scientific research has explored and 
produced numerous studies about medicinal plants’ biological properties and chemical 
constituents not only to advance plant drug discovery but also to validate the plant’s traditional 
uses. However, for halophytes with folk uses, research on their bioactivities and subsequent 
evidence supporting their medicinal claim is still scarce for many of those plants. 
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1.2. Biological Activities of Halophytes 
 Several examples of claimed medicinal uses of a plant have been successfully related to 
a biological activity, leading to the development of valuable plant-derived drugs (e.g. atropine, 
found in Atropa belladonna L.; digoxin, from Digitalis lanata Ehrh.; the opiate morphine, from 
Papaver somniferum L.; paclitaxel, found in Taxus brevifolia Nutt.; tubocurarine, from 
Chondrodendron tomentosum Ruiz&Pav. bark, etc.) (Stepp and Thomas 2005). A biological 
activity can be defined as the inherent ability of a substance (regarding its concentration) to 
produce an effect in a biological process. Measuring said biological activities, usually through 
specific bioassays that assess the potency of an agent for the aimed biological reaction, allows 
the discovery and development of new biologically active compounds (Jackson et al. 2007). 
New compounds, along with the source of those compounds, can become important products 
or material for the pharmaceutical, cosmetic and / or food industries.  
 Contemporary research exploring the biochemical properties of medicinal plants reports 
biological activities in some halophytes, frequently validating their ethnomedicinal use. Again, 
Ksouri et al. (2012) gives a comprehensive review of bioactivities found in different medicinal 
halophyte species, namely antioxidant activity in Atriplex halimus L. or M. edule, cytotoxic 
effects of Plantago species, anti-inflammatory potential of P. lanceolata and P. major, 
antibacterial properties in Cynara cardunculus L. or T. gallica, antifungal activity in Cakile 
maritima Scop., neuroprotective potential of Thespesia populnea (L.) Sol. ex Corrêa, or 
hypoglycaemic / anti-diabetic properties in Suaeda fruticosa Forssk. ex J.F.Gmel. and Capparis 
decidua (Forssk.) Edgew., activities associated to biologically active molecules found on those 
species (like phenolic compounds, for example). Other authors, particularly in ‘post-Ksouri 
review’ studies, also found antioxidant potential in many halophytes (Amessis-Ouchemoukh et 
al. 2014; Jallali et al. 2014; Oueslati et al. 2012; Qasim et al. 2016; Petropoulos et al. 2018a,b; 
Stanković et al. 2015; Zengin et al. 2018), along with antimicrobial effects in C. maritimum, 
Inula crithmoides L. or Limoniastrum species (Jallali et al. 2014; Trabelsi et al. 2013), anti-
inflammatory properties in S. fruticosa, C. dactylon or T. gallica (Oueslati et al. 2012; 
Petropoulos et al. 2018a), cytotoxic activity in S. fruticosa, A. halimus or Beta vulgaris L. 
(Oueslati et al. 2012; Petropoulos et al. 2018a,b), anti-cholinesterase / neuroprotective potential 
in E. maritimum and P. lentiscus (Amessis-Ouchemoukh et al. 2014) or even anti-diabetic 
properties in A. macrostachyum, Halimione portulacoides (L.) Aellen or Salicornia europaea 
L. (Zengin et al. 2018). However, it is noteworthy that reports of biological activities in 
halophytes from the Portuguese coast have only recently started to be unveiled. Figure 1.1 
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shows examples of halophyte species found in the Algarve (Portugal) coast, featured in such 
reports. Neuroprotective properties have been found in A. macrostachyum, C. edulis (Custódio 
et al. 2012), Juncus acutus L. (Rodrigues et al. 2017a), Polygonum maritimum L. (Rodrigues 
et al. 2018a) and Armeria pungens (Link) Hoffmanns&Link (Rodrigues et al. 2018b), while 
anti-inflammatory potential was detected in P. coronopus (Rodrigues et al. 2014), Limonium 
algarvense Erben (Rodrigues et al. 2016) and P. maritimum (Rodrigues et al. 2017b) (species 
in Fig. 1.1). P. maritimum has also shown anti-diabetic effects (Rodrigues et al. 2017b), whereas 
J. acutus also has cytotoxic potential (Rodrigues et al. 2014). Moreover, anti-melanogenic 
activities were present in P. lentiscus (Lopes et al. 2016) and A. pungens (Rodrigues et al. 
2018b) (species in Fig. 1.1). Additionally, some halophytes from the Algarve (Portugal) coast 
have also shown to be potential source of molecules against neglected tropical diseases, namely 
J. acutus against Trypanosoma cruzi (Oliveira et al. 2016) and I. crithmoides and S. rubra 
against Leishmania infantum (Oliveira et al. 2018) (species in Fig. 1.1). These studies also 
report the antioxidant potential present in most of those halophytic species. In fact, from the 
array of bioactivities that can be found in halophyte species, antioxidant activity attracts the 
greater interest.  
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(1)  (2)  (3)  
(4)  (5)  (6)  
(7)  (8)  (9)  
 
(10)  
 
Figure 1.1 Some halophyte species from the Portuguese coast: (1) Armeria pungens, (2) 
Arthrocnemum macrostachyum, (3) Carpobrotus edulis (syn. Mesembryanthemum edule), (4) 
Inula crithmoides, (5) Juncus acutus, (6) Limonium algarvense, (7) Pistacia lentiscus, (8) 
Plantago coronopus, (9) Polygonum maritimum, (10) Spergularia rubra. Photos by the author 
(1 and 8), http://flora-on.pt (2 – 5, 7, 9,10) and http://www.virboga.de (6). 
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1.2.1. Antioxidant properties  
 Reactive oxygen species (ROS) are naturally formed in metabolic processes, such as the 
respiratory electron transport chain, due to the capacity of the oxygen molecule to accept an 
additional electron, producing the oxygen free radical, superoxide anion (O2l¾). The majority 
of superoxide produced comes from the mitochondrial respiratory chain; ubisemiquinone 
species generated in the electron transport reactions donate electrons to oxygen, providing a 
constant source of superoxide. To protect against the toxicity of this free radical, the antioxidant 
enzyme, superoxide dismutase (SOD) dismutates superoxide anion producing the non-radical, 
hydrogen peroxide (H2O2). Superoxide and hydrogen peroxide are the primary ROS derived 
from mitochondria, but in the presence of ferrous iron, and other redox metals such as copper, 
hydrogen peroxide can participate in the Fenton reaction producing the highly reactive and toxic 
hydroxyl radical (OHl). !"#" + %&"' ⟶ %&)' + 	#!• + #!, 
Reactive nitrogen species (RNS) are also produced in cellular redox processes; they include 
nitric oxide (NO), which participates in a wide range of cellular processes, as for example, as 
signalling molecule in neurons and in the immune system. ROS / RNS perform some important 
roles, acting as signalling molecules or as chemical defence against microorganisms, but they 
can also cause damage to structure and function of biomolecules. In addition to the endogenous 
sources, exogenous factors such as UV and ionizing radiation, exposure to pollutants, drugs and 
stress can also generate ROS / RNS (Figure 1.2) (Pisoschi and Pop 2015; Raha and Robinson 
2000; Rashid et al. 2013; Saeidnia and Abdollahi 2013; Sen and Chakraborty 2011). In living 
systems, a balance is maintained between the production of reactive species and their 
neutralization by antioxidant defences, a redox balance, but overproduction of the first and / or 
diminishing of the second leads to an impairment in that redox balance (Figure 1.3) (Rashid et 
al. 2013; Sen and Chakraborty 2011). An enhanced level of ROS / RNS has deleterious effects 
as they can target almost all molecules in the cell. Lipids are the most susceptible to undergo 
oxidation, which is highly damaging to cell membranes, but ROS / RNS can also oxidise both 
the backbone and side chain of proteins, resulting in activity loss, and damage nucleic acids, 
leading to DNA mutations. Damage to cellular macromolecules and deregulation of cellular 
functions can, ultimately, lead to cell death, altered signalling pathways and degenerative 
processes (Figure 1.3). This imbalance between ROS / RNS and the organism’s capacity to 
counteract them and subsequent potential damage is called oxidative / nitrosative stress and its 
severity is associated not only with aging but also with various diseases as, for example, 
GENERAL INTRODUCTION 
 18 
neurodegeneration, inflammation, carcinogenesis, diabetes and cardiovascular disorders. 
(Figure 1.3) (Pisoschi and Pop 2015; Rashid et al. 2013; Sen and Chakraborty 2011). 
 
Figure 1.2 Examples of ROS / RNS and of their sources from endogenous and exogenous 
factors (adapted from Thanan et al. 2015).  
 
 To counteract oxidative stress, organisms have complex antioxidant defence systems that 
include antioxidant enzymes (superoxide dismutase [SOD], catalase [CAT], glutathione 
peroxidase [GPx], and glutathione reductase [GR]) and non-enzymatic antioxidants, namely 
metabolic (e.g.: reduced glutathione [GHS], coenzyme Q10, uric acid, metal-chelating proteins) 
and nutrient / dietary (e.g.: vitamins E and C, carotenoids, flavonoids, omega-3 and -6) 
molecules (Figure 1.3) (Rashid et al. 2013; Saeidnia and Abdollahi 2013; Sen and Chakraborty 
2011). Antioxidants exert their protective role by reducing the production of ROS / RNS, 
scavenging, stabilizing, deactivating, and / or destroying ROS / RNS, or binding to or 
inactivating metal ions that generate ROS. They are crucial in delaying or inhibiting oxidative 
stress and its cell damaging effects and, therefore, in maintaining ideal cellular and systemic 
conditions (Saeidnia and Abdollahi 2013; Sen and Chakraborty 2011). Considering the vital 
role of antioxidants to living organisms, their use is one approach to prevent or reduce the 
severity of diseases in which oxidative stress is an underlying factor, being recognized as 
important components in maintaining optimum health and wellbeing. Additionally, they can 
function as immune modulators and be used as prophylaxis or adjuvant therapy (Sen and 
Chakraborty 2011). In this sense, studies about natural and powerful antioxidants have gained 
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much momentum in the pursuit of antioxidant intake to boost the endogenous antioxidant 
system, either as part of a wholesome antioxidant diet or as nutritional supplements. Moreover, 
antioxidants are fundamental food additives that prevent oxidation and food spoilage and help 
maintain nutritional and organoleptic properties. They are also routinely used in the cosmetic 
and pharmaceutical industries to protect against oxidation particularly in products containing 
unsaturated oils and fats, which are particularly prone to oxidation. Synthetic antioxidants are 
regularly employed to inhibit product oxidation, namely butylated hydroxyanisole (BHA), 
butylated hydroxytoluene (BHT), or propyl gallate (PG), or to chelate metals and reduce their 
participation in reactions (e.g.: ethylenediaminetetraacetic acid, EDTA). But despite having a 
similar biological effect on the molecular, cellular and organ level as natural antioxidants, 
synthetic antioxidants are also associated with some degree of toxicity and carcinogenicity (Sen 
and Chakraborty 2011; Sindhi et al. 2013). These safety issues, together with consumers’ 
preferences, has shifted attention to natural antioxidants. It is accepted that plant-based 
antioxidants, being part of the physiological functions of living organisms, have higher 
compatibility with the human body (Sen and Chakraborty 2011). 
 
Figure 1.3 Redox balance / imbalance between reactive species and antioxidant defences; 
oxidative stress and potential deleterious effects.   
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 Extracts and / or compounds from natural sources with strong antioxidant properties are 
under high demand as alternatives to synthetic antioxidants in the food, pharmaceutical and 
cosmetic industries and, in this sense, halophytes appear as a very promising and almost 
untapped source of novel antioxidants. As mentioned before, these plants are exposed to hostile 
abiotic conditions, very prone to oxidative stress-inducing damage. To survive and flourish in 
such harsh environments they have developed powerful antioxidant systems that include highly 
bioactive molecules, many of which are potent antioxidants. In fact, the antioxidant activity is 
characteristically verified when studying halophytes (Amessis-Ouchemoukh et al. 2014; Jallali 
et al. 2014; Ksouri et al. 2012; Lopes et al. 2016; Oueslati et al. 2012; Qasim et al. 2016; 
Petropoulos et al. 2018a,b; Rodrigues et al. 2014, 2015, 2016, 2017a, 2018b; Stanković et al. 
2015; Zengin et al. 2018) and, in some species, the antioxidant potential exceeds that of many 
natural and synthetic antioxidants (e.g.: T. gallica, Ksouri et al. 2009; C. edulis, Custódio et al. 
2012; S. fruticosa, Salvadora persica L., Qasim et al. 2016).  
 
1.2.2. Anti-diabetic properties 
 Diabetes mellitus type 2 (T2DM), or non-insulin dependent diabetes, is a common 
chronic metabolic disorder characterized by high plasma glucose levels (hyperglycaemia) due 
to improper insulin secretion and / or insulin resistance in peripheral tissues. It is the most 
common form of diabetes and affects millions of people in both developed and developing 
countries, being estimated that it will affect roughly 450 million people by 2030; hence, it is 
considered an emerging health challenge. If left untreated, it can lead to major metabolic 
complications like retinopathy, neuropathy, accelerated atherosclerosis, and / or renal 
dysfunction. Currently, T2DM is treated through diet, low in carbohydrates, and oral 
hypoglycaemic drugs. Different classes of anti-diabetic drugs are available, each with specific 
action, but one effective therapeutic strategy includes inhibiting carbohydrate-hydrolysing 
enzymes like a-glucosidase and α-amylase, delaying carbohydrate absorption in the intestinal 
tract (Hung et al. 2012; Kumar et al. 2011; Panigrahy et al. 2017; Patel et al. 2012). These 
enzymes catalyse the hydrolytic cleavage of oligosaccharides into absorbable monosaccharides 
in the small intestine, facilitating glucose absorption. Inhibition of those enzymes decreases the 
rate of hydrolytic cleavage, which delays the overall glucose absorption into the blood. 
Therefore, inhibiting carbohydrate-hydrolysing enzymes delays carbohydrate digestion and 
glucose absorption, resulting in lowered postprandial blood glucose levels and overall reducing 
hyperglycaemia linked to T2DM (Kumar et al. 2011). Clinically used inhibitors of 
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carbohydrate-hydrolysing enzymes, such as acarbose, may induce side-effects like abdominal 
distension and flatulence, reinforcing the need for new anti-diabetic compounds with reduced 
side-effects (Hung et al. 2012). The World Health Organization (WHO) recommended 
assessing medicinal plants used to treat diabetes as they can be excellent candidates for effective 
therapy compounds with less or no side effects. Metformin, for example, is a potent glucose-
lowering agent developed from Galega officinalis L. and the only medication with approved 
use in children (Patel et al. 2012). Natural products have great structural diversity and can 
therefore be a good source for such therapeutic enzyme inhibitors (Kumar et al. 2011). In this 
sense, highly diverse plants like halophytes can be a great reservoir to search for that type of 
biologically active compounds. 
 In T2DM, oxidative stress has been found to mediate the disease’s effects. The condition 
is associated with increased formation of free radicals and decreased antioxidant potential, 
ultimately resulting in oxidative damage. Oxidative stress has been implicated as a causative 
factor in the induction and progression of the disease, contributing to the development of 
diabetes-associated complications (e.g.: cardiovascular, neurological, retinal or urological 
disorders) (Panigrahy et al. 2017; Patel et al. 2012; Saeidnia and Abdollahi 2013; Sindhi et al. 
2013). In this context, antioxidant phytochemicals, well recognized for effectively fighting and 
preventing oxidative damage, can be used to prevent or manage oxidative-stress related 
disorders, being positively associated in T2DM management (Saeidnia and Abdollahi 2013; 
Sindhi et al. 2013). New compounds / products that can include both inhibiting carbohydrate-
hydrolysing enzymes and oxidative stress prevention could be a future approach for patients 
better manage T2DM and related effects. In this sense, medicinal plants with anti-diabetic 
applications (e.g.: halophytes A. maritima, Sheikh et al. 2015; P. lentiscus, Bozorgi et al. 2013) 
and proved hypoglycaemic and antioxidant effects (e.g.: P. maritimum, Rodrigues et al. 2017b; 
A. macrostachyum, H. portulacoides, S. europaea, Zengin et al. 2018) can be vital in the search 
for better treatment of diabetes and associated complications (Patel et al. 2012). 
 
1.2.3. Anti-hyperpigmentation properties  
 Nowadays, natural products are in high demand especially for substances with anti-ageing 
or beauty-enhancement properties. One particular concern in human wellbeing and cosmetics 
is related to skin hyperpigmentation and agents that promote skin-whitening are increasingly 
sought after. Skin hyperpigmentation or melanogenic disorders, such as melasma, freckles, 
solar lentigos, or post-inflammatory hyperpigmentation, are a result of abnormal accumulation 
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and biosynthesis of melanin (Hakozaki et al. 2015; Khan 2007; Ribeiro et al. 2015). Melanin is 
produced and distributed in the skin and hair follicles, playing a protective role against UV 
light-damage. Over-production of melanin can be derived from the over-activity of tyrosinase, 
a multifunctional copper-containing enzyme that is essential in melanin biosynthesis as it is the 
first enzyme in the conversion of tyrosine to melanin (Hakozaki et al. 2015; Khan 2007; Ribeiro 
et al. 2015). Tyrosinase is also responsible for the undesirable browning of fruits and vegetables 
in post-harvest processing, which decreases their market value (Khan 2007; Chang 2009). In 
this context, chemicals with the ability to inhibit tyrosinase activity can be used in both the 
cosmetic and food industries as preventers of hyperpigmentation and enzymatic browning, 
respectively. Kojic acid, arbutin and hydroquinones are examples of synthetic tyrosinase 
inhibitors used as anti-hyperpigmenting agents (Chang 2009; Hakozaki et al. 2015; Khan 2007; 
Ribeiro et al. 2015). But herbal products, in the form of isolated molecules or extracts, are 
gaining increasing importance as active ingredients particularly in cosmetic formulations due 
to their recognized protective and skin-treatment features, coupled with their mild and 
biodegradable characteristics (Chanchal and Swarnlata 2008). Hence, novel anti-
hyperpigmentation phytochemicals from natural sources are required not only for cosmetic and 
pharmaceutical purposes but also for their potential in improving food quality. Plant 
polyphenols, flavonoids in particular, are reported effective natural tyrosinase inhibitors (Chang 
2009; Khan 2007; Ribeiro et al. 2015). Additionally, halophyte plants have been reported to 
have anti-tyrosinase activities, namely P. lentiscus (Lopes et al. 2016) and A. pungens 
(Rodrigues et al. 2018b), proving their potential value in preventing or managing undesired skin 
and food darkening. 
 
1.2.4. Anti-protozoan properties 
 Natural products have afforded important antiparasitic compounds and one emblematic 
example that awarded its discoverer, Youyou Tu, the joint 2015 Nobel Prize of Physiology and 
Medicine, is the anti-malarial compound artemisinin. Isolated from the plant Artemisia annua 
L., artemisinin established novel therapies for malaria, caused by the protozoan Plasmodium 
falciparum. Before artemisinin, the first effective western treatment for malaria was quinine, 
isolated from the cinchona tree bark (Cinchona sp.) (Efferth et al. 2015). While this reinforces 
the value of natural resources and their unlimited chemical diversity in finding new or 
alternative drugs, little is known regarding the potential of halophytes against protozoan 
infections, such as Chagas disease, caused by T. cruzi, or leishmaniasis, caused by Leishmania 
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species. Nevertheless, Oliveira et al. (2016, 2018) screened for in vitro anti-T. cruzi and anti-L. 
infantum properties in some halophytes, finding activity in J. acutus against T. cruzi and in I. 
crithmoides and S. rubra against L. infantum. This demonstrates that halophytes are an 
overlooked prospective source of anti-protozoan molecules.  
 
1.3. Preliminary toxicity screening  
 The potential toxicity of new compounds or products (herbal extracts, for example) for 
human use must be ascertained to establish its safe consumption. In this sense, cytotoxicity 
assays are common in vitro methods employed as preliminary toxicological assessment for 
substances, adopted for safety evaluation in numerous national and international standards. 
Assessing cytotoxicity of plant extracts and / or substances is usually accomplished through in 
vitro cell culture models using different cancer and non-cancer mammalian cell lines to assess 
endpoints of cellular viability such as metabolic activity and plasma membrane integrity 
following exposure to a test extract / compound. These assays are useful not only to determine 
potential and selective anti-tumoural activities, but also to predict potential toxicity of those 
extracts / compounds (Liu et al. 2018; Nogueira et al. 2011). Current approaches to measure 
the degree of potential toxicity include assays that evaluate various aspects of cell viability, and 
one of the most commonly used techniques is the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay, a colorimetric method to determine cell metabolic state. 
Preliminary toxicity screenings provide fast, standardized, sensitive, economical and reliable 
results to determine whether a substance contains potentially toxic activity (Liu et al. 1997; 
Nogueira et al. 2011; Saad et al. 2006). They also reduce in vivo testing, since a positive 
correlation has been established between in vitro toxicity towards mammalian cell lines and in 
vivo toxicity determined in animal models (Carballo et al. 2002; Parra et al. 2001). Overall, a 
decreased or absent cytotoxic effect when assessing herbal extracts / products suggests that they 
can be considered non-toxic and safe for consumption. Moreover, the fact that a species is 
widely used in traditional medicine and / or for nutritional purposes is by itself an indication of 
its low toxicity. 
 
1.4. Plant Metabolites 
 Plants have a high biosynthetic capacity, being able to generate a broad spectrum of 
metabolites generally classified as primary or secondary, depending on their role in plant 
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metabolism. Primary metabolites are produced within primary biosynthetic and metabolic 
routes aimed at plant growth and development and are vital for the plant’s functioning; they 
comprise carbohydrates, lipids, amino acids, proteins, and nucleic acids, and are found across 
all species within broad phylogenetic groups. Secondary metabolites are not directly needed for 
growth and development although holding important functions; they include alkaloids (derived 
from amino acids), terpenes (a group of lipids) and phenolics (derived from carbohydrates) and 
are often differentially distributed among taxonomic groups. They are important in mediating 
a vast array of interactions between plants and their environment, determining colour, acting as 
defensive agents against pathogens, insects and herbivores, providing reproductive advantages 
to attract pollinators and seed dispersers, inhibiting the growth of surrounding competitor 
plants, acting as cellular signalling molecules, or protecting against oxidative damage. These 
plant constituents are in fact the major source of antioxidants as the majority of these 
phytochemicals are redox active molecules. The biosynthesis and accumulation of this wide 
array of compounds provides unique chemical structures with unusual biological activities. 
While some primary metabolites can also show relevant biological properties (e.g.: carbasugars, 
a class of carbohydrates, exhibit various bioactivities including antimicrobial and glycosidase 
inhibition; the most well-known carbasugar is the anti-influenza oseltamivir phosphate 
[Tamiflu®]; Usami 2014), secondary metabolites are usually the bioactive compounds, some 
of them responsible for the health benefits attributed to botanical extracts and displaying 
interesting pharmacological activities (Bernhoft 2010; Hounsome et al. 2008; Saeidnia and 
Abdollahi 2013; Sen and Chakraborty 2011).  
 
1.4.1. Bioactive secondary compounds 
 More than 200 000 secondary metabolites are known, with many more yet to be 
discovered, providing mankind with a natural reservoir of potential pharmaceuticals. Typically, 
bioactive compounds in plants are produced as secondary metabolites. They can be defined as 
substances that elicit an effect (pharmacological or toxicological) on biological systems. There 
is no commonly agreed system of classification of active constituents, but they can be divided, 
for example, according to biosynthetic pathways. Based on their biosynthetic origins, the main 
chemical groups of bioactive compounds can be classified as terpenes and terpenoids, produced 
through the mevalonic acid pathway and non-mevalonate (MEP) pathway, alkaloids, produced 
through the shikimic acid pathway and the tricarboxylic acid cycle, and phenolic compounds, 
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synthesized through the shikimic and malonic acids pathways (Figure 1.4) (Azmir et al. 2013; 
Bernhoft 2010; Doughari 2012; Hounsome et al. 2008; Ncube and Staden 2015). 
  
 
Figure 1.4 A simplified general overview of the biosynthetic pathways involved in the 
biosynthesis of the three major groups of plant bioactive compounds (adapted from Azmir et 
al. 2013). 
 
1.4.1.1. Terpenes and terpenoids  
 Terpenes and terpenoids are among the most structurally diverse groups of secondary 
metabolites, derived by repetitive fusion of branched 5-carbon isoprene units. They are 
synthesised from two precursors, dimethylallyl pyrophosphate (DMAPP) and isopentenyl 
pyrophosphate (IPP), through two independent pathways, the mevalonate pathway that 
provides the precursors for sesquiterpenes and sterols, and the non-mevalonate pathway (MEP) 
in plastids that furnishes monoterpenes, diterpenes, and carotenoids. Their chemical diversity 
is probably a reflection of their numerous biochemical functions, such as electron carriers 
(ubiquinone, plastoquinone), components of membranes (sterols), photosynthetic pigments 
(carotenoids), hormones (gibberelins, abscisic acid), plant defence, pollinators’ attractants, etc. 
Examples of commonly known monoterpenes are camphor and menthol; diterpenes are usually 
considered resins; triterpenes include steroids and sterols; sesquiterpenes, like monoterpenes, 
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are major components of many essential oils. Major dietary terpenoids include carotenoids, 
tocopherols and tocotrienols, quinones, and sterols. Additionally, they also show biological 
activities such as antimicrobial, insecticidal, anti-inflammatory, sedative, or cytotoxic. 
Pharmaceuticals derived from terpenes include artemisinin, an anti-malarial sesquiterpenoid 
isolated from A. annua, taxol, a high-value diterpenoid-derived anti-cancer drug from the bark 
of T. brevifolia, or azadirachtin A, an insect antifeedant terpenoid isolated from Azadirachta 
indica A.Juss. (Doughari 2012; Hounsome et al. 2008; Ksouri et al. 2012; Ncube and Staden 
2015).  
 
1.4.1.2. Alkaloids  
 Alkaloids are one of the largest groups of secondary metabolites comprised by nitrogen-
containing molecules synthesized mainly from amino acids, although some purine-derived 
alkaloids are also known, with various radicals replacing one or more of the hydrogen atoms in 
the peptide ring. They are produced through the shikimic acid pathway with aromatic amino 
acids as starting precursor molecules, and through tricarboxylic acid cycle from aliphatic amino 
acids. These compounds present many structures with notable complexity and, although their 
exact roles are not well understood, they are believed to play an important ecological role 
enabling plants to interact defensively with the environment. Additionally, they often display 
important pharmacological properties. In fact, many of them are among the most worldwide 
used drugs: the analgesics morphine and codeine, the muscle relaxant tubocurarine, the 
vasodilating agents vincamine and ajmalicine, the anticancer agent vinblastine, or galanthamine 
for Alzheimer’s disease, to name a few. Other well-known alkaloids of plant origin include the 
stimulants caffeine, nicotine, atropine, and cocaine (Azmir et al. 2013; Doughari 2012; 
Hounsome et al. 2008; Ksouri et al. 2012; Ncube and Staden 2015). 
 
1.4.1.3. Phenolic compounds  
 Phenolic compounds, or polyphenols, are perhaps the most widely occurring group of 
secondary metabolites. They are comprised by at least one aromatic ring bearing one or more 
hydroxyl substituents and other functional derivatives (e.g. esters, methyl esters, glycosides), 
which confers structural diversity to the group. The wide range of resulting compounds can be 
categorised into subgroups (Table 1.2) according to its structural components; from these 
subgroups, phenolic acids, flavonoids and tannins are considered the main dietary polyphenols 
(Balasundram et al. 2006; Ncube and Staden 2015). Although ubiquitous in the plant kingdom, 
the type of polyphenol produced varies greatly between genera and species (Ncube and Staden 
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2015). In fact, the ability to synthesize phenolic compounds has been naturally selected through 
evolution in different plant lineages according to specific needs, therefore allowing plants to 
adapt to different habitats and ever-changing environmental characteristics (Lattanzio 2013).  
 
Table 1.2 Classes of phenolic compounds in plants (Soto et al. 2015). 
Classes of phenolic compounds Examples of compounds in the respective class 
Simple phenols  
     Phenolic acids  
               Hydroxybenzoic acids Gallic, gentisic, protocatechuic, syringic acids 
               Hydroxycinnamic acids Caffeic, p-coumaric, ferulic, sinapic acids 
     Coumarins Esculetin, scopoletin, umbelliferone 
Polyphenols  
     Flavonoids  
               Flavonols Kaempferol, myricetin, quercetin 
               Flavones Apigenin, luteolin, tangeretin 
               Isoflavones Daidzein, genistein 
               Flavanones Eriodictyol, hesperetin, naringenin, neohesperidin 
               Flavanols (flavan-3-ols) Catechin, epicatechin, epigallocatechin, gallocatechin 
               Anthocyanins Delphinidin, cyanidin, malvidin, pelargonidin, petudinin 
               Chalcones Arbutin, phloretin, phloridzin 
     Lignans Matairesinol, pinoresinol, secoisolariciresinol 
     Stilbenes Piceid, pinosylvin, resveratrol 
     Tannins Ellagitannins, gallotannins, proanthocyanidins 
 
 Plant phenolics derive either from the shikimate / phenylpropanoid pathway, providing 
phenylpropanoids, or the “polyketide” acetate / malonate pathway, producing simple phenols, 
or both. These monomeric and polymeric phenols and polyphenols produced fulfil a very broad 
range of roles in plants (Lattanzio 2013). They are physiologically and morphologically 
important, playing significant roles in many functions: they provide structure in cell walls, 
protect from ultraviolet radiation, act as feeding deterrents for many herbivores, defend against 
pathogens and parasites, while also contributing to colour and sensory properties that attract 
pollinators, promoting the plant’s reproduction (Balasundram et al. 2006; Dai and Mumper 
2010; Hounsome et al. 2008; Soto et al. 2015). Phenolic compounds also display free radical-
scavenging activity, determined largely by their reactivity as hydrogen- or electron- donating 
agents, and the stability of the resulting antioxidant-derived radical prevents oxidation (Ncube 
and Staden 2015). This antioxidant activity depends on the compounds’ structure, in particular 
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on the number and positions of the hydroxyl groups in relation to the carboxyl functional group, 
and the nature of substitutions on the aromatic rings (Balasundram et al. 2006; Ksouri et al. 
2012). Besides their powerful antioxidant properties, which by itself attracts considerable 
interest, these compounds also exhibit many other biological effects of great importance to 
human health (Dai and Mumper 2010; Ksouri et al. 2012). They were found to modulate the 
activity of a wide range of enzymes, cell receptors, and cell signalling pathways, which credits 
them not only with the prevention of oxidative-stress related conditions (like aging and 
cardiovascular and neurodegenerative disorders, for example), but also with anti-tumoural, anti-
inflammatory, anti-diabetic, antimicrobial, anti-histaminic, or even immuno-modulatory, 
vasodilator and anti-obesity activities (Balasundram et al. 2006; Dai and Mumper 2010; 
Hounsome et al. 2008; Ksouri et al. 2012; Ncube and Staden 2015). For example, salicylic acid 
has analgesic, antipyretic, anti-inflammatory, keratolytic, and other properties associated to it 
(Hounsome et al. 2008; Khadem and Marles, 2010). This hydroxybenzoic acid was first isolated 
from the willow bark (Salix spp.) in pursuit of the active ingredient responsible for the tree’s 
healing properties. Soon after, acetylsalicylic acid (aspirin) was synthesized with the same 
efficacy but less irritation to the gastric mucosa, rapidly becoming one of the world’s best-
selling drugs (Raskin 1992). Catechins (catechin, epicatechin and gallates of epicatechin), the 
main polyphenols present in tea (Camellia sinensis L. (Kuntze)), have been implicated in many 
of its health-promoting benefits (cancer prevention, cardiovascular risk reduction, anti-diabetic 
and anti-obesity properties, etc.), particularly epigallocatechin-3-gallate that is the major tea 
catechin (Khan and Mukhtar 2007). Catechins are examples of flavonoids used in the food 
industry as natural antioxidants against lipid oxidation of oils and fats and as antimicrobial 
agents. Additionally, they are also used as health functional ingredient in foods, dietary 
supplements, and animal feeds (El Gharras 2009). Ferulic acid is also used in the food industry 
as food additive / preservative, nutraceutical, and functional ingredient, while also 
pharmacologically used as a photoprotective constituent in sunscreens and skin lotions and as 
a cross-linking agent to increase viscosity and form gels from some polysaccharides. This 
almost ubiquitous phytochemical is present in numerous foods (from rice, wheat, oats, grains, 
beans, fruits and vegetables to seeds, nuts, herbs and spices) and exhibits a wide variety of 
biological activities (antioxidant, anti-diabetic, anticarcinogenic, cardio- and neuroprotective, 
anti-inflammatory, antimicrobial, etc.) (Kumar and Pruthi 2014; Ou and Kwok 2004). Another 
phenolic compound associated to the health benefits of a food product is chlorogenic acid. This 
major component of coffee is considered a promising nutraceutical and food additive attending 
to its multifunctional properties, namely antioxidant, antimicrobial, anti-diabetic, anti-obesity, 
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anti-inflammatory, and anti-hypertensive activities (Meng et al. 2013; Santana-Gálvez et al. 
2017). Many other phytochemicals could be added as examples of bioactive compounds 
essential to the pharmaceutical, cosmetic and / or food industries and as dietary constituents 
with health-promoting benefits for both human and animal welfare. Most importantly, there are 
still many more compounds / activities / applications to be uncovered. 
 
1.4.1.3.1. Phenolic compounds in halophytes 
 Phenolic compounds in plants have a key role in dealing with environmental stresses such 
as intense light, extreme temperatures, water scarcity, and / or salinity. These challenging 
conditions lead to increased production of free radicals and other oxidative species, to which 
plants respond by increasing their capacity to scavenge them, namely synthesizing antioxidant 
phenolic compounds. In fact, a positive correlation between abiotic stress and increasing 
polyphenolic contents has been demonstrated in many halophytes (Buhmann and Papenbrock 
2013; Hounsome et al. 2008; Lattanzio 2013; Soto et al. 2015). In this sense, due to the harsh 
conditions in which they survive and thrive, halophytes are a great source of phenolics. 
 Numerous phenolic compounds have been described in halophyte species, many of them 
conferring the plants with medicinal properties due to their biological activities (Ksouri et al. 
2012). One of the most relevant biological properties of phenolics is antioxidant activity; a 
myriad of studies have reported them as radical scavengers, hydrogen and electron donors, 
singlet oxygen quenchers, and / or metal chelators (Balasundram et al. 2006; Ksouri et al. 2012). 
For example, the flavonol glycoside isorhamnetin 3-O-b-D-glucopyranoside, isolated from 
Salicornia herbacea (syn. S. europaea), successfully scavenged radicals in both cellular-free 
and cellular-based systems, and significantly elevated cellular glutathione levels and expression 
levels of antioxidant enzymes such as superoxide dismutase, catalase, glutathione reductase and 
heme oxygenase-1 (Kong et al. 2009). In Tamarix boveana Bunge, the flavanone naringenin 
was isolated from the aerial-parts’ methanolic extract (ethyl acetate fraction) and identified as 
the molecule responsible for the detected antioxidant properties (Naija et al. 2014). Chlorogenic 
acid was another phenolic compound established as an effective antioxidant compound in C. 
maritimum (Mekinić et al. 2016), esculetin and luteolin 7-O-rutinoside were the main 
antioxidant components in Artemisia montana (Nakai) Pamp. (Buhmann and Papenbrock 
2013), and rutin and apigenin were the most active radical scavengers in Teucrium polium L. 
(Sharififar et al. 2009). 
 Phenolic compounds also display other important biological properties, apart from 
antioxidant. For example, Gálvez et al. (2003) identified the flavone luteolin-7-O-b-glucoside, 
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the major flavonoid in Plantago species, as the molecule responsible for the cytotoxic capacity 
of leaves’ methanolic extracts on breast and renal adenocarcinomas and melanoma cell lines. 
Caffeic and chlorogenic acids were identified among 11 pure compounds previously reported 
in P. major as the molecules with strongest antiviral activity against some herpes simplex and 
adenovirus types (Ksouri et al. 2012). Two flavonol glycosides isolated in S. herbacea, 
isorhamnetin 3-O-b-D-glucopyranoside and quercetin 3-O-b-D-glucopyranoside, effectively 
suppressed adipogenic differentiation in mouse 3T3-L1 preadipocyte cells, proving to be potent 
anti-obesity agents via alleviation of lipid accumulation (Kong et al. 2012). Additionally, 
several studies assessed the in vitro bioactivities of extracts from different halophyte species, 
along with its major constituents, associating the displayed activities to already known 
properties of the main compounds. Atriplex halimus, for instance, has its potent antioxidant 
activity attributed to the presence of flavonols common in Atriplex species such as kaempferol, 
quercetin, or isorhamnetin (Ksouri et al. 2012). Cynara cardunculus leaves’ methanolic extracts 
exhibited activity against human pathogenic bacteria (e.g. Staphylococcus aureus, Escherichia 
coli), possibly due to the predominant phenolics identified in the extracts, namely syringic and 
transcinnamic acids, epicatechin and quercitrin (Falleh et al. 2008). The major constituents of 
Artemisia scopariae Waldst. et Kit. are p-hydroxyacetophenone, chlorogenic and caffeic acids, 
which are probably responsible for the antioxidant, anti-inflammatory, antitumor and 
antibacterial properties of the plant (Ksouri et al. 2012). However, one must keep in mind that 
while the properties of individual compounds can be specifically determined, the bioactivities 
displayed by extracts made from halophyte species (and other organisms) can also be the result 
of synergistic and / or additive effects of the phytoconstituents’ mixture in those extracts. On 
the other hand, one single compound can be responsible for multiple bioactivities (Buhmann 
and Papenbrock 2013). 
 
1.5. Halophytes from the Algarve Coast, Southern Portugal 
 Considerable biodiversity in terms of halophyte species occurs in southern Portugal, some 
with known therapeutic applications (e.g.: A. donax, C. coronopifolia, P. lentiscus, R. 
raphanistrum; S. fruticosa, S. ramosissima, see Table 1.1; Carapeto 2006), but reports of their 
bioactivities are particularly scarce. In fact, few species have been investigated despite their 
high potential as source of bioactive molecules. Some halophytes from the Algarve coast have 
recently been studied showing promising results in terms of antioxidant, neuroprotective, anti-
inflammatory, anti-diabetic, anti-melanogenic and anti-tumoural activities (see section 1.2 
GENERAL INTRODUCTION 
 31 
Biological Activities of Halophytes). Still, significant part of the species in this area, many with 
medicinal uses, has never been tested for biological activities or evaluated for phytochemical 
composition. In fact, medicinal halophytes remain largely unexplored and underutilized despite 
their outstanding potential as a reservoir of bioactive compounds, drugs, novel food-products 
and innovative health-promoting products, or as raw material for the pharmaceutical, cosmetic 
and / or food industries. Indeed, their ethnopharmacological uses suggest a high ethnic and 
traditional value still untapped.  
 This work focuses on five halophyte plants common in the Algarve, chosen for their 
ethnopharmacological value in the Mediterranean region and potential bioactivities: Artemisia 
campestris subsp. maritima, Crithmum maritimum, Eryngium maritimum, Helichrysum 
italicum subsp. picardii, and Plantago coronopus, whose brief description follows next.  
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1.5.1. Halophytes used in this study  
1.5.1.1. Artemisia campestris L. subsp. maritima Arcangeli 
     
Figure 1.5 Specimens of A. campestris subsp. maritima in the field with detail of the leaves 
(photos from http://flora-on.pt). 
 
Taxonomic 
classification* 
 
Kingdom: Plantae 
Division: Spermatophyta 
Subdivision: Magnoliophytina 
Class: Magnoliopsida 
Sub-classe: Asteridae 
Order: Asterales 
Family: Asteraceae 
Genus: Artemisia 
Species: Artemisia campestris L. 
Sub-species: Artemisia campestris L. subsp. maritima Arcangeli 
Synonyms Artemisia crithmifolia L. 
Common name Dune wormwood, “madorneira” or “erva-lombrigueira” in Portugal 
Habitat Coastal sand dunes; perennial  
Distribution Temperate European Atlantic coast (Almargem 2018; Dib et al. 2016) 
Medicinal uses To treat gastric disorders, hypertension and rheumatics; anthelmintic and 
abortifacient properties (Almargem 2018). The species, A. campestris, is 
also described as having anti-diabetic, anti-inflammatory and antipyretic 
uses (Dib et al. 2016). 
Used 
formulations 
Herbal teas made from stems and leaves (Almargem 2018). 
Biological 
activities 
Antioxidant and anti-microbial activities (Megdiche-Ksouri et al. 2015). 
Bioactive 
compounds 
Phenolic acids, flavonoids, coumarins, sesquiterpenes and acetophenone 
derivatives (Rauter et al. 1989; Sanz et al. 1991; Vasconcelos et al. 1998; 
Megdiche-Ksouri et al. 2015). 
*according to Checklist da Flora de Portugal (2010) 
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1.5.1.2. Crithmum maritimum L. 
     
Figure 1.6 Specimens of C. maritimum in the field (Martinhal beach, Sagres, south Portugal), 
with detail of the flowers (photos by the author). 
 
Taxonomic 
classification* 
 
Kingdom: Plantae 
Division: Spermatophyta 
Subdivision: Magnoliophytina 
Class: Magnoliopsida 
Sub-classe: Rosidae 
Order: Umbellales 
Family: Apiaceae 
Genus: Crithmum 
Species: Crithmum maritimum L. 
Synonyms - 
Common name Sea fennel, rock samphire, “funcho marítimo” in Portugal 
Habitat Rocky shores and coastal cliffs; perennial 
Distribution European and North-African Atlantic, Mediterranean and Black Sea coasts 
(Atia et al. 2011; Castroviejo et al. 2003) 
Medicinal uses Described as appetizer, tonic, purgative, carminative, anthelmintic, 
diuretic; used to prevent scurvy and to treat renal and urinary complaints, 
digestive disorders, colic and inflammation of the urinary tract and prostate 
(Atia et al. 2011; Cornara et al. 2009; Franke 1982). 
Used 
formulations 
Infusions and decoctions of aerial parts (Atia et al. 2011; Cornara et al. 
2009; Franke 1982). 
Biological 
activities 
Antioxidant and antimicrobial activities (Atia et al. 2011; Buhmann and 
Papenbrock 2013). 
Bioactive 
compounds 
Phenolic acids and flavonoids (Atia et al. 2011; Buhmann and Papenbrock 
2013). 
*according to Checklist da Flora de Portugal (2010) 
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1.5.1.3. Eryngium maritimum L. 
     
Figure 1.7 Specimens of E. maritimum in the field (Amoreira beach, Aljezur, south Portugal) 
and after collection, with detail of the flowers (photos by the author). 
 
Taxonomic 
classification* 
 
Kingdom: Plantae 
Division: Spermatophyta 
Subdivision: Magnoliophytina 
Class: Magnoliopsida 
Sub-classe: Rosidae 
Order: Umbellales  
Family: Apiaceae 
Genus: Eryngium 
Species: Eryngium maritimum L. 
Synonyms - 
Common name Sea holly, “cardo marítimo” in Portugal 
Habitat Dunes and sandy beaches; perennial 
Distribution Mediterranean, Black Sea, Atlantic and Baltic coasts; introduced in eastern 
North America and Australia (Castroviejo et al. 2003; Isermann and 
Rooney 2014) 
Medicinal uses Used as diuretic, kidney stone inhibitor, aphrodisiac, expectorant, anthelmintic, 
antitoxin against various infections, for oedema reabsorption and / or pain relief 
(Erdem et al. 2015; Isermann and Rooney, 2014; Lisciani et al. 1984). Eryngium 
species also have uses like hypoglycaemic, anti-inflammatory, poison antidote, 
stimulant and antitussive, among others (Erdem et al. 2015; Wang et al. 2012). 
Used 
formulations 
Tinctures, infusions and decoctions of whole plant, including roots (Hool 
1922). 
Biological 
activities 
Antimicrobial, antioxidant and / or anti-inflammatory activities (Amessis-
Ouchemoukh et al. 2014; Conea et al. 2016; Darriet et al. 2014; Erdem et al. 
2015; Kholkhal et al. 2012; Lisciani et al. 1984; Mejri et al. 2017; Meot-
Duros et al. 2008; Rjeibi et al. 2017; Wang et al. 2012; Yurdakok et al. 2014). 
Bioactive 
compounds 
Phenolic acids, flavonoids and terpenes (Amessis-Ouchemoukh et al. 2014; 
Conea et al. 2016; Darriet et al. 2014; Erdem et al. 2015; Kholkhal et al. 
2012; Mejri et al. 2017; Rjeibi et al. 2017; Wang et al. 2012). 
*according to Checklist da Flora de Portugal (2010)  
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1.5.1.4. Helichrysum italicum (Roth) G. Don subsp. picardii (Boiss & Reuter) Franco 
     
Figure 1.8 Specimens of H. italicum subsp. picardii in the field (Ancão beach, Loulé, south 
Portugal), with detail of the flowers (photos by the author). 
 
Taxonomic 
classification* 
 
Kingdom: Plantae 
Division: Spermatophyta 
Subdivision: Magnoliophytina 
Class: Magnoliopsida 
Sub-classe: Asteridae 
Order: Asterales 
Family: Asteraceae 
Genus: Helichrysum 
Species: Helichrysum italicum (Roth) G. Don 
Sub-species: Helichrysum italicum (Roth) G. Don subsp. picardii (Boiss & 
Reuter) Franco 
Synonyms Helichrysum picardii Boiss. & Reuter 
Common name Everlasting, “perpétua das areias” or “erva-caril” in Portugal 
Habitat Dunes and sandy beaches; perennial 
Distribution Southern Europe (Bingre et al. 2007; Viegas et al. 2014) 
Medicinal uses Associated to analgesic properties and used in dermatologic, respiratory 
and digestive disorders with inflammatory, allergic or infectious 
components (Facino et al. 1990; Viegas et al. 2014). Helichrysum plants 
are also used as diuretic and to treat urinary disorders, burns, venomous 
bites and hernias (Viegas et al. 2014). 
Used 
formulations 
Infusions and decoctions of whole plant (Facino et al. 1990; Bingre et al. 
2007; Viegas et al. 2014). 
Biological 
activities 
Antimicrobial and anti-inflammatory properties (Facino et al. 1990; Viegas 
et al. 2014). 
Bioactive 
compounds 
Different classes of bioactive molecules, the most common being phenolic 
compounds and terpenes (Facino et al. 1990; Maksimovic et al. 2017; 
Viegas et al. 2014). 
*according to Checklist da Flora de Portugal (2010) 
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1.5.1.5. Plantago coronopus L. 
     
Figure 1.9 Specimens of P. coronopus in the field (Ludo area in Ria Formosa lagoon, Olhão, 
south Portugal), with detail of the flowers (photos by the author). 
 
Taxonomic 
classification* 
 
Kingdom: Plantae 
Division: Spermatophyta 
Subdivision: Magnoliophytina 
Class: Magnoliopsida 
Sub-classe: Asteridae 
Order: Plantaginales 
Family: Plantaginaceae 
Genus: Plantago 
Species: Plantago coronopus L. 
Synonyms - 
Common name Buckshorn plantain, “diabelha” in Portugal 
Habitat Saline or disturbed areas, mainly in coastal habitats; annual or biennial 
Distribution Mediterranean and Atlantic-European areas, North-west Africa and West 
Asia; introduced in North America, Australia and New Zealand (Almargem 
2018; Castroviejo et al. 2009). 
Medicinal uses Described uses as analgesic, anti-inflammatory, antipyretic, anticancer, 
emollient and to treat the respiratory system (Ksouri et al. 2012; Redzic 
2006). Plantago species are also used for their antimicrobial, astringent, 
expectorant and diuretic properties (Gonçalves and Romano 2016; Ksouri 
et al. 2012). 
Used 
formulations 
Infusions, decoctions and tinctures of roots, leaves and / or flowers (Aflosul 
2006; Carvalho 2006; Redzic 2006; Neves et al. 2009) 
Biological 
activities 
Cytotoxic, anti-inflammatory and antioxidant properties (Gálvez et al. 
2003, 2005; Rodrigues et al. 2014). 
Bioactive 
compounds 
Phenolic compounds and glycosides (Gálvez et al. 2003, 2005; Grubešić et 
al., 2013; Janković et al. 2012). 
*according to Checklist da Flora de Portugal (2010) 
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1.6. Scope and Main Objectives of this Study 
 The main scope of this study was to expand our limited knowledge on the potential 
therapeutic and health-promoting properties of medicinal halophytes.  
 Although halophyte chemistry implies them as sources of both novel and known 
compounds, they are still largely unexplored, and reports of their bioactivities are scarce, 
namely with halophytes from southern Portugal (Algarve). Medicinal halophytes in particular, 
considering their ethnopharmacological use, can be a reservoir of new compounds and 
applications. Hence, this study intended to explore the potential of medicinal halophytes from 
the Algarve coast as sources of bioactive compounds with therapeutic application, validating 
their uses in folk medicine and searching for new bioactivities and thereby answering the 
following biological questions: 
- Can the traditional use of halophytes in folk medicine be supported by scientific evidence?  
- Do these halophytes and / or their extracts have potential application as therapeutic, health-
promoting or food-additive commodities? 
- Can these plants be good candidates for identification and commercialization of bioactive 
compounds and / or nutraceuticals from natural sources? 
  
 The author believes that the biological and chemical characterization of these halophytes 
is bound to produce an array of extracts and / or compounds with potential application as health 
promoting commodities. 
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Table S1. Information pertained to the quantification of total polyphenol content (TPC), total 
flavonoid content (TFC) condensed tannin content (CTC), hydroxycinnamic acid derivatives 
(HAD), flavonols and anthocyanins: calibration curve equations, linearity, detection limits 
and limits of quantification. 
 CCE Linearity DL (mg/mL) LOQ (mg/g DW) 
TPC1 y = 1.2800x + 0.1287 R2 = 0.9882 0.006 2.067 1 
TFC2 y = 3.4394x + 0.1132 R² = 0.9940 0.002 0.599 2 
CTC3 y = 1.0453x + 0.1385 R² = 0.9857 0.002 0.781 3 
HAD4 y = 3.9839x + 0.3250 R² = 0.9984 0.005 1.534 4 
Flavonols5 y = 3.3706x + 0.1116 R² = 0.9990 0.003 1.146 5 
Anthocyanins6 y = 15813x + 0.0769 R2 = 0.9808 0.001 0.316 6 
CCE: Calibration curve equation; DL: Detection limits; LOQ: Limit of quantification 
1 mg GAE/g DW, GAE: gallic acid equivalents 
2 mg QE/g DW, QE: quercetin equivalents 
3 mg CE/g DW, CE: catechin equivalents 
4 mg CAE/g DW, CAE: caffeic acid equivalent 
5 mg QE/g DW, QE: quercetin equivalents 
6 mg CCE/g DW, CCE: cyanidin chloride equivalents 
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Table S1. Information pertained to the quantification of total polyphenol content (TPC), total 
flavonoid content (TFC) condensed tannin content (CTC), hydroxycinnamic acid derivatives 
(HAD) and flavonols: calibration curve equations, linearity, detection limits and limits of 
quantification. 
 Calibration curve equation Linearity 
Detection limits 
(mg/mL) 
Limit of quantification 
(mg/mL) 
TPC y = 1.2534x + 0.0592 R2 = 0.9976 0.0 0.0 
TFC y = 0.8952x + 0.0431 R² = 0.9990 0.004 0.014 
CTC y = 0.6663x + 0.1081 R² = 0.9973 0.004 0.012 
HAD y = 3.5106x + 0.28 R² = 0.9986 0.002 0.007 
Flavonols y = 2.5187x + 0.1547 R² = 0.9975 0.003 0.010 
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This work searched for the biotechnological potential and chemical characterisation of the medicinal halophyte
Eryngium maritimum L. as source of bioactive natural products with enzymatic inhibitory properties and antiox-
idant capacity. With that aim, herbal formulations traditionally used in folk medicine, namely tisanes (infusions
and decoctions) and tinctures, were prepared from four different anatomical organs (roots, stems, leaves and
flowers) and assessed for in vitro inhibition of enzymes related with diabetes and for antioxidant potential. Phe-
nolic fingerprinting and mineral contents were also assessed. Sea holly's tisanes, particularly from flowers and
leaves, had the highest phenolic content although tinctures were comparatively richer considering the ingestion
dosage. The main constituents identified were carvacrol, 2,3-dimethoxybenzoic acid, naringenin, catechin and t-
cinnamic acid; from the several compounds identified, naringin, naringenin and 2,3-dimethoxybenzoic acid are
here firstly described in the genus and epicatechin and carvacrol in the species. In all extracts, sodium was the
most abundant mineral, followed by potassium, calcium and magnesium, pointing to possible nutritional appli-
cations of these beverages/tinctures asmacronutrients supplementary source. Sea holly's tinctures (stems, leaves
and flowers) were capable of inhibiting dietary carbohydrate digestive enzymes (α-glucosidase andα-amylase)
and had in vitro antioxidant potential, particularly flowers. Altogether, results highlight that sea holly extracts, es-
pecially tinctures from stems, leaves and flowers, could be a novel source ofα-glucosidase andα-amylase inhib-
itors, antioxidant compounds and also phenolic and mineral constituents, thus suggesting they may be
interesting to further explore as potential health-promoting herbal beverages, food additives or other products.
© 2018 Published by Elsevier B.V. on behalf of SAAB.
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Oxidative stress
HPLC-PDA phenolic profile
Minerals
1. Introduction
The Eryngium genus comprises around 250 species widespread
throughout theworld (Castroviejo et al., 2003) and, like othermembers
of the Apiaceae family such as fennel, parsley or celery, many Eryngium
plants have ornamental, culinary or medicinal uses. In traditional med-
icine, Eryngium species have numerous applications namely as diuretic,
kidney stone inhibitor, hypoglycaemic, anti-inflammatory, poison anti-
dote, stimulant and antitussive, amongmany others (Wang et al., 2012;
Erdem et al., 2015). Eryngiummaritimum L., commonly named sea holly,
is a halophyte plant typically native to the dunes and sandy beaches of
the Mediterranean region, Black Sea, Atlantic and Baltic coasts, and
has been introduced into parts of Eastern North America and Australia
(Castroviejo et al., 2003; Isermann and Rooney, 2014). Its roots and
young shoots are eaten cooked in someMediterranean regions like Apu-
lia in Italy (Isermann and Rooney, 2014; Guarrera and Savo, 2016). In
Mediterranean countries it is a folk remedy used as diuretic, kidney
stone inhibitor, aphrodisiac, expectorant, anthelmintic, antitoxin
against various infections, for oedema reabsorption and/or pain relief
(Lisciani et al., 1984; Isermann and Rooney, 2014; Erdem et al., 2015).
Moreover, sea holly has been introduced into cosmetics as cell-
suspension cellulosomes in anti-ageing face creams (Rossanalabs,
2018). Research on E.maritimum has been conductedmainly on organic
extracts and essential oils from either aerial parts or roots, and reports
antimicrobial, antioxidant and/or anti-inflammatory activities and
main constituents like phenolic acids, flavonoids and terpenes
(Lisciani et al., 1984; Meot-Duros et al., 2008; Kholkhal et al., 2012;
Wang et al., 2012; Amessis-Ouchemoukh et al., 2014; Darriet et al.,
2014; Yurdakok et al., 2014; Erdem et al., 2015; Conea et al., 2016;
Mejri et al., 2017; Rjeibi et al., 2017). Few reports focused on aqueous
or hydroethanolic extracts namely following the usage given in folk
practices (infusions, decoctions and tinctures of the medicinal plant)
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and seldom did studies perform a comparative assessment of the differ-
ent plant organs.
Herbal medicine has always had a strong presence throughout hu-
mankind history, playing a fundamental role in human welfare as a
first-line health support for patients with any type of condition, and it
still is of utmost importance in many cultures today (Mehta et al.,
2015). In fact, due to their great biosynthetic capacity, plants are a valu-
able source of bioactive compounds (e.g. polyphenols) that are respon-
sible for the health benefits of botanical extracts (Mehta et al., 2015;
Schmidt et al., 2008). With scientific research attracting the attention
to medicinal plants as reservoirs of novel compounds and/or natural
products, the demand for these health-promoting herbal commodities
continues to increase (Gruenwald, 2009; Mehta et al., 2015). Although
many traditional medicinal plants like Aloe vera [aloe], Aloysia citrodora
[lemon verbena], Camelia sinensis [tea] or Aspalathus linearis [rooibos]
are explored by the food industry as beverages or additives for func-
tional foods (Gruenwald, 2009; Melucci et al., 2013; Pohl et al., 2016),
medicinal halophytes are typically overlooked despite being great
sources of highly bioactive molecules and of potential new-generation
products with beneficial properties (Ksouri et al., 2012). Nonetheless,
recent scientific endeavours have set a new perspective on these salt-
tolerant plants, namely their prospective uses in herbal beverages, like
Crithmum maritimum, Helichrysum italicum subsp. picardii or Limonium
algarvense, or as raw material for different commercial segments and/
or industries, like Polygonum maritimum, Artemisia campestris subsp.
maritima, Lithrum salicaria or Juncus species (Lopes et al., 2016;
Rodrigues et al., 2016, 2017a, 2017b; Rodrigues et al., 2017; Pereira
et al., 2017a, 2017b, in press). Moreover, different researchers that em-
braced the current effort to value medicinal plants, halophyte species
included, have focused on their in vitro capacity to inhibit key-
enzymes associated with human health conditions like diabetes, neuro-
degeneration or skin hyperpigmentation (e.g. Schisandra chinensis
(Turcz.) Baill., Euphorbia denticulata Lam., Lycium barbarum L., Capparis
spinosa L. or halophytes P. maritimum, H. italicum subsp. picardii,
A. campestris subsp. maritima, J. acutus, L. algarvense) (Mocan et al.,
2016, 2017, 2018; Zengin et al., 2016, 2017; Rodrigues et al., 2017a,
2017b; Rodrigues et al., 2017; Pereira et al., 2017b, in press; Mollica
et al., 2018).
It is acknowledged that natural products are in high demand for pos-
itive outcomes particularly in anti-ageing, cognitive well-being and/or
other effects such as managing diabetes (Gruenwald, 2009). Following
these considerations and in addition to the increased demand of raw
plant materials for therapeutic purposes, studying medicinal plants,
particularly halophytes, bearing in mind their folk use, can reveal new
sources of compounds, products or material for different segments
like the food, pharmaceutical and/or cosmetic industries. In this context,
the current work aims at assessing sea holly from a medicinal use per-
spective, i.e., focusing on tisanes and tinctures and their respective in-
gestion dosage (cup-of-tea or drops). Extracts from four different
anatomical organs were prepared and assessed for in vitro inhibition
of carbohydrate digestive enzymes and radical scavenging activity
(RSA) and metal-related potential, coupled with a chemical characteri-
sation comprised of phenolic fingerprinting and mineral contents to
better characterise the plant material (Melucci et al., 2018). To the
best of our knowledge, this is the first study of sea holly in terms of its
anti-diabetic and antioxidant properties and as source of
phytoconstituents and minerals in the form of common therapeutic
dosages of the different organs.
2. Material and methods
2.1. Plant collection
Eryngium maritimum L. (Apiaceae) whole plants were collected in
Praia de Faro beach (36°59′50.4″N 7°58′44.4″W), located in the south
Portuguese coast, in June of 2015. Dr. Manuel J. Pinto, botanist in the
National Museum of Natural History (University of Lisbon, Botanical
Garden, Portugal), carried out the taxonomical classification and the
herbarium of Marbiotech laboratory keeps a voucher specimen
(voucher code MBH37). Plants were divided in roots, stems, leaves
and flowers, and they were oven-dried until complete dryness at 45
°C (~3 days), milled and stored at−20 °C until use.
2.2. Extracts preparation
Aqueous extracts were prepared by homogenising 1 g of dried plant
material in 200 mL of ultrapure water, similarly to a regular cup-of-tea.
The biomass was immersed in boiling water for 5 min to prepare infu-
sions, while for decoctions biomass was boiled in water during 5 min.
The hydroethanolic extracts were prepared as a home-made tincture:
20 g of dried plantmaterialwas homogenised in 200mL of 80% aqueous
ethanol for seven days. Independent extractions (n ≥ 3) of the different
plant materials were made. Extracts were filtered (Whatman n° 4) and
stored in their original form at−20 °C until use. Some aliquots of the
extracts were freeze-dried and/or vacuum-dried for yield determina-
tion and high-performance liquid chromatography (HPLC-PDA) analy-
sis, and, in the case of tinctures, also to test for bioactivities (dried
extracts were re-suspended in aqueous ethanol and tested at a concen-
tration of 10 mg/mL). Samples from the independent extractions were
tested for bioactivities, phenolic (spectrophotometric) andmineral con-
tent and, since no significant differences were found among corre-
sponding extracts from the different extractions, freeze-dried extracts
were pooled accordingly for the HPLC-PDA analysis.
2.3. Phytochemical composition of the extracts
2.3.1. Total phenolic (TPC), flavonoid (TFC) and condensed tannin (CTC)
content
TPC, TFC and CTC were estimated by the spectrophotometric
methods Folin–Ciocalteu, aluminium chloride colorimetric and 4-
dimethylaminocinnamaldehyde (DMACA) assays, respectively, using
gallic acid, quercetin and catechin as standards, as described in
Rodrigues et al. (2015). Results are presented as milligrammes of stan-
dard equivalents (GAE, QE and CE, respectively) per cup-of-tea for infu-
sions and decoctions (mg/200 mL) or per mL for tinctures (mg/1 mL;
1 mL equals approximately 3 to 5 drops, the more common ingestion
dosage; Cook, 1896). Further information related to these methods is
provided in the Supplementary materials section S1 (Table S1.1).
2.3.2. Phenolic fingerprinting by high-performance liquid chromatography
– photodiode array detection (HPLC-PDA)
HPLC analyses were performed on a Waters liquid chromatograph
equipped with a solvent pump model 600 and a 2996 photodiode
array detector, and data was acquired with Empower v2 Software (Wa-
ters Spa, Milford, MA, USA). A C18 reversed-phase packing column
(Prodigy ODS(3), 4.6 × 150 mm, 5 μm; Phenomenex, Torrance, CA,
USA) was used for separation and the column was thermostated at 30
± 1 °C with a Jetstream2 Plus column oven. The UV/Vis acquisition
wavelength was set within the 200–500 nm range and the quantitative
analyses were achieved at maximum wavelength for each compound,
as reported in the Supplementary materials section S2. The injection
volume was 20 μL and the mobile phase was directly on-line degassed
using Biotech DEGASi mod. Compact (LabService. Anzola dell'Emilia.
Italy). Gradient elution was performed using the mobile phase water-
acetonitrile (93:7, v/v, 3% acetic acid). Stock solutions of 22 standards
(benzoic acid, catechin, carvacrol, t-cinnamic acid, chlorogenic acid, o-
coumaric acid, p-coumaric acid, 2,3-dimethoxybenzoic acid, epicate-
chin, t-ferulic acid, gallic acid, harpagoside, p-hydroxybenzoic acid, 3-
hydroxybenzoic acid, 3-hydroxy-4-methoxybenzaldehyde, naringenin,
naringin, quercetin, rutin, sinapinic acid, syringic acid, and vanillic
acid) were made at a concentration of 1 mg/mL in a final volume of
10 mL of methanol. Extracted samples were dissolved in the mobile
205C.G. Pereira et al. / South African Journal of Botany 120 (2019) 204–212
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phase at a concentration of 1 mg/mL. All prepared sample solutions
were centrifuged and the supernatant was injected into the HPLC-PDA
system. Analytical figures of merit on method validation are reported
in literature (Locatelli et al., 2017) and were confirmed herein after
evaluation of matrix interferences. Concentrations of identified pheno-
lics were calculated asmg/cup-of-tea (water extracts) or μg/1mL (tinc-
tures), based on the extracts' yield.
3. Mineral composition
Tisanes and tinctures were analysed directly for mineral content (in
appropriately diluted samples) by Microwave Plasma–Atomic Emission
Spectrometer (MP-AES; Agilent 4200 MP-AES, Agilent Victoria,
Australia), as described in Pereira et al. (2017a). Appropriate blanks
were produced and analysed. Limits of quantification (LOQs) were cal-
culated using the lowest calibration point included in the calibration
curve (Ca: 0.540, Cd: 0.047, Cr: 0.004, Cu: 0.002, Fe: 0.048, K: 0.467,
Mg: 0.146, Mn: 0.001, Na: 0.293, Ni: 0.005, Pb: 0.016, Zn: 0.014 μg/L).
Results were expressed as mg or μg per cup-of-tea for tisanes and per
mL for tinctures.
3.1. Biological activities
3.1.1. In vitro anti-diabetic activity: inhibition of the enzymesmicrobial and
mammalian α-glucosidases and α-amylase
The capacity of the extracts to inhibit the α-glucosidase enzymes
was assessed following Kwon et al. (2008), using acarbose
(10 mg/mL) as positive control. The microbial α-glucosidase enzyme
was obtained from Saccharomyces cerevisiae yeast; an example of a
mammalian-origin α-glucosidase enzyme was obtained from a crude
extract from rat's intestine acetone powder. The α-amylase inhibitory
activity was determined according to the method described in
Rodrigues et al. (2017a), using acarbose (10mg/mL) as positive control.
Results were calculated in relation to a control (ultrapure water/aque-
ous ethanol) and expressed as percentage of inhibitory activity in a
cup-of-tea for tisanes and as percentage (%) activity in 10 mg/mL ex-
tracts for tinctures.
3.1.2. Antioxidant activity assessed by four radical-based assays
The radical scavenging activity (RSA) of the extracts was assessed
against four different radicals (DPPH [1,1-diphenyl-2picrylhydrazyl],
ABTS [2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)], NO [ni-
tric oxide], and O2·− [superoxide]) as described elsewhere (Rodrigues
et al., 2015, 2016), using BHT (butylated hydroxytoluene), ascorbic
acid and catechin as positive controls. Results were calculated in rela-
tion to a control containing ultrapure water or aqueous ethanol and
expressed as percentage of antioxidant activity in a cup-of-tea for ti-
sanes and as percentage (%) activity in 10 mg/mL extracts for tinctures.
3.1.3. Antioxidant activity assessed by three metal-related assays
The Fe3+ reducing activity (ferric reducing antioxidant power,
FRAP) of the extracts and their capacity to chelate copper (CCA) and
iron (ICA) were assessed as previously described (Rodrigues et al.,
2015), using EDTA (ethylenediaminetetraacetic acid) and BHT as posi-
tive controls. Results were calculated in relation to a positive control
for FRAP and in relation to a negative control (ultrapure water/aqueous
ethanol) for CCA and ICA. They are presented as percentage of antioxi-
dant activity in a cup-of-tea for tisanes and as percentage (%) activity
in 10 mg/mL extracts for tinctures.
3.2. Statistical analysis
Experiments were performed at least in triplicate and results are
presented asmean± standard deviation (SD). One-way analysis of var-
iance (ANOVA) was employed to assess significant differences (p b
0.05) or, when parametricity of data did not prevail, the Kruskal Wallis
one-way analysis of variance on ranks; if significant, the respective
pairwise multiple comparison tests Tukey or Dunn's were carried out.
XLStat® version 19.5 was used to execute statistical analyses.
4. Results and discussion
4.1. Phytochemical fingerprinting
Phenolics are some of the most important plant bioactive metabo-
lites, and herbal extracts, such as tisanes for example, are important
sources of these compounds in the human diet (Balasundram et al.,
2006). In this context, tisanes and tinctures from E. maritimum were
assessed spectrophotometrically for their total phenolic (TPC), flavo-
noid (TFC) and condensed tannin (CTC) contents and results are
summarised on Table 1. The polyphenolic contents are presented as
milligrammes per cup-of-tea for infusions and decoctions (mg/
200 mL), given that the “cup-of-tea” is a worldwide measure for drink-
ing tisanes, or mg per mL for tinctures (mg/1 mL) since 1mL equals ap-
proximately 3 to 5 drops, which is a common ingestion therapeutic
dosage (Cook, 1896). When comparing TPC and TFC among all the sea
holly's organs and extracts, flowers' herbal teas have higher TPC
(14.9–17 mg/200 mL) and leaves' tisanes have higher TFC
(1.62–1.85 mg/200 mL). However, given the two different ingestion
dosages, tinctures are comparatively richer in TPC (particularly roots,
7.61 mg/mL) and TFC (leaves in particular, 0.61 mg/mL) considering
that's their content in 1 mL as opposed to the content in 200 mL (cup-
of-tea) of the water extracts. Other authors reported TPC values in sea
holly's leaves' methanol extracts between 16 and 44 mg GAE/g dry
weight (Meot-Duros et al., 2008; Amessis-Ouchemoukh et al., 2014),
which are comparable to those presently obtained in the same organ
when considering the corresponding TPC values adjusted to mg/g
based on the extraction yields (32–34mg GAE/g; Table 1). TFC reported
by those authors (24mgQE/g dw)was similar to the current totalflavo-
noids in leaves' hydroethanolic extracts (22mgQE/g; Table 1) but aque-
ous extracts had lower TFC. Rjeibi et al. (2017)was the only study found
comparing sea holly's organs and using aqueous extracts but the TPC re-
ported (roots 4.3, stems 1.7, leaves 8.1 mg GAE/g dw) was lower than
that currently obtained, as was TFC in leaves' extracts (Table 1). How-
ever, these authors determined TFC in roots and stems, which, in the
present study, was not found. Species-specific factors such as prove-
nance, harvesting and/or environmental characteristics are variables
that can influence the synthesis of plants' secondary metabolites,
Table 1
Phenolic contents in infusions, decoctions (mg/cup-of-tea, 200 mL) and tinctures
(mg/mL) from E.maritimum organs and respective yields (infusion and decoctions:mg ex-
tract/200 mL, tinctures: mg extract/mL).
Organ Extract Yield TPC1 TFC2 CTC3
Roots Infusion 521 3.32 ± 0.29f bLQ bLQ
Decoction 443 3.72 ± 0.30f bLQ bLQ
Tincture 53.6 7.61 ± 0.65d bLQ bLQ
Stems Infusion 214 4.25 ± 0.21ef bLQ bLQ
Decoction 224 5.34 ± 0.40e bLQ bLQ
Tincture 22.6 0.42 ± 0.02g 0.15 ± 0.01f bLQ
Leaves Infusion 350 12.0 ± 0.69c 1.85 ± 0.12a bLQ
Decoction 348 11.2 ± 0.82c 1.62 ± 0.10b bLQ
Tincture 27.7 0.88 ± 0.04g 0.61 ± 0.04e bLQ
Flowers Infusion 263 17.0 ± 0.62a 1.19 ± 0.19c bLQ
Decoction 268 14.9 ± 0.39b 0.80 ± 0.08d bLQ
Tincture 24.9 0.76 ± 0.06g 0.12 ± 0.01f bLQ
Data represent the mean ± SD (n ≥ 6). In each column, different letters mean significant
differences (p b 0.05). LQ: limit of quantification.
1 TPC: total polyphenol content, mg GAE/200 mL or GAE/mL, GAE: gallic acid equiva-
lents; LQ (TPC) = 4.0 μg GAE/mL.
2 TFC total flavonoid content; mg QE/200 mL or QE/mL, QE: quercetin equivalents; LQ
(TFC) = 6.0 μg QE/mL.
3 CTC: condensed tannin content, mg CE/200mL or CE/mL, CE: catechin equivalents; LQ
(CTC) = 7.8 μg CE/mL.
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reflected in the different phytochemical contents reported (Ksouri et al.,
2012; Buhmann and Papenbrock, 2013). Nonetheless, Meot-Duros et al.
(2008) considered that E. maritimum leaves' extracts have lower pheno-
lic content comparatively to other halophyte species, although
possessing bioactive compounds with great potential for food or cos-
metic industries. In fact, sea holly's tisanes showed lower phenolic and
flavonoid contents (3.32–17.0 mg GAE/cup-of-tea and 0.80–1.85 mg
QE/cup-of-tea, Table 1) when compared with herbal teas from other
halophyte species already assessed by Pereira et al. (2017a, 2017b),
C. maritimum (12.4–35.3 mg GAE/cup-of-tea and 22.9–57.2 mg RE/
cup-of-tea) and H. italicum subsp. picardii (13.9–76.5 mg GAE/cup-of-
tea and 20.3–119 mg RE/cup-of-tea).
The phytochemical fingerprint of infusions, decoctions and tinctures
from sea holly was further explored by HLPC-PDA to identify and quan-
tify individual phenolic compounds in these samples. The described
HPLC method is simple, accurate (precise and true) and selective for
separation and quantification of phenolics in the considered samples,
while reasonably sensitive for direct quantitative determination of
these compounds in real matrices. Obtained results (mg/cup-of-tea for
water extracts and μg/1mL for tinctures, calculated based on the extrac-
tion yields) are presented in Table 2. Chromatograms obtained from real
sample analyses at 278 nm are reported in Supplementary materials
section S3. Sixteen phenolic compounds were identified and quantified
in sea holly's tisanes and tinctures: nine phenolic acids, five flavonoids
and two other constituents (Table 2). Most of these phenolics were al-
ready described in Eryngium species except for naringin, naringenin
and 2,3-dimethoxybenzoic acidwhich are, to the best of our knowledge,
here firstly described in the genus.Moreover, no reportswere foundde-
tailing epicatechin and carvacrol in E. maritimum, which are being here
described for the first time in this species.
The phenolic fingerprint of sea holly's organs showed that roots'
herbal teas, particularly infusions, had the higher quantity of com-
pounds determined (infusions 25.5 and decoctions 10.5 mg/cup-of-
tea), mainly due to the dominant phenolic monoterpene found in this
organ, carvacrol. Nevertheless, if considering the two ingestion dosages,
tinctures have comparatively higher amounts (particularly roots, 833
μg/mL, and leaves 669 μg/mL). Carvacrol was the major constituent
found, the only one identified in all samples and reaching 21 mg/cup-
of-tea in roots' infusion. This phenolic monoterpene, more abundant
in roots (4.05% of the infusion extract, 0.69% of decoction and 0.37% of
tincture extracts; Table 2, considering the yields obtained), has not
been reported in E. maritimum but is described in E. bungei as a major
constituent in aerial parts' essential oils (8.9%; Erdem et al., 2015). Car-
vacrol is mostly known for being the predominant component in the
Table 2
Phenolic fingerprint in infusions, decoctions (mg/cup-of-tea, 200 mL) and tinctures (μg/mL) from E. maritimum organs, determined by HPLC-PDA.
Compound (Peak) Roots Stems Leaves Flowers
Infusion Decoction Tincture Infusion Decoction Tincture Infusion Decoction Tincture Infusion Decoction Tincture
Phenolic acids
Hydroxybenzoic
acids
Gallic acid – – 67.5 ±
2.7
– – – – – – – – –
3-OH-benzoic acid – – – – – – 0.19 ±
0.02
– – – 0.11 ±
0.01
9.5 ± 1.0
Vanillic acid – – – – – – 0.13 ±
0.02
– 17.5 ±
0.3
bLOQ bLOQ bLOQ
Syringic acid – – – – – – – 0.17 ±
0.01
– – – –
Hydroxycinnamic
acids
Chlorogenic acid – – – 0.15 ±
0.01
0.11 ±
0.03
4.8 ± 0.5 0.77 ±
0.03
0.69 ±
0.11
16.1 ±
1.1
0.07 ±
0.01
– –
Sinapinic acid – – – – – – – 0.07 ±
0.01
– bLOQ bLOQ bLOQ
t-Ferulic acid 0.40 ±
0.04
0.09 ±
0.01
bLOQ – – – 0.18 ±
0.02
0.18 ±
0.02
18.8 ±
1.4
0.07 ±
0.01
0.06 ±
0.01
7.2 ± 1.0
o-Coumaric acid – – – – – bLOQ 0.18 ±
0.02
0.15 ±
0.01
13.3 ±
1.1
0.05 ±
0.01
0.06 ±
0.01
–
t-Cinnamic acid 1.6 ± 1.3 0.19 ±
0.01
28.4 ±
7.5
0.07 ±
0.01
0.10 ±
0.09
– – – 8.6 ± 0.8 bLOQ – –
Flavonoids
Flavanols
Catechin 0.15 ±
0.07
0.47 ±
0.05
12.3 ±
1.0
1.6 ± 0.3 – 186 ± 13 3.34 ± 0.4 1.7 ± 0.2 195 ± 18 0.8 ± 0.5 2.10 ±
0.02
109 ± 12
Epicatechin – – – – bLOQ – bLOQ bLOQ 10.8 ±
2.8
bLOQ 0.19 ±
0.03
–
Flavonols
Rutin – – – – – 11.8 ± 2.3 0.32 ±
0.03
– 19.4 ±
0.6
– – 5.5 ± 0.5
Flavanones
Naringin – – – – – – 0.11 ±
0.01
0.3 ± 0.2 – 0.10 ±
0.01
0.11 ±
0.01
–
Naringenin – 3.22 ±
0.70
276 ± 49 1.0 ± 0.4 2.1 ± 0.5 105 ± 51 0.91 ±
0.07
3.6 ± 0.4 274 ± 36 1.2 ± 0.1 1.3 ± 0.3 57.3 ± 5.6
Other constituents
2,3-DiMeObenzoic
acid
2.2 ± 0.2 3.5 ± 0.4 254 ± 47 – 0.07 ±
0.01
– 0.21 ±
0.03
– 23.8 ±
4.4
– 0.11 ±
0.01
29.9 ±
0.01
Carvacrol 21.1 ± 0.4 3.1 ± 0.3 196 ± 67 0.6 ± 0.2 0.8 ± 0.2 37.7 ±
15.1
0.39 ±
0.01
1.2 ± 0.9 71.7 ±
7.6
0.3 ± 0.1 0.5 ± 0.1 42.8 ±
19.7
TOTAL 25.5 10.5 833 3.42 3.14 346 6.78 8.06 669 2.63 4.52 261
Data represent the mean ± SD of 2 different and independent measurements. Limit of quantification (LOQ) = 0.20 μg/mL.
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essential oils of Origanum and Thymus species and has several demon-
strated bioactivities, namely proliferative (wound-healing), anti-
carcinogenic and anti-mutagenic, analgesic, insecticidal, among others,
but its most remarkable one is antimicrobial (Baser, 2008). Considering
the levels of this constituent in sea holly's roots infusion, this extract
could be an alternative source of carvacrol for the food and feed indus-
tries given its potential as flavouring additive with antimicrobial prop-
erties (Baser, 2008). Also prominent in roots' extracts was 2,3-
dimethoxybenzoic acid (2.2 and 3.5 mg/cup-of-tea in infusion and de-
coction, 254 μg/mL in tincture, Table 2), here firstly reported in the
Eryngium genus. Although present in fruits and vegetables,
dimethoxybenzoic acids are not very common but some have described
antifungal activity concerning fruit and vegetable decay (Lattanzio et al.,
1994). Another main constituent determined was naringenin, higher in
roots and leaves' decoctions (3.2 and 3.6 mg/cup-of-tea, respectively,
Table 2) and also higher in those organs' tinctures (276 and 274
μg/mL, respectively, Table 2). Naringenin was not found described in
Eryngium species but it is an abundant flavonoid in Citrus fruits, partic-
ularly grapefruit, where it is reported at a mean concentration of
2.7 mg/100 mL of C. paradisi juice (Nakajima et al., 2014; Patel et al.,
2014). This value is slightly higher than those presently found in a
cup-of-tea (200 mL) of sea holly's decoctions from roots and leaves,
but 10 mL of those organs' tinctures would suffice to match the
grapefruit's naringenin content. Considering that this flavanone is
used in the cosmetic and pharmaceutical industries (Patel et al.,
2014), sea holly's extracts seem relevant as an alternative source for
this phenolic compound. Moreover, naringenin has shown a promising
pharmacological profile with reported antioxidant, anti-inflammatory,
anti-cancer, anti-diabetic and anti-obesity activities (Nakajima et al.,
2014; Patel et al., 2014). Catechin was also among themain compounds
detected, higher in leaves' water extracts (1.7–3.4 mg/cup-of-tea),
flowers' decoction and stems' infusion (2.1 and 1.6 mg/cup-of-tea, re-
spectively); in tinctures this flavonoid reached almost 0.2 mg/mL in
stems and leaves. Rjeibi et al. (2017) also found higher catechin levels
in water extracts from E. maritimum's stems (0.88%) and leaves
(0.74%) in values comparable to those herein determined (stems
0.74%, leaves 0.47–0.97%; Table 2, considering the yields obtained). Ac-
cording to Gadkari and Balaraman (2015), cocoa consists of several cat-
echins and a cocoa-product like dark chocolate may contain around
6.6 mg/100 g of catechin, which is only twice as much as a cup-of-tea
from sea holly's leaves infusion can supply. The catechin polyphenol
group has various biological activities described such as anti-
carcinogenic, antioxidant, antidiabetic, protection against degenerative
diseases, among others; catechin itself is associated with a decreasing
risk of coronary heart disease, antiplatelet effects and anticancer activity
(Sutherland et al., 2006; Gadkari and Balaraman, 2015). Yet another
main phenolic found was t-cinnamic acid in roots' infusion (1.6 mg/
cup-of-tea), although at much lower levels or undetected in the other
extracts. Rjeibi et al. (2017) have also identified this constituent as a
major compound in sea holly's water extracts but at higher concentra-
tions (1.5–3.8%). Besides being described as antioxidant, antitumoural,
cytotoxic and antimicrobial (Heleno et al., 2015), cinnamic acid has re-
ported benefits related to its anti-diabetic properties namely lowering
of triglycerides levels and improvement of carbohydrate metabolising
enzymes, of glucose tolerance and insulin resistance (Alam et al.,
2016). The remaining phenolics identified were detected in lower
amounts comparatively to the above mentioned main constituents,
but chlorogenic acid in leaves tisanes (0.7–0.8mg/cup-of-tea) and gallic
acid in roots tinctures (68 μg/mL)were detected at noteworthy concen-
trations. In fact, other authors (Mejri et al., 2017; Rjeibi et al., 2017)
found these among the major phenolics in E. maritimum's methanol
and water extracts from different organs, along with caffeic,
protocatechuic and vanillic acids, kaempferol and quercetin, all except
vanillic acid not presently determined. Chlorogenic acid has been dem-
onstrated to possess antioxidant, anti-carcinogenic, antimicrobial,
hypoglycaemic, hypolipidaemic and hypotensive effects (Meng et al.,
2013; Santana-Gálvez et al., 2017), and gallic acid has shown antioxi-
dant, anti-carcinogenic and anti-inflammatory activities (Khadem and
Marles, 2010; Ksouri et al., 2012). Altogether, the phenolic fingerprint
of sea holly's tisanes and tinctures reveals the presence of compounds
described in literature as valuable bioactive phytochemicals, highlight-
ing the potential use of sea holly's extracts as source of bioactive mole-
cules/products. Actually, phenolic compounds are an essential part of
the human diet; in edible plant-products they act as pigments, antioxi-
dants, flavour precursors and, as part of our diet, they can be considered
health-promoting commodities (Ksouri et al., 2012).
4.2. Mineral composition
Besides possessing a variety of polyphenolic compounds, herbal ex-
tracts like tisanesmay also be an additional source of other constituents
in the human diet such as minerals (Pohl et al., 2016; Pereira et al.,
2017a). Hence, the extracts from sea holly's organs were analysed for
the presence of these essential nutrients as it could increase their poten-
tial value as food products. Table 3 presents the samples' mineral con-
tent as mg per cup-of-tea for infusions and decoctions (mg/200 mL)
or mg per mL for tinctures (mg/mL), according to the respective com-
mon ingestion dosage. Sodium was the mineral more abundantly
found in sea holly's extracts, particularly in tisanes from stems
(41.6–44.1 mg/cup-of-tea) and leaves (25.3–25.7 mg/cup-of-tea); in
tinctures, although in a different dosage, the highest Na levels were
also determined in stems (1.5 mg/mL) and leaves (1 mg/mL) extracts.
Values of this element in sea holly's stems and leaves herbal teas are
similar to those detected in another halophyte's tisanes, the sea fennel
C. maritimum (20–49 mg/cup-of-tea; Pereira et al., 2017a), although
higher than usually found in various regularly consumed tisanes from
plants like Matricaria chamomilla L. (chamomile) or Tilia species (lin-
den) (Pohl et al., 2016). Still, the recommended daily Na intake is
2000 mg maximum (WHO, 2012), hence, a cup-of-tea from any of sea
holly's organs is reasonably safe to include in a daily diet although
some caution would be advisable due to the cumulative intake of so-
dium from other food sources. Potassium was also fairly abundant in
sea holly's tisanes with levels reaching 20 mg/cup-of tea in flower's de-
coction and between 16 and 18 mg/cup-of tea in stems and leaves'
herbal teas. The sea fennel also showed higher K concentration in
flowers' tisanes and in comparable levels (19–23 mg/cup-of-tea;
Pereira et al., 2017a). Herbal teas from commonly used plants can
range from as little as 2.88 μg/mL up to 852 μg/mL of K (aprox.
170 mg/200 mL; Pohl et al., 2016), which was only surpassed by the K
content in sea holly's flowers tincture (913 μg/mL). Of the other
macro-elements, calcium was higher in leaves' tisanes (3.6–3.7 mg/
cup-of-tea) and magnesium in flowers' decoction (2.3 mg/cup-of-tea)
and leaves' herbal teas (2.2 mg/cup-of-tea). In tinctures, these minerals
were present in lower concentrations (Ca: 4.1–20 μg/mL, Mg: 20–51
μg/mL) comparatively to Na or K. Comparing to sea fennel's herbal
teas, Ca and Mg reached higher maximum levels in that halophyte's
leaves decoction (20 and 5.6 mg/cup-of-tea, respectively; Pereira
et al., 2017a), although in the remaining organs values were akin to
those here reported in sea holly. As for micronutrients, manganese con-
centration was higher in leaves' tisanes (4.3–4.4 μg/cup-of-tea) while
iron and zinc were not found in the aqueous extracts (below LOQ). In
tinctures, these microelements' content was below 1 μg/mL. Altogether,
our results indicate that sea holly's tisanes and tincturesmay contribute
to the human daily intake of some elements like Na, K, Ca andMg (par-
ticularly extracts from leaves). Still noteworthy is that Cu and Ni levels
were well below reference tolerable upper intake levels (Cu: 10, Ni:
1 mg/day; Otten et al., 2006) and can therefore be considered safe for
consumption. Potentially toxic elements like Cr and Cd were not
found (below LOQs) and Pb,whendetected,was below legislated values
for plants (0.3 mg/kg wet weight, maximum levels in finished herbal
products are not regulated; EC Regulation, 1881/2006).
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4.3. Biological activities: anti-diabetic (enzyme inhibiting) and antioxidant
properties
Numerous plants have long been used in traditional herbalmedicine
to manage conditions such as type 2 diabetes mellitus (T2DM) (Hung
et al., 2012). For example, leaves from another Eryngium species,
E. creticum, are drank in decoction for its hypoglycaemic properties
(Yaniv et al., 1987). T2DM is a common metabolic disorder
characterised by high plasma glucose levels and, in modern medicine,
its management includes inhibiting carbohydrate-hydrolysing en-
zymes, such asα-glucosidase andα-amylase, therefore retarding carbo-
hydrate digestion and glucose absorption, lowering postprandial blood
glucose and reducing hyperglycaemia (Kwon et al., 2008; Kumar et al.,
2011). In this context, sea holly's extracts were assessed for their anti-
diabetic potential by testing their capacity to inhibit microbial and
mammalian α-glucosidases and α-amylase. Results (Table 4) are
expressed as percentage of activity in a cup-of-tea for tisanes but as per-
centage of activity in 10 mg/mL extracts for tinctures. Tinctures were
not tested in their ingestion dosage form (crude extracts) like the herbal
teas because some tinctures' colouring interfered with the assays and
hence had to be diluted. Consequently, results may be underestimating
the tinctures real potential in terms of bioactivitieswhile used tradition-
ally. All extracts except roots' tisanes had the capacity to inhibit the mi-
crobialα-glucosidase, althoughwith varying degrees, but only tinctures
showed activity towards the mammalian α-glucosidase and amylase
enzymes. In fact, following a classification to describe the inhibitory ac-
tivity (%) of plant extracts against enzymes as potent (N50%), moderate
(30–50%) and low (b30%) (Vinutha et al., 2007; Custódio et al., 2015),
tinctures from stems, leaves and flowers can be considered as potent in-
hibitors of the three enzymes. However, the tincture was more active
towards the microbial α-glucosidase (58–72%) than for its mammalian
counterpart (29–55%), a result commonly reported for some com-
pounds/natural extracts (Oki et al., 1999; Rodrigues et al., 2017a;
Pereira et al., in press) indicating that enzyme source may influence
the extract's inhibitory capacity (Oki et al., 1999). Nevertheless, despite
the idea of themammalian enzyme being a more trustworthy proxy for
in vivo activity (Oki et al., 1999), aqueous extracts from another
Eryngium, E. creticum, that lacked favourable in vitro effectiveness exhib-
ited substantial anti-hyperglycaemic activity in rats (Wang et al., 2012).
Moreover, it is also usually reported that natural compounds/extracts
have stronger inhibitory activity towards α-glucosidase than against
α-amylase (Kwon et al., 2008; Custódio et al., 2015; Rodrigues et al.,
2017a) but in the present work, stems and flowers' tinctures had
slightly higher activity towards α-amylase. This could be due to partic-
ular compounds or to additive/synergistic interactions of compounds
present in those extracts. It is increasingly documented that dietary
polyphenolic phytochemicals, among multiple biological effects, can
Table 3
Mineral content in infusions, decoctions (mg or μg/cup-of-tea, 200 mL) and tinctures (μg/mL) from E. maritimum organs.
Mineral Roots Stems Leaves Flowers
Infusion Decoction Tincture Infusion Decoction Tincture Infusion Decoction Tincture Infusion Decoction Tincture
Macro-elements
Na 10.3 ±
0.07d
9.9 ± 0.3d 367 ± 10g 41.6 ±
0.98b
44.1 ± 0.4a 1482 ± 91f 25.3 ± 0.3c 25.7 ± 0.2c 977 ± 62fg 4.19 ±
0.07e
4.9 ± 0.08e 152 ± 10g
Ca 1.77 ±
0.03de
1.76 ±
0.01de
7.7 ± 0.3f 2.25 ±
0.06c
2.5 ± 0.3b 13.7 ± 0.2f 3.58 ±
0.05a
3.71 ±
0.08a
19.7 ± 0.3f 1.57 ±
0.01e
1.83 ±
0.02d
4.1 ± 0.1f
K 10.6 ± 0.2e 9.3 ± 0.1f 500 ± 45g 16.3 ±
1.1cd
17.5 ±
0.07b
736 ± 17g 15.6 ± 0.2d 16.2 ±
0.3cd
677 ± 15g 17.0 ±
0.4bc
20.1 ±
0.02a
913 ± 48g
Mg 0.61 ±
0.05g
0.85 ± 0.01f 19.5 ± 0.5h 1.32 ±
0.01e
1.51 ±
0.03d
44.3 ± 0.4h 2.23 ±
0.04b
2.19 ±
0.03b
50.9 ± 0.3h 1.72 ±
0.02c
2.31 ±
0.01a
45.9 ± 0.7h
Micro and trace-elements
Fe bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ 0.09 ±
0.01a
bLOQ bLOQ 0.15 ±
0.03a
Mn bLOQ bLOQ 0.002 ±
0.001f
1.37 ±
0.04d
1.52 ±
0.03d
0.03 ±
0.01f
4.3 ± 0.1b 4.4 ± 0.1a 0.10 ± 0.01f 1.74 ±
0.03c
1.11 ±
0.07e
0.03 ±
0.01f
Zn bLOQ bLOQ 0.43 ± 0.01b bLOQ bLOQ 0.35 ±
0.01c
bLOQ bLOQ 0.72 ±
0.01a
bLOQ bLOQ 0.69 ±
0.04a
Cu 8.63 ±
0.06a
8.0 ± 0.3a 0.84 ± 0.02e 4.6 ± 0.3c 5.9 ± 0.1b 0.62 ±
0.01e
0.6 ± 0.5e bLOQ 0.43 ±
0.01e
1.9 ± 0.3d 0.60 ±
0.03e
0.40 ±
0.01e
Cr bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ
Ni 5.83 ±
0.06b
6.3 ± 0.2a 0.04 ± 0.01e 2.1 ± 0.1d 1.8 ± 0.2d 0.04 ±
0.01e
2.6 ± 0.2c 2.7 ± 0.2c 0.03 ±
0.01e
2.6 ± 0.2c 2.07 ±
2.05d
0.04 ±
0.01e
Pb bLOQ bLOQ 0.17 ± 0.01ab bLOQ bLOQ 0.14 ±
0.01b
bLOQ bLOQ 0.16 ±
0.01ab
bLOQ bLOQ 0.18 ±
0.03a
Cd bLOQ bLOQ b LOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ bLOQ
Data represent the mean ± SD (n= 3). In each row, different letters mean significant differences (p b 0.05).
LOQs: Fe, 9.7 μg/cup-of-tea or 0.05 μg/1 mL; Mn, 0.2 μg/cup-of-tea or 0.001 μg/1 mL; Zn, 2.9 μg/cup-of-tea or 0.01 μg/1 mL; Cr, 0.8 μg/cup-of-tea or 0.004 μg/1 mL; Pb, 3.3 μg/cup-of-tea or
0.02 μg/1 mL; Cd, 9.5 μg/cup-of-tea or 0.05μg/1 mL.
Table 4
Anti-diabetic activity of infusions, decoctions (% activity in a cup-of-tea, 200mL) and tinc-
tures (% activity in 10 mg/mL extracts) from E. maritimum organs: inhibitory activities on
microbial and mammalian α-glucosidase enzymes, and on α-amylase enzyme.
Samples Organ Extract Microbial
α-glucosidase
Mammalian
α-glucosidase
α-Amylase
Eryngium
maritimum
Roots Infusion n.a. n.a. n.a.
Decoction n.a. n.a. n.a.
Tincture 63.1 ± 2.2c 29.0 ± 2.3c 23.9 ±
1.3d
Stems Infusion 21.7 ± 1.6j n.a. n.a.
Decoction 25.7 ± 2.0i n.a. n.a.
Tincture 57.8 ± 1.8d 52.1 ± 3.8b 66.8 ±
2.5b
Leaves Infusion 38.8 ± 1.4f n.a. n.a.
Decoction 43.1 ± 0.8e n.a. n.a.
Tincture 72.3 ± 1.4b 50.8 ± 3.4b 58.2 ±
3.9c
Flowers Infusion 30.2 ± 1.9h n.a. n.a.
Decoction 33.9 ± 1.4g n.a. n.a.
Tincture 62.6 ± 0.8c 55.0 ± 6.7b 66.5 ±
3.4b
Acarbose* 85.0 ± 0.3a 96.0 ± 0.3a 82.2 ±
3.9a
Values represent the mean ± SD of at least three experiments in triplicate (n = 9). n.a.:
not active (% activity lower than 20%). *Positive control, tested at 10 mg/mL.
In each column, different letters mean significant differences (p b 0.05).
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also modulate enzymatic activity like inhibiting glucosidase and amy-
lase activities and therefore contribute to T2DMmanagement by reduc-
ing post-prandial hyperglycaemia (Kumar et al., 2011; Hung et al.,
2012). The stronger enzymatic inhibition exerted by stems, leaves and
flowers tinctures could be related to their main constituents, namely
naringenin, reported to improve hyperglycaemia among other anti-
diabetic activities (Nakajima et al., 2014; Patel et al., 2014), catechin,
which has known activity against T2DM and hypoglycaemic properties
(Sutherland et al., 2006; Meena et al., 2017), and carvacrol, previously
described as α-glucosidase and α-amylase inhibitor (Govindaraju and
Arulselvi, 2018). Moreover, other phenolics found in sea holly's extracts
also have described hypoglycaemic properties, namely chlorogenic and
ferulic acids (Meng et al., 2013; Alam et al., 2016), and inhibitory activ-
ity towards the digestive enzymes, like chlorogenic, vanillic and gallic
acids (Kumar et al., 2011;Williamson, 2013). Overall, these results sug-
gest that sea holly's tinctures, particularly from stems, leaves and
flowers, contain compounds capable of inhibiting dietary carbohydrate
digestive enzymes and hence could be beneficial in controlling glucose
levels and aid in managing T2DM. To the best of our knowledge this is
the first time that sea holly is associated to any kind of anti-diabetic
properties.
In T2DM, oxidative stress by overproduction of reactive oxygen spe-
cies (ROS) has been implicated as a causative factor in the induction and
progression of the condition, as in several other degenerative alterations
like vascular and neurodegenerative diseases, inflammation or carcino-
genesis (Saeidnia and Abdollahi, 2013; Panigrahy et al., 2016). Antioxi-
dant phytochemicals are well recognised for effectively fighting ROS
thus preventing oxidative damage and reducing or ameliorating
oxidative-stress related disorders; they are also positively associated
in managing T2DM (Saeidnia and Abdollahi, 2013; Sindhi et al., 2013).
Therefore, the antioxidant potential of the sea holly's extracts was
assessed, using seven methods targeting RSA and metal-related poten-
tial (Table 5). Just like for enzyme inhibiting activities, results are
expressed as percentage (%) of activity in a cup-of-tea for tisanes and
as percentage (%) of activity in 10 mg/mL extracts for tinctures, which
could possibly underestimate the real antioxidant potential of crude
tinctures. The classification previously used to describe the inhibition
of the carbohydrate digestive enzymes can also be applied to the ex-
tracts' antioxidant activity. Overall, tinctures showed potent (N50%) an-
tioxidant capacity except against the NO radical and for iron chelation
while infusions and decoctions from leaves and flowers varied between
moderate (30–50%) and potent (N50%) antioxidant activity. Flowers'
tinctures had consistently the higher activities, closely followed by
leaves' tinctures, in scavenging DPPH, ABTS and O2·− radicals, in
reducing iron (FRAP) and in chelating copper. Flowers' infusion was
equally effective as its tincture in scavenging DPPH and this organ's ti-
sanes had the highest NO scavenging capacity among extracts. On the
other hand, roots, stems and leaves' decoctionswere the only beverages
able to qualify as potent iron chelators. Other studies have reported on
the strong antioxidant properties of different types of extracts from
E. maritimum (Kholkhal et al., 2012; Amessis-Ouchemoukh et al.,
2014; Darriet et al., 2014; Yurdakok et al., 2014;Mejri et al., 2017; Rjeibi
et al., 2017), but very few analysedmore than one organ. Only Amessis-
Ouchemoukh et al. (2014), Rjeibi et al. (2017) and Yurdakok et al.
(2014) compared different plant parts: the first two described higher
RSA towards DPPH and NO in leaves' methanol and water extracts, re-
spectively, while the later depicted similar results in scavenging DPPH
between roots and aerial-parts' water extracts. However, flowers,
whose extracts showed the best antioxidant results in the present
study, were not mentioned in literature as analysed separately and
comparatively to the other organs. Furthermore,medicinal plant studies
seldom focus on bioactivities associated to the ingestiondosage of either
tisanes (cup-of-tea) or tinctures (drops) and this was the first such at-
tempt with sea holly extracts, as was the use of a comprehensive and
complementary battery of seven antioxidant assessing in vitro assays.
The present results confirm sea holly's in vitro antioxidant potential,
particularly from flowers, thus showing that hydro-alcoholic extracts
and beverages from this plant could be useful in preventing oxidative-
stress related disorders. Additionally, as oxidative stress has been con-
sidered a mediator in diabetes (Saeidnia and Abdollahi, 2013;
Panigrahy et al., 2016), the tinctures combined antioxidant and anti-
diabetic potential could reduce oxidative stress and help control glucose
levels, benefiting T2DM patients and those at risk of developing the
condition.
Many studies in literature credit the extracts' antioxidant activity to
their polyphenolic content (Ksouri et al., 2012) but some authors did
not find that association (Kähkönen et al., 1999). Accordingly, flowers'
tisanes had higher TPC but roots' tinctures were comparatively richer
in total phenolics, which does not totally correspond to the antioxidant
results obtained. Nevertheless, it is important to mention that colori-
metric assays give a TPC estimate and may not incorporate all the
phyto-antioxidants in the extract (Tawaha et al., 2007). The presence
and amount of individual phenolics (Table 2) in theflowers' extracts, es-
pecially tinctures, may contribute for its antioxidant superiority al-
though no particular phenolic compound was found exclusively or at
higher concentrations in flowers' tinctures except for 3-
hydroxybenzoic acid (9.5 μg/mL, Table 2). Yet, this compound is de-
scribed as having weak antioxidant activity since the number of
Table 5
Antioxidant activity of infusions, decoctions (% activity in a cup-of-tea, 200 mL) and tinctures (% activity in 10 mg/mL extracts) from E. maritimum organs: radical scavenging on DPPH,
ABTS, NO and O2·− radicals, ferric reducing antioxidant power (FRAP) and metal-chelating activities on copper (CCA) and iron (ICA).
Samples Organ Extract Antioxidant activity
DPPH ABTS NO O2·− FRAP CCA ICA
Eryngium maritimum Roots Infusion 31.7 ± 2.3g n.a. 43.9 ± 3.4c n.a. 32.9 ± 2.0f 34.4 ± 3.3g 38.4 ± 3.9de
Decoction 31.5 ± 1.4g n.a. 41.8 ± 2.0c n.a. 30.6 ± 0.9f 37.0 ± 1.7fg 50.3 ± 5.1bc
Tincture 51.3 ± 3.1e 43.2 ± 1.2c n.a. 23.3 ± 1.9f 54.1 ± 4.4d 51.0 ± 3.6e n.a.
Stems Infusion 27.6 ± 1.7g n.a. 33.4 ± 2.1d n.a. 23.3 ± 1.5g 35.7 ± 2. 6fg 33.5 ± 2.5ef
Decoction 28.4 ± 1.8g na.a 32.5 ± 2.3d 23.1 ± 1.6f 23.4 ± 0.9g 37.4 ± 3.5fg 54.9 ± 4.3b
Tincture 68.1 ± 5.1c 94.9 ± 3.9b n.a. 77.0 ± 2.2b 100 ± 0.01a 64.1 ± 2.7d 22.5 ± 1.2g
Leaves Infusion 58.3 ± 2.3d 32.5 ± 2.8d 53.7 ± 2.9b 38.5 ± 3.9e 57.8 ± 1.7d 37.1 ± 3.1fg 43.1 ± 3.9cd
Decoction 39.1 ± 2.6f 29.0 ± 0.9d 50.1 ± 1.6b 52.9 ± 3.5c 43.0 ± 1.7e 34.5 ± 3.0fg 54.5 ± 5.6b
Tincture 84.2 ± 4.5b 99.7 ± 0.7a n.a. 75.6 ± 1.8b 100 ± 0.01a 73.7 ± 1.3c 27.0 ± 1.2fg
Flowers Infusion 92.6 ± 0.4a 40.9 ± 3.4c 54.3 ± 3.9b 47.2 ± 1.4d 72.3 ± 2.9b 37.9 ± 2.7fg 24.7 ± 4.4g
Decoction 84.3 ± 3.1b 28.5 ± 0.9d 53.1 ± 3.8b 54.8 ± 1.9c 66.0 ± 2.8c 39.9 ± 3.7f n.a.
Tincture 93.6 ± 0.2a 99.5 ± 1.0a n.a. 73.6 ± 2.8b 100 ± 0.01a 82.6 ± 1.5b 21.3 ± 1.0g
BHT* 95.7 ± 0.1a 99.6 ± 0.3a –
Ascorbic acid* 94.0 ± 0.4a
Catechin* 91.1 ± 0.5a
EDTA* 98.4 ± 0.9a 95.0 ± 0.1a
Values represent the mean ± SD of at least three experiments in triplicate (n = 9). n.a.: not active (% activity lower than 20%). *Positive controls, tested at 10 mg/mL.
In each column, different letters mean significant differences (p b 0.05).
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hydroxyl groups bound to the aromatic ring seems to influence the an-
tioxidant capacity of phenolic compounds and 3-hydroxybenzoic acid
only has one (Sroka and Cisowski, 2003). Possible additive/synergistic
effects of phytoconstituents in the extract could contribute to its higher
antioxidant activity, for example between naringenin and catechin,
both known antioxidants (Sutherland et al., 2006; Patel et al., 2014),
or between other compounds not identified in the present study. As al-
ready mentioned, other authors also found some major phenolics in
E. maritimum's extracts not presently determined, such as caffeic and
protocatechuic acids, kaempferol or quercetin (Mejri et al., 2017;
Rjeibi et al., 2017), which attests to the hypothesis that non-identified
constituents could be at play. Still noteworthy is the fact that, globally,
extracts with higher enzyme inhibitory capacity were also themore po-
tent antioxidants, namely tinctures from stems, leaves and flowers, an
association previously described by Kwon et al. (2008) where eggplant
α-glucosidase andα-amylase inhibitory capacitieswere proportional to
scavenging-related antioxidant activity, confirming a possible associa-
tion between antioxidant and carbohydrate-hydrolysing enzymes in-
hibitory activities.
5. Conclusions
This work is pioneer in describing the biotechnological assessment
of a medicinal halophyte, E. maritimum, in terms of its anti-diabetic
and antioxidant potential and as source of phytoconstituents and min-
erals in the formof common therapeutic dosages (cup-of-tea for tisanes,
drops for tinctures) of the different anatomical organs. Results highlight
the potential role of sea holly's herbal teas and tinctures in managing
T2DM and help preventing oxidative-stress related diseases, particu-
larly tinctures from stems, leaves and flowers. More precisely, these ex-
tracts could be a novel source of phenolic and mineral constituents,
antioxidants and inhibitors of dietary carbohydrate digestive enzymes
to be further explored as potential health-promoting herbal beverages,
food additives or other products for the food, cosmetic and/or pharma-
ceutical industries. Still, in vivo studies should be pursued to fully ex-
plore this plant's therapeutic benefits.
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SECTION S1: Total phenolic, flavonoid and condensed tannin content parameters 
Table S1.1 Parameters pertained to the quantification of total polyphenol content (TPC), total 
flavonoid content (TFC) and condensed tannin content (CTC): calibration curve equations, 
linearity, detection limits and limits of quantification. 
Phenolic 
group 
Calibration curve 
equation Linearity 
Detection limits 
(mg/mL) 
Limit of quantification 
(mg/mL) 
TPC1 y = 1.2534x + 0.0592 R2 = 0.9976 0.001 0.004 
TFC2 y = 3.4394x + 0.1132 R² = 0.9940 0.002 0.006 
CTC3 y = 1.0453x + 0.1385 R² = 0.9857 0.002 0.008 
1 mg GAE/mL, GAE: gallic acid equivalents 
2 mg QE/mL, QE: quercetin equivalents 
3 mg CE/mL, CE: catechin equivalents 
 
 
 
 
SECTION S2: HPLC-PDA analytical method parameters 
Preparation of standard solutions 
The stock solutions of twenty standards were made at the concentration of 1 mg/mL in a final 
volume of 10 mL of methanol. Working solutions of mixed standards at the concentrations of 
0.20, 0.5, 1, 2.5, 5, 10, and 20 μg/mL were made by dilution of stock solution in volumetric 
flasks with the mobile phase. Then the standards were injected into the HPLC-UV/Vis system. 
 
Chromatographic separation 
A C18 reversed-phase packing column (Prodigy ODS(3), 4.6  150 mm, 5 μm; Phenomenex. 
Torrance, CA, USA) was used for the separation and the column was thermostated at 30 ± 1°C 
using a Jetstream2 Plus column oven and a gradient elution using a mobile phase of water-
acetonitrile (93:7, v/v, 3% acetic acid) was selected, as reported in Table S2.1. Figure S2.1 
illustrates the separation of the mixture containing the phenolics standards at 278 nm 
(wavelength where all compounds are detectable). A robust baseline separation was achieved 
in 60 minutes (Figure S2.1). Retention times and other calibration parameters are reported in 
Table S2.2. 
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Table S2.1 Gradient elution profile. 
Time (min) % water (3% acetic acid) % acetonitrile (3% acetic acid) Flow (mL/min) 
0 93 7 
1 
0.1 93 7 
30 72 28 
38 75 25 
45 2 98 
47 2 98 
48 93 7 
58 93 7 
 
Table S2.2: Calibration parameters, maximum wavelength and retention times. 
Phenolic standard Slope Intercept r2 Wavelength Ret. time 
Gallic acid 44126 1005 0.9858 271 nm 4.99 
Catechin 7022 972.4 0.9361 278 nm 13.36 
Chlorogenic acid 22136 2475 0.9650 324 nm 14.29 
p-Hydroxybenzoic acid 108088 -774.6 0.9504 256 nm 14.71 
Vanillic acid 51494 1141 0.9665 260 nm 17.31 
Epicatechin 8841 838.9 0.9542 278 nm 17.87 
Syringic acid 21596 369.6 0.9672 274 nm 18.30 
3-Hydroxybenzoic acid 17280 -1815 0.9541 295 nm 19.41 
3-Hydroxy-4-methoxybenzaldehyde 60154 -187.5 0.9882 275 nm 22.08 
p-Coumaric acid 96213 4217 0.9416 309 nm 22.65 
Rutin 35896 1420 0.9429 256 nm 25.38 
Sinapinic acid 498115 -85290 0.9737 324 nm 26.18 
t-Ferulic acid 63520 -1361 0.9969 315 nm 27.75 
Naringin 22064 -769 0.9964 285 nm 29.78 
2,3-Dimethoxybenzoic acid 7163 -579.3 0.9592 299 nm 30.36 
Benzoic acid 12500 842.4 0.9901 275 nm 31.20 
o-Coumaric acid 111357 -4293 0.9944 276 nm 34.81 
Quercetin  74660 -6774 0.9837 367 nm 40.57 
Harpagoside 48111 1000000 0.9921 280 nm 45.49 
t-Cinnamic acid 168680 -6103 0.9933 276 nm 45.87 
Naringenin 40329 305.8 0.9577 290 nm 46.74 
Carvacrol 91780 -25903 0.9896 275 nm 49.95 
CHAPTER 6 
 127 
 
Figure S2.1: Chromatogram of phenolics standards illustrating the separation of standards’ 
mixture (gallic acid, catechin, chlorogenic acid, p-hydroxy-benzoic acid, vanillic acid, 
epicatechin, syringic acid, 3-hydroxybenzoic acid, 3-hydroxy-4-methoxybenzaldehyde, p-
coumaric acid, rutin, sinapinic acid, t-ferulic acid, naringin, 2,3-dimethoxybenzoic acid, 
benzoic acid, o-coumaric acid, quercetin dehydrate, harpagoside, t-cinnamic acid, naringenin, 
carvacrol; wavelength, 278 nm; flow-rate, 1 mL/min; injection volume, 20,0 μL; 4 μg/mL 
each). 
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SECTION S3: Chromatograms at 278 nm 
Eryngium maritimum roots infusion 
 
Eryngium maritimum roots decoction 
 
Eryngium maritimum roots tincture 
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Eryngium maritimum stems infusion 
 
Eryngium maritimum stems decoction 
 
Eryngium maritimum stems tincture 
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Eryngium maritimum leaves infusion 
 
Eryngium maritimum leaves decoction 
 
Eryngium maritimum leaves tincture 
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Eryngium maritimum flowers infusion 
 
Eryngium maritimum flowers decoction 
 
Eryngium maritimum flowers tincture 
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Abstract 
Marine halophytes are an outstanding reservoir of natural products and / or molecules and many 
species have ethnopharmacological uses as antimicrobial and / or anti-helminthic. However, 
little is known of the halophytes’ potential against neglected tropical diseases, as for example 
Chagas disease. This work evaluated for the first time the in vitro anti-Trypanosoma cruzi 
activity of natural extracts from the aromatic and medicinal species Helichrysum italicum 
subsp. picardii (everlasting) and Crithmum maritimum (sea fennel). For that purpose, 
decoctions, tinctures and essential oils from everlasting’s flowers and sea fennel’s stems, leaves 
and flowers were tested against intracellular amastigotes of two T. cruzi strains. From the 12 
extracts tested one was active, namely sea fennel’s flowers decoction, with significant anti-
trypanosomal activity and no toxicity towards the host cell (EC50 = 17.7 µg/mL, selectivity 
index > 5.65). This extract was characterized in terms of phenolic profile by high performance 
liquid chromatography – diode array detection (HPLC-DAD) and the major compounds 
identified were hydroxycinnamic acids, particularly chlorogenic acid. This sample was then 
fractionated using liquid-liquid extraction affording 5 fractions, all re-tested in the same model 
of anti-parasitic activity. Fraction 1 was the most active and selective (EC50 = 0.47 μg/mL, 
selectivity index = 59.6) and was tentatively characterized by liquid chromatography – high 
resolution mass spectrometry (LC-HRMS). However, the major compound present, and likely 
responsible for the observed anti-trypanosomal activity, was not successfully identified. A 
characterization of this fraction by nuclear magnetic resonance (NMR) is currently underway 
and further research will confirm whether the major compound present is the active molecule. 
To the best of our knowledge, this is the first report of sea fennel’s in vitro anti-trypanosomal 
activity. 
 
Keywords: Chagas disease, marine halophytes, Trypanosoma cruzi, Crithmum maritimum 
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7.1. Introduction 
 Neglected tropical diseases (NTDs) are a group of disabling and chronic infections that 
flourish primarily in impoverished environments impairing the lives of over one billion people 
worldwide (Hotez 2007; WHO 2010). Among them is Chagas disease (CD), a potentially life-
threatening zoonosis caused by the protozoan Trypanosoma cruzi. CD is mainly vector-borne, 
transmitted to humans through contact with faeces / urine of triatomine bugs (kissing bugs), but 
can also be transmitted by ingestion of contaminated foods, congenital transmission (mother to 
foetus), blood transfusion and organ transplants. Traditionally confined to Central and South 
America, CD is a health and socioeconomic burden that due to growing population movements 
has spread to other continents and is now an emergent global epidemic with around 6 - 7 million 
people infected worldwide (Pérez-Molina and Molina 2018; WHO 2017; Zingales 2017). CD 
involves acute and chronic phases, being more often diagnosed in the chronic stage as the acute 
infection is typically asymptomatic. In the acute phase, trypomastigotes circulate in the blood 
(parasitaemia) and infect cells, where they transform into asexually-multiplying amastigotes. 
When the amastigotes-containing cell is broken, parasites are released and infect other cells. 
An intense inflammatory response with activation of the innate immune response controls the 
parasite, and after 4 to 8 weeks parasitaemia decreases substantially. The acute stage usually 
resolves spontaneously leaving patients chronically infected, if untreated. In the chronic phase, 
parasites reach and establish in target organs, forming amastigote nests. This stage progresses 
slowly, and most chronic patients have no further evidence of the disease. After several years, 
30 – 40% of chronic patients will develop potentially fatal organ involvement (cardiomyopathy, 
megaviscera). Recent evidence shows that tissue damage is a result from T. cruzi action and the 
chronic inflammatory response it elicits (Bermudez et al. 2016; Pérez-Molina and Molina 2018; 
Zingales 2017). Currently only two anti-parasitic drugs are approved for CD treatment, namely 
nifurtimox and benznidazole, and their efficacy, although high at the acute stage onset, is low 
in the chronic phase. Moreover, they are rather toxic showing several side effects and require 
prolonged administration (Bermudez et al. 2016; WHO 2017; Zingales 2017). 
 Notwithstanding the recent successes in the struggle to eradicate some NTDs, including 
CD, achieved by specific WHO strategies (e.g. disease monitoring, vector control and 
preventive chemotherapy; WHO 2010, 2017), the development of new, effective, safe and 
affordable drugs for CD remains an urgent need (Pérez-Molina and Molina, 2018; Zingales, 
2017). With this in mind, researchers have (re)turned to nature to identify new anti-parasitic 
compounds. For example, the 2015 Nobel Prize of Physiology and Medicine was awarded to 
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three scientists for their contribution in the field of anti-parasitic drugs, namely the discovery 
of avermectin from Streptomyces avermitilis and of artemisinin from Artemisia annua L. These 
compounds established new therapies to treat lymphatic filariasis, onchocerciasis and malaria, 
reinforcing the value of natural resources in finding new or alternative drugs (Efferth et al. 
2015).  
 Marine halophytes, a specialized group of plants able to thrive in saline environments, 
have evolved several adaptations in response to the osmotic and ionic challenges of living in 
such harsh conditions, including the synthesis of highly bioactive molecules. They represent an 
outstanding reservoir of natural compounds with some species being used in folk medicine as 
anti-parasitic and anti-helminthic (Ksouri et al. 2012). However, reports on their potential use 
against NTDs like CD are scarce (López et al. 2015; Oliveira et al. 2016). Crithmum maritimum 
L. (sea fennel) and Helichrysum italicum (Roth) G. Don subsp. picardii (Boiss & Reuter) 
Franco (everlasting) are two aromatic halophytes with described anti-infective uses, namely 
anti-helminthic and anti-mycotic, and validated antimicrobial activities (Atia et al. 2011; 
Viegas et al. 2014). In this context, this work evaluated for the first time the in vitro anti-
trypanosomal properties of decoctions, tinctures and essential oils from both halophytes, 
namely against the intracellular amastigotes of two T. cruzi strains. The active extract was also 
chemically characterized in terms of phenolic composition by high performance liquid 
chromatography – diode array detection (HPLC-DAD). The most active extract was further 
fractionated and all fractions were re-tested; the most promising fraction was tentatively 
characterized by liquid chromatography – high resolution mass spectrometry (LC-HRMS) to 
identify the major compound(s) likely responsible for the anti-trypanosomal activity. 
 
7.2. Materials and Methods 
7.2.1. Chemicals 
 All chemicals were of analytical grade. Culture media were purchased from Welgene, 
Inc. (South Korea), fetal bovine serum (FBS) and penicillin / streptomycin from Gibco Inc. 
(Life Technologies, USA) and DRAQ5TM from BioStatus Ltd. (UK). Benznidazole was 
synthesized by Epichem Pty Ltd. (Australia). Commercial standards were supplied by Sigma-
Aldrich (Germany). Additional reagents / solvents were obtained from VWR International 
(Belgium). 
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7.2.2. Sample collection  
 Everlasting plants (Asteraceae family; voucher code MBH32) were collected in Ria 
Formosa coastal lagoon, south Portugal, in Cabanas de Tavira (37°07'51.3"N 7°36'35.6"W) in 
June 2013, while sea fennel plants  (Apiaceae family; voucher code MBH33) were collected in 
Aljezur beach, in Alentejo coast (37°20'30.7"N 8°51'06.0"W) in August of 2013. Botanist Dr. 
Manuel J. Pinto (National Museum of Natural History, University of Lisbon, Botanical Garden, 
Portugal) performed the taxonomical classification. Voucher specimens are kept in the 
herbarium of XtremeBio’s laboratory (CCMAR, University of Algarve, Portugal). Sea fennel 
plants were divided in stems, leaves and flowers, while only flowers from the everlasting were 
used. Plant material was oven-dried for 3 days at 40°C until complete dryness, powdered and 
stored at -20°C until needed.  
 
7.2.3. Preparation of the extracts  
 Water extracts were prepared similarly to decoctions, by boiling 1 g of dried biomass for 
5 minutes in 200 mL of ultrapure water. Hydro-ethanolic extracts were prepared similarly to 
tinctures, by homogenising 20 g of dried biomass in 200 mL of 80% aqueous ethanol during a 
week. Extracts were filtered (Whatman nº 4), vacuum and / or freeze-dried and stored in a cool 
and moist-free environment. To obtain the essential oils (EO), fresh biomass (500 – 1000 g, 
depending on biomass availability) was cut in small pieces and subjected to hydro-distillation 
in a Clevenger-type apparatus for 3 hours; EOs were dried with sodium sulphate, filtered, 
weighed and stored in sealed glass vials at -20°C until further use. 
 
7.2.4. Fractionation of the active extract 
 After a primary screening of the extracts’ anti-trypanosomal activity (described in section 
7.2.5), the active extract, sea fennel’s decoction from flowers, was fractionated: a 500 mL 
decoction was prepared and subjected to a sequential liquid-liquid extraction using solvents of 
increasing polarity (hexane, dichloromethane, chloroform and ethyl acetate; fractions 1 to 4, 
respectively). All fractions, including the water residue (fraction 5), were vacuum concentrated 
and / or freeze-dried and stored until assessment for anti-trypanosomal activity in a secondary 
screening (described in section 7.2.5). 
 
CHAPTER 7 
 140 
7.2.5. Evaluation of in vitro anti-trypanosomal activity 
 All mammalian cell lines, namely human osteosarcoma, U2OS, and Macaca mulatta 
kidney epithelial, LLC-MK2, cells, previously available in C.B. Moraes laboratory (Brasil), 
were cultured in DMEM medium supplemented with 10% heat-inactivated FBS, 100 U/mL 
penicillin and 100 mg/mL streptomycin in humid atmosphere (5% CO2, 37ºC). LLC-MK2 
cultures maintained the T. cruzi mammalian cycle in vitro and these tissue-derived 
trypomastigote forms were used to infect U2OS cells in the anti-trypanosomal assay. Two T. 
cruzi strains corresponding to two of the six discrete typing units (DTUs; Sylvio X10/1 strain, 
DTU I; Y strain, DTU II) were chosen pragmatically based on stocks available at the time the 
study started. In vitro culture of T. cruzi was performed as described in Moraes et al. (2014).  
 Extracts or fractions were dissolved in 100% DMSO either at 5, 10 or 20 mg/mL 
(according to the different saturation points) and the positive control compound benznidazole 
was dissolved at 40 mM in DMSO. The anti-trypanosomal assays were executed following 
Moraes et al. (2014), in duplicate (2 independent experiments); plates were fixed, and parasite 
and host cell DNA were stained with DRAQ5TM for microscope imaging (high content 
screening imaging system, Operetta, Perkin Elmer). Data was analysed according to Moraes et 
al. (2014): acquired images were analysed with high content analysis software (Harmony, 
Perkin Elmer) to detect host cell cytoplasm boundary, host cell nucleus and T. cruzi DNA, 
which in turn were quantified to determine total number of cells, number of infected cells, ratio 
of infected cells, and average number of parasites per infected cell. Only intracellular parasites 
were scored. Values for ratio of infected cells (infection ratio) were normalized to the average 
ratio of infected cells from all negative (infected, non-treated cells) and positive (non-infected 
cells) controls to obtain normalized activity; average cell ratio was determined by the ratio 
between total cells number in a test well and average total cells number in negative control 
wells. A primary single-concentration screening was carried out with the extracts (100 µg/mL 
final concentration, 200 µM for benznidazole) to assess normalized activity (percentage of 
infection ratio reduction) and average cell ratio (extracts cytotoxicity). The active extract, and 
afterwards fractions 1 to 5 (see section 2.4), were subjected to a secondary confirmatory dose-
response screening, following a 2-fold serial dilution (10 points, 100 µg/mL as the highest 
concentration tested), with T. cruzi Y strain (only strain yielding results for the active extract). 
Normalized activity datasets were fitted in dose-response curves using GraphPad Prismâ to 
determine EC50 (concentration that reduces the infection in 50%), CC50 (concentration that 
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reduces the number of host cells in 50%), selectivity index (CC50/EC50), and maximum activity 
(max. infection inhibition).  
 
7.2.6. Chemical analysis  
 As the active extract, sea fennel’s decoction from flowers was characterized in terms of 
phenolic composition by HPLC-DAD. The extract was dissolved at a concentration of 10 
mg/mL in ultrapure water and analyzed by HPLC–DAD (Agilent 1100 Series LC system, 
Germany), equipped with vacuum degasser (G1322A), quaternary pump (G1311A), 
autosampler (G1313A), thermostated column compartment (G1316A) and a diode array 
detector (G1315B). Analyses were carried out on a mediterranea sea 18 column (15 × 0.21 cm, 
5 μm particle size; Teknokroma, Spain). The mobile phase consisted on a mixture of methanol 
(solvent A) and 2.5% acetic acid aqueous solution, following a gradient of 0-5 min: 10% A, 5-
10 min: 10-30% A, 10-40 min: 30-90% A, 40-45 min: 90% A, 45-55 min: 90-10% A, and 55-
60 min: 10% A, with a flow of 0.5 ml/min. The injection volume was 20 μL with a draw speed 
of 200 μL/min; the detector was set at 210, 280 (for quantification), 320 and 350 nm. 
Compounds’ concentrations were calculated using calibration curves prepared for each 
commercial standard (4-hydroxybenzaldehyde, apigenin, catechin hydrate, epicatechin, 
epigallocatechin, epigallocatechin gallate, pyrocatechol, quercetin, and caffeic, caffeoylquinic, 
chlorogenic, coumaric, ferulic, gallic, gentisic, p- hydroxybenzoic, neochlorogenic, rosmarinic, 
salicylic, syringic and vanillic acids) dissolved in methanol at 1.00 mg/mL and diluted to the 
required concentrations in ultra-pure water. Data acquisition and instrumental control were 
performed with LC3D ChemStation software (Agilent Technologies). Results were calculated 
as µg/mg extract dry weight (DW).  
 From the fractionated extracts (described in section 7.2.4), the active and selective 
fraction 1 was further tentatively characterized by a liquid chromatography – high resolution 
mass spectrometry (LC-HRMS) method developed for the characterisation of apolar 
phytochemicals, to determine its major constituent(s). For LC-HRMS analysis, 1.25 µL of 
extract was injected with a CTC PAL™ autosampler (CTC Analytics, Switzerland) on a Waters 
Acquity UPLC HSS C18 SB column (2.1 mm × 100 mm, 1.8 µm; Waters) and thermostatically 
(35°C) eluted with an Accela™ quaternary solvent manager and a ‘Hot Pocket’ column oven 
(Thermo Fisher Scientific). The mobile phase solvents consisted of 50:22.5:22.5:5 (v:v:v:v) 
water + 5 mM ammonium acetate:methanol:acetonitrile:ethyl acetate (A) and 50:50 (v:v) 
acetonitrile:ethyl acetate (B); the gradient was set as follows (min/A%): 0.0/90, 0.1/90, 0.8/70, 
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20.0/9, 20.1/0, 22.4/0, 22.5/90, 25.0/90. For detection, a HRMS (Q Exactive™, Thermo Fisher 
Scientific) was used: analysis was performed using data dependent fragmentation (ddMS2) in 
positive and negative ionization mode with heated electrospray ionization (HESI) and 
atmospheric pressure chemical ionization (APCI). During analysis with both HESI and APCI, 
ddMS2 data were acquired in positive and negative ionization mode (one analysis per mode) 
over a mass range (m/z) of 120-1800 to obtain structural information. With HESI, spray voltage 
was set at ±2.5 kV, sheath gas and auxiliary gas at 47 and 15 (adimensional), respectively, and 
capillary temperature at 350°C; with APCI, the corona discharge current was set at 5 μA, the 
vaporizer and capillary temperatures were set at 450°C. For both HESI and APCI, resolving 
power of 140,000 and 17,500 at full width at half maximum (FWHM) at m/z 200 was used in 
full MS mode and ddMS2 mode, respectively (stepped collision energy 10, 30, 50 V, isolation 
window: 6 m/z, isolation offset: 2 m/z).  
 
7.3. Results 
 Dried biomass was extracted with water (decoctions) and 80% aqueous ethanol (tinctures) 
while fresh biomass was used to extract EOs, resulting in higher yields (Table 7.1) for sea 
fennel’s water extracts, particularly leaves (45.7%) and flowers (37.8%), and for everlasting’s 
tinctures (32.6%). EOs yields were lower reaching 0.53% for sea fennel’s flowers. 
 To assess the in vitro anti-trypanosomal properties of sea fennel and everlasting samples 
(decoctions, tinctures and EOs) against intracellular amastigotes of two T. cruzi strains, a 
primary single-concentration screening was carried out. Results for normalized activity (Table 
7.1), which gives the percentage of infection inhibition in relation to controls, point to 5 
promising extracts with ³ 50% activity against the T. cruzi Y strain and 4 extracts against the 
T. cruzi Sylvio X10/1 strain. However, when cross-checking with average cell ratio (Table 7.1), 
an indicator of extracts’ cytotoxicity toward host cells and that should desirably be ³ 0.5, only 
sea fennel’s flowers decoction covers both parameters and only for the Y strain (65% activity, 
0.73 cell ratio). This active extract was subjected to a confirmatory dose-response screening 
with the T. cruzi Y strain and its anti-parasitic activity was corroborated (Table 7.2, Fig. 7.1): 
an EC50 of 17.7 µg/mL and almost 90% maximum activity indicate potency and efficacy against 
the parasite, and with no toxicity towards the host cell detected within the tested concentrations 
(if CC50 is not determined, the highest tested concentration is used to estimate the SI). 
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 Being the most active and least cytotoxic extract, sea fennel’s flowers decoction was then 
fractionated by liquid-liquid extraction using hexane, dichloromethane, chloroform and ethyl 
acetate, and all fractions (including the water residue) were evaluated for anti-trypanosomal 
activity against T. cruzi Y strain. Results (Table 7.3, Fig. 7.2) show that the hexane fraction 
(fraction 1) was the most active and selective, presenting higher potency (EC50 = 0.47 µg/mL) 
and efficacy (113% max. activity), least cytotoxicity (CC50 = 28.0 µg/mL) and higher selectivity 
towards the host cells (SI = 59.6). The positive control benznidazole had comparatively lower 
potency (EC50 = 0.92 µg/mL) while similar efficacy and similar or higher selectivity (109% 
max. activity, SI > 56). Still noteworthy, fraction 2 (dichloromethane) exhibited high efficacy 
against the parasite (97% max. activity) and moderate selectivity (SI > 6.47), with an EC50 
slightly lower and therefore more potent than that of the crude extract (fraction 2, EC50 = 12.3 
µg/mL, Table 7.3; sea fennel’s flowers decoction, EC50 = 17.7 µg/mL, Table 7.2). 
 
Table 7.2 Dose-response screening of anti-parasitic activity of the active extract, sea fennel’s 
flowers decoction, against T. cruzi Y strain.  
Extract / 
Compound 
T. cruzi Y strain 
EC50b Max. activityc (%) CC50 (µg/mL)d SIe 
Active extract 17.7 ± 1.38 µg/mL 89.4 ND > 5.65 
Benznidazole a 3.97 ± 0.93 µM 100 ND > 101 
Data represent the mean ± SD of two independent experiments. ND: not determined 
a Positive control (3.97 µM = 1.03 µg/mL); b EC50 is a measure of potency; c Maximum activity is a measure of 
efficacy against the parasite; d CC50 is a measure of cytotoxicity towards host cells; e SI indicates extract/compound 
selectivity towards the parasite. 
 
Figure 7.1 Anti-parasitic activity of the active extract, sea fennel’s flowers decoction, and of 
the control benznidazole: dose-response curves normalized to infected and non-infected 
controls. Data refers to mean values of at least two independent experiments. Black dots refer 
to normalized activity while red dots refer to cell ratio. 
 
CHAPTER 7 
 145 
Table 7.3 Dose-response screening of anti-parasitic activity of the active extract’s fractions 1 
to 5 (hexane, dichloromethane, chloroform, ethyl acetate, water) against T. cruzi Y strain.  
Extract / 
Compound 
T. cruzi Y strain 
EC50 (µg/mL)b Max. activityc (%) CC50 (µg/mL)d SIe 
Fraction 1, Hex 0.47 ± 0.01 113 28.0 ± 0.90 59.6 
Fraction 2, Dcm 12.3 ± 0.35 97.0 79.3* > 6.47 
Fraction 3, Clor 23.3* 56.6 ND > 4.29 
Fraction 4, Acet ND 39.4 ND - 
Fraction 5, H2O ND 42.0 ND - 
Benznidazolea 0.92 ± 0.02 109 ND > 56 
Data represent the mean ± SD of two independent experiments. ND: not determined 
Hex: hexane, Dcm: dichloromethane, Clor: chloroform, Acet: ethyl acetate, H2O: water 
a Positive control (3.97 µM = 1.03 µg/mL); b EC50 is a measure of potency; c Maximum activity is a measure of 
efficacy against the parasite; d CC50 is a measure of cytotoxicity towards host cells; e SI indicates extract/compound 
selectivity towards the parasite; *Values obtained in one experiment. 
 
Figure 7.2 Anti-parasitic activity of the active extract’s fractions (F1 - Hex, hexane; F2 - Dcm, 
dichloromethane; F3 - Clor, chloroform; F4 - Acet, ethyl acetate; F5 - H2O, water), and of the 
control benznidazole: dose-response curves normalized to infected and non-infected controls. 
Data refers to mean values of at least two independent experiments. Blue dots refer to 
normalized activity while red dots refer to cell ratio. 
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 The phenolic composition of the active extract, sea fennel’s decoction from flowers, was 
investigated by HPLC-DAD, aiming at the identification of individual phenolic compounds. 
Table 7.4 (and Fig. 7.3) shows 10 polyphenolics were identified and quantified. The extract is 
composed of mainly hydroxycinnamic acids (13.7 out of 14.9 mg/g extract DW) with 
chlorogenic acid as the dominant compound (9.40 mg/g extract DW), followed by crypto and 
neochlorogenic acids (1.65 and 1.10 mg/g extract DW, respectively). Epicatechin was the only 
flavonoid found, at almost 1 mg/g extract (0.9 mg/g extract DW). However, it should be 
mentioned that non-identified peaks in the chromatogram (Fig. 7.3) indicate the presence of 
other (non-identified) compounds. 
 
Table 7.4 HPLC–DAD analysis of the phenolic profile (mg/g extract DW) of the active extract, 
C. maritimum’s flowers decoction. Peak numbers refer to the compounds in Figure 7.3. 
Compound Peak nº RT (min) Extract 
Phenolic acids    
Hydroxybenzoic acids    
Gallic acid 1 1.5 < LOQ 
p-Hydroxybenzoic acid 2 4.4 0.12 
Hydroxycinnamic acids    
Neochlorogenic acid 3 2.8 1.10 
Cryptochlorogenic acid 4 7.4 1.65 
Chlorogenic acid 5 7.8 9.40 
Coumaric acid 6 11.6 0.79 
Ferulic acid 7 13.0 0.72 
Flavonoids    
Flavanols    
Epicatechin 8 10.5 0.90 
Other polyphenols    
Pyrocatechol 9 2.5 0.21 
4-Hydroxybenzaldehyde 10 5.0 < LOQ 
TOTAL   14.9 
RT – retention times; LOQ – Limit of quantification = 0.01 mg compound/g extract dw 
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Figure 7.3 HPLC-DAD analysis of phenolic compounds in the active extract, C. maritimum’s 
flowers decoction: chromatogram at 280 nm. Peak numbers refer to the compounds in Table 
7.4. 
 
 The active and selective fraction 1 (hexane fraction from the active extract) was 
tentatively characterized by a LC-HRMS method developed for the characterisation of non-
polar phytochemicals. Based on the LC-MS analysis, there is one main compound present in 
that fraction but, unfortunately, the spectral information was inconclusive and the compound 
was not identified (Table 7.5). Several other compounds were detected in considerately lower 
intensity; they are most probably similar in structure, judging from the fragmentation data, and 
detected in less amounts (data not shown). Other low abundant compounds were tentatively 
identified as fatty acids (data not shown). 
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Table 7.5 LC-HRMS analysis of the active fraction 1 (hexane): spectral data of the main 
compound present (but not identified). 
  Accurate mass of 
precursor ion 
Molecular 
Formula 
Mass 
deviation 
(ppm) 
Fragmentation 
  Mass Molecular formula 
APCI pos 663.4546 C43H60N4P -0.574 551.32805 C34H48O4P or C35H44N4P 
   C42H64O4P 1.442 495.26613 C30H40O4P  C31H36N4P 
     439.20258 C26H32O4P  C27H28N4P 
     383.13969 C22H24O4P  C23H20N4P 
     327.07876 C18H16O4P  C19H12N4P 
     251.04654 C12H12O4P  C13H8 N4P 
     233.03576 C12H10O3P  - 
     153.07003 C12H9  C12H9 
     91.05416 C7H7  C7H7 
        
APCI neg 473.28375 C29H38N4P -0.437 457.25234 C27H38O4P or C28H34N4P 
   C28H42O4P 2.389 441.22127 C26H34O4P  C27H30N4P 
     267.11595 C14H20O3P  C21H15 
     251.08463 C13H16O3P  C20H11 
     205.15989 C14H21O  C8H22N4P 
     189.12847 C13H17O  C7H18N4P 
     175.11284 C12H15O  C6H16N4P 
        
HESI pos 663.45438 C43H60N4P -0.951 Same as for APCI 
   C42H64O4P 1.065     
        
HESI neg No ions detected that correspond to the major ion in positive ion mode (at m/z 663) 
HESI heated electrospray ionization; APCI: atmospheric pressure chemical ionization; pos: positive; neg: negative 
 
 
7.4. Discussion 
 Current anti-parasitic treatment for CD relies on the drugs benznidazole and nifurtimox, 
both associated with severe side effects and debatable efficacy in the chronic phase, which 
highlights the need to find novel anti-trypanosomal therapies (Bermudez et al. 2016; Zingales 
2017). Recent efforts include improvement of current treatments, like combining benznidazole 
with other compounds or dosing adjustments, molecular targeted drug development, 
repositioning of known drugs, and discovery of novel compounds, like metal–drug complexes, 
chemically modified nitro-aromatic molecules, or plant-derived products (Bermudez et al. 
2016; Moraes and Franco 2016). However, although many promising drugs have been 
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documented, others are needed due to the slow and rigorous validation process and high 
downstream failure of drug candidates (Bermudez et al. 2016; Moraes et al. 2014). 
 Plants represent an immense source of potentially bioactive molecules with anti-
microbial activity including against T. cruzi, as for example rosemary (Rosmarinus officinalis 
L.) or green tea (Camellia sinensis (L.) Kuntze) (Bermudez et al. 2016), to name a few. But 
halophytes have been overlooked as prospective sources of anti-protozoal compounds, 
especially against T. cruzi. To the best of our knowledge, only Oliveira et al. (2016) screened 
several halophytes for in vitro anti-trypanosomal activity finding one extract from Juncus 
acutus L. roots able to decrease T. cruzi’s growth, while López et al. (2015) found that α-
amyrine and quercetin isolated from the mangrove plant Pelliciera rhizophorae Planch. & 
Triana were active against T. cruzi. No reports were found in literature concerning the potential 
anti-parasitic activity of sea fennel and the everlasting towards T. cruzi, although aerial parts, 
including flowers, have reported anti-infective medicinal uses (Atia et al. 2011; Viegas et al. 
2014). In this context, this work evaluated for the first time the in vitro anti-trypanosomal 
activity of decoctions, tinctures and essential oils from those aromatic halophytes against 
intracellular amastigotes of two T. cruzi strains. Anti-trypanosomal screenings are more 
relevant when performed against the intracellular amastigote since it better represents the T. 
cruzi tissue infection leading to CD and it is the main parasite form in the chronic stage 
(Zingales 2017; Palace-Berl et al. 2018). 
 Most of the tested samples did not yield promising anti-chagasic activity, either by low 
efficacy or due to high host cell toxicity, particularly when compared to the reference compound 
benznidazole (200 µM final concentration; Table 7.1). The exception was the decoction from 
sea fennel’s flowers, which presented moderate activity with a percentage of infection reduction 
of 65% without affecting significantly the host cell. However, these results were obtained for 
the Y strain only, probably due to Sylvio X10/1 strain higher infectivity and superior number 
of intracellular amastigotes. The confirmatory dose-response screening of the active extract 
with the T. cruzi Y strain corroborated its anti-parasitic activity (EC50 = 17.7 µg/mL) and with 
no toxicity detected towards the host cells (Table 7.2, Figure 7.1). This active extract, sea 
fennel’s flowers decoction, was characterized in terms of phenolic composition to identify 
individual phenolic compounds that could, in turn, be already described in literature as 
possessing anti-parasitic properties. The extract has mainly hydroxycinnamic acids, with 
chlorogenic acid as the dominant phenolic reaching almost 10 mg/g extract DW (Table 7.4). 
However, to the best of our knowledge, only Clavin et al. (2016) reported a weak in vitro 
activity of this phenolic against T. cruzi epimastigotes (IC50 > 100 μg/mL); Tasdemir et al. 
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(2008) describes its in vitro growth-inhibition against T. brucei rhodesiense amastigotes (IC50 
= 18.9 μg/mL) but not against T. cruzi. Isomers neo and cryptochlorogenic acids have never 
been reported as anti-trypanosomal compounds. As for the remaining phenolics in sea fennel’s 
flowers decoction, catechol and gallic acid revealed good in vitro trypanocidal activity against 
T. cruzi trypomastigotes (IC50 = 7.5 and 67 μg/mL, respectively; Tasdemir et al. 2006) and 
epicatechin had high in vitro lytic activity on bloodstream trypomastigotes (50% parasites lysed 
at 85 pM; Paveto et al. 2004), although not showing in vitro activity against T. cruzi 
trypomastigotes in another study (Tasdemir et al. 2006). Ferulic acid presented weak in vitro 
anti-T. cruzi trypomastigotes activity (IC50 > 150 μg/mL; Grecco et al. 2014), while coumaric 
acid displayed in vitro growth-inhibition of T. b. rhodesiense trypomastigotes but not of T. cruzi 
(Tasdemir et al. 2006); p-hydroxybenzoic and 4-hydroxybenzaldehyde were not found 
described as trypanocidal compounds. Overall, although some of the identified phenolics are 
portrayed as anti-trypanosomal, considering their reported IC50 and their lower amounts in the 
active extract (gallic acid, for example, was below the LOQ = 10 μg/g extract DW), only a 
synergistic effect between them could eventually justify the extract’s anti-parasitic activity 
(EC50 = 17.7 µg/mL). Moreover, only Tasdemir et al. (2008) used T. cruzi amastigotes, the 
same life stage presently assayed, which can hamper this analysis of whether those phenolics 
are responsible for the extract’s anti-protozoal activity considering that different T. cruzi forms 
can have different compound-susceptibilities. The amastigote form can be more difficult to 
affect since it is inside the host cells that have themselves protection mechanisms against 
cytotoxic agents (Izumi et al. 2011). 
 Sea fennel’s flowers decoction was subsequently fractionated by liquid-liquid extraction 
and the resulting 5 fractions were assessed for anti-trypanosomal activity. The hexane fraction 
(fraction 1) was the most active and selective and was further analysed and tentatively 
characterized by LC-HRMS. One major compound was present, likely the one responsible for 
the anti-trypanosomal activity, but the information provided by the HRMS analysis was, 
however, not enough for its identification (Table 7.5). Identification of compounds can be fairly 
easy when analytical standards are available but, in natural products research, analytical 
standards are often very expensive or not commercially available, leaving the identification task 
to be based on the available chromatographic and spectrometric information. In this case, that 
information was not sufficient to uncover the main compound in the active fraction. 
Nevertheless, a characterization by NMR (nuclear magnetic resonance) spectroscopy is 
currently underway and further research will confirm whether the major compound present is 
the active molecule. 
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 Species belonging to the Apiaceae family, including sea fennel, have been shown to 
possess EOs with compounds active and selective against T. brucei, such as a-pinene, b-
ocimene, limonene and sabinene, all monoterpenes found in C. maritimum’s EOs (Kamte et al. 
2018). Another main compound already described in sea fennel’s leaves, the polyacetylene 
falcarinol (also known as panaxynol; Cunsolo and Ruberto 1993), has been reported as very 
toxic (EC50 = 0.01 µg/mL) and highly selective against T. b. brucei (Herrmann et al. 2013). 
Moreover, a less abundant monoterpene found in sea fennel, linalool (Atia et al. 2011), showed 
potent trypanocidal effect against T. cruzi trypomastigotes (IC50 = 0.31 µg/mL; Villamizar et 
al. 2017). However, none of these compounds was identified as the main molecule in the active 
fraction 1. Nevertheless, monoterpenes and polyacetylenes represent classes of secondary 
metabolites with promising lead compounds to develop novel trypanocidal drugs (Kamte et al. 
2018). To affect the intracellular amastigote form of the parasite, compounds must be able to 
pass through the host-cell’s plasma membrane (Izumi et al. 2011). Several monoterpenes and 
polyacetylenes are lipophilic and can therefore cross the plasma membrane and disturb 
biomembranes within the cell (Wink 2008); monoterpenes in particular can cause 
destabilization of the protozoal plasma membrane and / or cause cell lysis (Raut and Karuppayil 
2014). Overall, literature shows that there are many secondary plant metabolites that can have 
anti-trypanocidal activity and medicinal plants in particular, like sea fennel in the present study, 
can provide effective anti-parasitic molecules. The importance of identifying new trypanocidal 
compounds lies in the possibility of using them as novel or integrative therapies in CD 
treatment and / or as starting material for new drugs design. 
 
6.5. Conclusions 
 To the best of our knowledge, this is the first report of sea fennel’s in vitro anti-
trypanosomal activity. Its flowers decoction showed activity against T. cruzi intracellular 
amastigotes with no toxicity towards the host cells; the anti-trypanosomal properties resided in 
fraction 1. Despite some of the identified phenolics in the active extract being described as 
trypanocidal, the LC-HRMS tentative characterization of fraction 1 was not able to identify the 
major compound present, which is most likely responsible for the anti-trypanosomal activity. 
However, an NMR characterization of the fraction is currently underway. Additionally, when 
identified, structure–activity relationship (SAR) studies may disclose the mode of action and 
possible pharmacological applications of these molecules, encouraging further research. 
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Overall, this work shows that sea fennel can provide effective anti-parasitic molecule(s) with 
potential pharmacological application in the treatment of CD.  
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8.1. General Discussion 
  Traditional medicinal plants like, for example, the tea plant (C. sinensis), lemon verbena 
(Aloysia citrodora Palau), rooibos (A. linearis), chamomile (Matricaria recutita L.), coffee 
(Coffea species), and aloe (Aloe vera (L.) Burm.f.) are explored by the food industry as 
beverages or additives for functional foods (Gruenwald 2009; Pohl et al. 2016). Aloe, tea, 
chamomile, and other medicinal plants such as coconut (Cocos nucifera L.), ginkgo (Ginkgo 
biloba L.), ginseng (Panax ginseng C.A.Mey.), grape vine (Vitis vinifera L.), jojoba 
(Simmondsia chinensis (Link) C.K.Schneid.), lavender (Lavandula angustifolia Mill.), olive 
(Olea europea L.), sage (Salvia officinalis L.), turmeric (Curcuma longa L.), Colchicum and 
Solanum species, to name a few, are also ingredients in nutra- and pharmaceutical, cosmetic 
and nutricosmetic formulations for health purposes, beauty care and / or as overall well-being 
promoters (Aburjai and Natsheh 2003; Atanasov et al. 2015; Gruenwald 2009; Jivad and Rabiei 
2014). However, medicinal halophytes are typically overlooked despite being great sources of 
highly bioactive molecules and of potential new-generation products with beneficial properties 
(Ksouri et al. 2012; Petropoulos et al. 2018a,b). In an effort to value medicinal halophytes, 
recent scientific endeavours have, nonetheless, set a new perspective on these salt-tolerant 
plants, namely their prospective uses as gourmet food (like Sarcocornia perennis (Mill.) 
A.J.Scott, S. ramosissima, and A. macrostachyum; Barreira et al. 2017), in herbal beverages 
(like L. algarvense; Rodrigues et al. 2016, 2017c), as sources of relevant molecules (e.g. 
juncunol, a potential anti-cancer drug from J. acutus L.; antiparasitic compounds from J. acutus, 
I. crithmoides, and S. rubra; Rodrigues et al. 2014; Oliveira et al. 2016, 2018), or as raw 
material for the cosmetic industry (like P. lentiscus and A. pungens as anti-hyperpigmentation; 
Lopes et al. 2016; Rodrigues et al. 2018b), the pharmaceutical industry (e.g.: P. maritimum and 
L. algarvense to manage diabetes and inflammation; Rodrigues et al. 2016, 2017b) and the 
nutraceutical / functional foods commercial segment (e.g.: C. edulis, Juncus species, P. 
maritimum, or A. pungens, as cognitive-enhancers or to mitigate age-associated conditions; 
Rocha et al. 2017; Rodrigues et al. 2017a, 2018a,b).  
 In this study, five medicinal halophyte plants common in the Algarve (southern Portugal), 
namely A. campestris subsp. maritima (dune wormwood), C. maritimum (sea fennel), E. 
maritimum (sea holly), H. italicum subsp. picardii (everlasting), and P. coronopus (buckshorn 
plantain), were selected for their traditional folk uses and promising biological activities, to 
unveil their potential as source of bioactive compounds and / or bioactive extracts with 
therapeutic, cosmetic and / or nutritional applications. Aiming at a consistent and timely 
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publication of the results, the work effort was focused at one halophyte at a time, rendering a 
chapter for each halophyte in the present thesis, plus a sixth chapter dedicated to the 
antiparasitic activity against T. cruzi (the causative agent of Chagas disease) of two aromatic 
species (sea fennel and everlasting). The present chapter endeavours a general discussion of the 
work developed, comparing the results obtained for each of the halophytes studied. It is 
important to mention that, while all plant extracts were to be sequentially extracted with 
solvents such as hexane, ethyl acetate, methanol and water, this was only accomplished with 
buckshorn plantain. For the other halophytes, preliminary results and contemporaneous 
literature being published dictated the need to alter this approach. Most literature studies deal 
with organic extracts despite the fact that traditional medicinal uses favour infusions, decoctions 
or tinctures of parts of, or the whole plant, to convey the plants’ healing properties (Handa 
2008). Hence, focusing on aqueous extracts seemed of greater significant importance to 
scientifically validate the folk-medicinal knowledge. Therefore, for the remaining four 
halophytes, extracts were prepared following the traditional uses of the plants, namely 
replicating infusions, decoctions and also tinctures in the case of the dune wormwood and sea 
holly. Moreover, for sea fennel, the everlasting and sea holly, tisanes (and tinctures for sea 
holly) were studied in their respective ingestion dosage, the “cup-of-tea” measure (or drops for 
sea holly’s tinctures), to assess the plants from a medicinal use perspective, given that the “cup-
of-tea” (200 mL) is a worldwide measure for drinking tisanes (for tinctures, 1 mL equals 
approximately 3 to 5 drops, which is a common ingestion therapeutic dosage).  
 
8.1.1. Phytochemical profile 
 The chemical composition of halophytes comprised the analysis of known bioactive 
compounds such as phenolic compounds. As detailed in chapter 1, these are perhaps the most 
widely occurring group of secondary metabolites and some of the most important plant 
bioactive compounds, and herbal extracts are important sources of them (Balasundram et al. 
2006).  Hence, extracts from the five halophyte plants under study (different anatomical organs: 
roots, stems, leaves and / or flowers) were characterized in terms of phytochemicals present by 
spectrophotometric methods to determine total polyphenolic content (TPC) and other phenolic 
groups (total flavonoids, condensed tannins, etc). For simplification purposes, only the TPC 
will be presently discussed.  
 Although there is no established classification in terms of high / low values of total 
phenolics, some authors consider that natural extracts are rich in phenolic compounds if their 
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TPC (expressed as GAE, gallic acid equivalents) is higher than 20 mg/g DW (Kähkönen et al. 
1999; Lopes et al. 2016; Rodrigues et al. 2015). This was the case for all organs of buckshorn 
plantain (roots 41.3, leaves 42.6, flowers 29.5 mg GAE/g DW) and of the dune wormwood 
(roots 114 – 118, aerial-organs 119 – 134 mg GAE/g DW), and also for all organs of sea fennel 
and the everlasting and most organs of sea holly (roots’ tisanes and stems’ tinctures were the 
exception) when considering the extraction yields obtained and the TPC per cup-of-tea (see 
Table 8.1).  
 
Table 8.1 Yields (infusion and decoctions: g extract/200mL, tinctures: g extract/mL) and 
phenolic contents in infusions and decoctions (mg/cup-of-tea) from sea fennel, everlasting and 
sea holly, and tinctures (mg/mL) from sea holly. 
Plant Organ Extract Yields TPCa 
C. maritimum Stems Infusion 0.302 12.4 ± 0.36 
(sea fennel)  Decoction 0.319 12.8 ± 0.92 
 Leaves Infusion 0.478 33.7 ± 0.91 
  Decoction 0.500 35.3 ± 2.98 
 Flowers Infusion 0.404 21.2 ± 0.17 
  Decoction 0.389 22.6 ± 0.99 
H. italicum subsp. picardii Roots Infusion 0.071 13.9 ± 0.49  
(everlasting)  Decoction 0.091 20.5 ± 1.45 
 Vegetative aerial-organs Infusion 0.239 62.0 ± 0.95 
  Decoction 0.265 70.2 ± 4.35 
 Flowers Infusion 0.265 69.9 ± 3.88 
  Decoction 0.326 76.5 ± 2.62 
E. maritimum Roots Infusion 0.521 3.32 ± 0.29 
(sea holly)  Decoction 0.443 3.72 ± 0.30 
  Tincture 0.054 7.61 ± 0.65 
 Stems Infusion 0.214 4.25 ± 0.21 
  Decoction 0.224 5.34 ± 0.40 
  Tincture 0.023 0.42 ± 0.02 
 Leaves Infusion 0.350 12.0 ± 0.69 
  Decoction 0.348 11.2 ± 0.82 
  Tincture 0.028 0.88 ± 0.04 
 Flowers Infusion 0.263 17.0 ± 0.62 
  Decoction 0.268 14.9 ± 0.39 
  Tincture 0.025 0.76 ± 0.06 
a TPC: total polyphenol content, mg GAE/200 mL or mg GAE/mL, GAE: gallic acid equivalents. 
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 In this sense, these halophytes’ extracts can be considered of high polyphenolic content 
and a potentially good source of these bioactive phytochemicals. Overall, in comparison with 
each other, the everlasting had the highest phenolic content, followed by the dune wormwood. 
Tisanes from sea holly showed the lowest phenolic contents, particularly when compared with 
herbal teas from sea fennel and everlasting. It is also noteworthy that, globally, aerial organs 
(leaves and flowers) from all studied plants had higher phenolic contents than the other organs, 
an accumulation pattern probably linked to the phenolics role in the plants’ interaction with 
their environment. Phenolic compounds can accumulate in different plant tissues due to the 
different physiological roles of each organ: they can act as UV filters (flavonoids in particular) 
protecting larger radiation-exposed areas, phago-deterrents against herbivores, or contribute to 
pigmentation that attracts pollinators (Harborne and Williams 2000; Hutzler et al. 1998; 
Petersen and Simmonds 2003).  
 Phenolic compounds in plant extracts can be extremely diverse, hence extracts were 
further characterized by High Performance Liquid Chromatography (HLPC) (in the case of 
buckshorn plantain, sea fennel and sea holly) or Ultra-HPLC – Photodiode Array – accurate 
mass-Mass Spectrometry (UHPLC-PDA-amMS) (in the case of the everlasting and dune 
wormwood) to determine their polyphenolic profile. The UHPLC-PDA-amMS also allowed the 
identification of other tentatively identifiable compounds in the more promising halophyte 
species (see section 8.1.4. Biological activities). A wide diversity of phenolics was identified 
in these halophyte plants, the most abundant ones being verbascoside and luteolin-7-O-
glucoside in buckshorn plantain, chlorogenic, neo- and crypto-chlorogenic acids in sea fennel, 
quinic and chlorogenic acids in the everlasting and dune wormwood, and carvacrol and 
naringenin in sea holly. Phenolic acids were the most common phenolic compounds found 
among the studied plants, with a slightly higher prevalence of hydroxycinnamic acids (HCAs). 
HCAs occur in most plant tissues: they are incorporated into cell walls contributing to its 
mechanical strength, play a regulatory role in plant growth and morphogenesis, are involved in 
cells’ responses to stress and pathogens, and often form the polymeric waxes coating plants’ 
external surfaces (El-Seedi et al. 2012). The most common compounds determined were 
coumaric and ferulic acids, present in all five halophytes. These HCAs are associated with plant 
cell walls and have a role in plant growth, contributing to lignin biosynthesis, which may 
explain their occurrence in all of the studied plants (Lattanzio et al. 2006). Moreover, p-
hydroxybenzoic, syringic and chlorogenic acids were present in at least four of the halophyte 
species. Some hydroxybenzoic acids, like p-hydroxybenzoic and syringic acids, seem to have 
allelopathic effects, inhibiting the nearby growth of others plant species (Seal et al. 2004; Weir 
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et al. 2004). Chlorogenic acid acts as an antioxidant, protecting plant tissues against oxidative 
stress (Niggeweg et al. 2004). It has also been associated with plant resistance to fungal attack 
(Friend 1979), and its synthesis is increased in response to plant wounding (Ananthakrishnan 
1990). This may explain the occurrence of these three phenolic acids in most of the studied 
halophytes. Additionally, while the concentration of phenolic compounds varied considerably 
between the different halophytes’ organs, overall, aerial organs (flowers and leaves) had the 
highest sum of identified compounds in all plants except sea holly (where roots had the higher 
quantity, mainly due to the dominant compound found in this organ, carvacrol). Again, the 
higher phenolic accumulation in aerial organs suggests their protective role in the above-ground 
organs, possibly against excessive UV-radiation, predation or towards reproductive success 
conferring appealing colours and / or taste to pollinators and / or seed dispersers.  
 These molecules determined in the plants’ extracts have been shown to possess several 
biological activities with potential important health effects. To exemplify, the most abundant 
phenolics identified in the five halophyte plants are all strong antioxidant compounds (Gálvez 
et al. 2005; Patel et al. 2014; Pero et al. 2008; Santana-Gálvez et al. 2017; Shahidi and 
Ambigaipalan 2015), some with cytotoxic / anti-carcinogenic properties (carvacrol, chlorogenic 
acid, luteolin-7-O-glucoside, naringenin, verbascoside; Baser 2008, Gálvez et al. 2003; Meng 
et al. 2013; Patel et al. 2014) and antimicrobial activity (carvacrol, chlorogenic acid, 
verbascoside; Baser 2008; Egorov et al. 2004; Santana-Gálvez et al. 2017), others with anti-
inflammatory capacity (naringenin and verbascoside; Alipieva et al. 2014; Patel et al. 2014) or 
even hypoglycaemic / anti-diabetic and hypo-lipidemic / anti-obesity properties (chlorogenic 
acid and naringenin; Meng et al. 2013; Nakajima et al. 2014; Patel et al. 2014). In fact, almost 
all the phenolics identified in the halophytes’ extracts are described in literature as interesting 
and valuable natural bioactive phytochemicals, and their presence may help explain some of 
the plants’ main traditional medicinal uses while also highlighting the potential use of these 
halophytes as a source of bioactive molecules and / or products with health promoting potential. 
 
8.1.2. Mineral composition 
 Besides being important sources of polyphenolic compounds, herbal extracts may also be 
an added source of other components for the human diet such as minerals (Pohl et al. 2016). 
Additionally, halophytes have been referred as generally having high mineral content (Barreira 
et al. 2017; Buhmann and Papenbrock 2013; Guil-Guerrero 2001; Guil-Guerrero et al. 1998; 
Ventura et al. 2011), a trait potentially related to the saline environment in which they live (Díaz 
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et al. 2013; Redondo-Gómez et al. 2010). As previously mentioned, halophytes have unique 
features that allow them to cope with high salinity levels, including accumulation and 
compartmentalization of selective ions and compatible solutes for osmotic adjustment. 
Moreover, they can regulate transpiration and accumulate elements, as for example K, in the 
presence of high Na and Cl concentrations (Flowers et al. 2010). Therefore, the presence of 
minerals in the halophytes’ extracts could be of added value for their potential use as food 
products. In this sense, the mineral content in the extracts of buckshorn plantain leaves and of 
sea fennel, dune wormwood and sea holly organs were analysed. Sea fennel and sea holly 
extracts were analysed considering the cup-of-tea (200 mL) measure. As expected, sodium was 
the most abundant element determined in the halophytes’ extracts, particularly those from 
aerial-organs like leaves. Values of this element were higher than those usually found in 
regularly consumed tisanes from glycophyte plants like M. recutita (chamomile), Cymbopogon 
citratus (DC.) Stapf. (lemongrass), or Tilia species (linden) (Pohl et al. 2016), although not 
reaching the maximum recommended daily intake of Na (2000 mg; WHO 2012a) in terms of 
both cup-of-tea and gram of extract measures. The other macro-elements (Ca, K, Mg) were also 
fairly abundant in the halophytes’ extracts, overall higher in leaves and flowers, supplying up 
to 2.0% of Ca (in sea fennel’s leaves), 0.6% of K (in sea fennel and sea holly’s flowers) and 
2.9% of Mg (in sea fennel’s leaves) of the adult daily recommended intakes (Ca: 1000 – 1300 
mg/day, Mg: 190 – 260 mg/day, K: 3510 mg/day; WHO/FAO 2004; WHO 2012b). As for 
microelements (Fe, Mn, Zn), although found in lower concentrations, their presence in the 
extracts still represents up to 12% of Fe (in dune wormwood’s roots), 1.8% Mn (in dune 
wormwood’s aerial-organs) and 1.7% of Zn (in buckshorn plantain’s leaves) of the 
recommended daily intakes (Fe: 9.1 – 58.5 mg/day, Zn: 3 – 14 mg/day, Mn: 5-5.5 mg/day; 
NHMRC 2006; WHO/FAO 2004; WHO 2012b). Tinctures from dune wormwood and sea holly 
had overall lower mineral content which was expected given the better ability of water to extract 
these nutrients from plants. Moreover, levels of potentially toxic minerals like Cu, Cr, Ni, Cd 
and Pb, when detected, were below legislated values for plants (Pb: 0.3 mg/kg wet weight, Cd: 
0.2 mg/ kg wet weight of plant material, maximum levels in finished herbal products are not 
regulated; EC Regulation 1881/2006), pointing to the safe consumption of these extracts. 
Altogether, results highlight a possible nutritional role of these halophytes’ herbal extracts as a 
mineral supplementary source, particularly from sea fennel for macronutrients and dune 
wormwood for microelements, therefore contributing to the adult daily intakes of some major 
and minor elements. 
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8.1.3. Toxicological assessment 
 It is crucial to determine the potential toxicity of new herbal products, such as plant 
extracts, to ascertain its safe consumption. Preliminary toxicological screenings of natural 
extracts can be assessed by in vitro models that address cytotoxicity of the extracts towards 
mammalian cell lines, delivering fast and reliable results and reducing in vivo testing (Nogueira 
et al. 2011; Rodrigues et al. 2016; Saad et al. 2006). As sea fennel, dune wormwood and 
everlasting extracts were, overall, the best promising extracts, they were submitted to a 
preliminary toxicological evaluation on N9 (murine microglia), S17 (murine bone marrow 
stromal), HepG2 (human hepatocellular carcinoma), and SH-SY5Y (human neuroblastoma) 
cell lines to assess cellular viabilities and therefore predict the extracts’ potential toxicity. All 
samples had overall low toxicity. Sea fennel’s samples in particular did not exhibited toxicity 
against both tumoural (SH-SY5Y, HepG2) and non-tumoural (N9, S17) cells, since cellular 
viability values were all equal to or higher than 90%. The everlasting’s and dune wormwood’s 
aqueous extracts had moderate to very low toxicity towards N9 cells (from 63 to > 90% cell 
viability values); S17 cells were more sensitive to toxic effects but, nevertheless, these 
halophytes’ extracts had also moderate to low toxicity (53 – 77% viability values). Additionally, 
they exerted no toxic effects in the HepG2 cell line. However, sea wormwood’s tinctures 
induced lower cellular viabilities for all cell lines than those obtained for the aqueous extracts. 
Green tea (C. sinensis) and rooibos (A. linearis) aqueous extracts were assessed alongside for 
comparison purposes as they are widely consumed as tea / tisanes. Cellular viabilities for these 
commercial plants’ extracts were similar or even lower than those of the halophytes under 
study. Rooibos samples had moderate toxicity towards non-tumoural cells (56 – 66% viability 
values), as had green tea extracts against S17 cells (59 – 60% viability values). As a preliminary 
toxicological evaluation of these halophytes’ extracts, results are quite promising particularly 
when compared to those obtained for the largely consumed green tea and rooibos tisanes, 
suggesting that they may be regarded as safe for consumption, specially the sea fennel. 
However, some caution is advised regarding the use of hydro-alcoholic extracts. In vitro 
toxicity studies of extracts from these plants are scarce but their large use for medicinal, 
nutritional and / or culinary purposes also points to their safe consumption. Nonetheless, 
although in vitro cell culture methods are accepted as an effective method for safety testing 
(Saad et al. 2006), further experiments on mammalian animal models should be pursued. 
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8.1.4. Biological activities 
 The five halophytes under study were tested for biological activities aiming at unravelling 
their potential therapeutic and health-promoting properties, while also attempting to validate 
their uses in folk medicine. All halophytes were tested through a battery of in vitro assays 
targeting antioxidant (radical scavenging and metal-related activities), anti-diabetic (digestive-
enzymes inhibitory activity) and anti-hyperpigmentation (tyrosinase inhibiting activity) 
properties. However, not all halophytes had positive outcomes for these bioactivities and 
therefore each chapter detailed the bioactivities uncovered for each of the halophyte species. 
Other activities included in the work program, namely neuroprotective, anti-tumoural, and anti-
obesity, were also tested but with unsuccessful results; they were not included in this thesis. A 
comparative analysis of the properties found in these plants follows. 
 
8.1.4.1. Antioxidant properties 
 Antioxidant phytochemicals are scavengers of free radicals or ROS / RNS, and 
deactivators of metal catalysts by chelation, among other activities, reducing oxidative stress 
and consequent potential cell damage. It is increasingly documented that antioxidants 
effectively fight and prevent oxidative damage and thus are able to reduce the risk of oxidative 
stress-related conditions like neurodegenerative and vascular diseases, carcinogenesis or 
inflammation (Lu and Yen 2015; Saeidnia and Abdollahi 2013; Shahidi and Ambigaipalan 
2015; Sindhi et al. 2013). Antioxidants are also associated with the management of diabetes 
mellitus (Sindhi et al. 2013) and amelioration of skin ageing conditions (Ribeiro et al. 2015). 
These are thus an essential group of potentially therapeutic / cosmetic molecules, also used as 
food additives to prevent harmful modification of oxidation-sensitive foods, such as oils and 
fats (Ksouri et al. 2012). Moreover, natural antioxidants are currently in high demand in the 
market as consumers are aware of the potential benefits of natural products and are willing to 
spend more on nutrition, cosmetics and supplements (Gruenwald 2009; Sindhi et al. 2013). In 
this context, there is a growing economic and health safety interest on the identification of 
halophyte species with high antioxidant content aiming at its use as an alternative to synthetic 
antioxidants in the food, cosmetic and pharmaceutical industries (Ksouri et al. 2012; Sindhi et 
al. 2013).  
 To understand the antioxidant potential of the halophytes under study, extracts were 
tested for radical scavenging activity using complementary in vitro assays, attending at the 
multifaceted aspects of antioxidants and their reactivity. Several methods targeting radical 
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scavenging activity (RSA) and redox metals were used to determine the antioxidant activity of 
the different extracts, namely the antiradical activity against DPPH, ABTS, NO, O2l¾ and OHl 
radicals, along with ferric reducing antioxidant power (FRAP) and metal chelating activities on 
Cu2+ and Fe2+. For the everlasting, sea fennel, and sea holly extracts, results were expressed as 
percentage of activity in a cup-of-tea (and as % activity in 10 mg/mL extracts, for sea holly’s 
tinctures). In these cases, a classification to describe the antioxidant activity of the extracts as 
potent (> 50% activity), moderate (30 – 50% activity) and low (< 30% activity) can be useful 
for comparison purposes (Vinutha et al. 2007; Custódio et al. 2015). Following this 
classification, almost all of the everlasting extracts had potent (> 50%) antioxidant activity 
(roots were the exception, week against the OHl radical and at chelating copper), although 
being week (< 30%) in iron chelation. Similarly, most of sea fennel’s extracts had potent RSA 
(only decoctions were potent NO and OHl scavengers) and iron reducing capacity (FRAP), 
while being low to moderate (30 – 50%) at metal chelating. As for sea holly, tinctures showed 
overall potent antioxidant capacity (except against the NO radical and at chelating iron), 
whereas leaves and flowers aqueous extracts varied between moderate and potent antioxidant 
activity; however, stems and leaves’ decoctions were the only potent iron chelators. Aqueous 
extracts of the commercial green tea and rooibos plants were assessed alongside for comparison 
purposes since they are sought for their strong antioxidant properties. Overall, the antioxidant 
activity of most of the everlasting’s extracts matched or even surpassed that of green tea and 
rooibos, and the antioxidant capacity of the sea fennel’s leaves and flowers samples were at 
least as effective as those of rooibos. For the dune wormwood and buckshorn plantain, results 
were expressed as IC50 values (mg/mL; half maximal inhibitory concentration, ascertained for 
extracts with activities > 50% at 10 mg/mL). The dune wormwood extracts were all effective 
at radical scavenging and at reducing iron, having IC50 values lower than 0.5 mg/mL for all 
assays. In fact, all extracts were better at scavenging NO and O2l¾ than the standard antioxidant 
controls (ascorbic acid and catechin, respectively) and almost all were similar or better DPPH 
scavengers than the standard control BHT. However, the chelating properties of this halophyte’ 
extracts were moderate for copper (IC50 values: 1.3 – 3.6 mg/mL) and low for iron (IC50 values: 
6.3 – > 10 mg/mL). As for the buckshorn plantain, globally, extracts had moderate to high RSA, 
particularly the roots’ extracts towards DPPH (IC50 values: 0.5 – 0.8 mg/mL) and ABTS (IC50 
values: 0.6 – 2.4 mg/mL) radicals. However, these samples did not match the standard 
antioxidants used in comparison. Metal chelating capacities of this plantain’s extracts were 
moderate to low (IC50 values: Cu2+ 3.0 – > 10 mg/mL, Fe2+ 1.1 – >10 mg/mL). Comparing the 
five halophytes in terms of antioxidant potency is difficult considering the difference in the 
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study approach for the everlasting, sea fennel, and sea holly, where results were expressed as 
activity in a cup-of-tea. Still, the everlasting and dune wormwood seem to have scored potent 
antioxidant capacity in all of the assays, closely followed by sea fennel, while sea holly had the 
only potent iron chelating extracts; buckshorn plantain did not distinguish itself comparatively.  
 Several studies credit the pronounced antioxidant activity of halophytes’ extracts to their 
polyphenolic content, an association not always verified in this work. Colorimetric assays give 
a TPC estimate and may not incorporate all the antioxidants in the extract (Tawaha et al. 2007), 
but the presence and amount of individual phenolics and possible additive / synergistic effects 
of constituents might help explain the discrepancy. Nevertheless, the phenolics’ role as 
antioxidants, especially in halophyte plants, is widely reported (Ksouri et al. 2012). In summary, 
and bearing in mind other research studies on these five halophytes already detailed in the 
respective chapters, results confirm the strong in vitro antioxidant capacity of them and thus 
show these plants as useful sources of antioxidant compounds / products. Moreover, when 
considering the cup-of-tea / tisanes approach, those beverages may contribute to a regular 
dietary intake of oxidative-stress preventing molecules.  
 
8.1.4.2. Anti-diabetic properties 
 Type 2 diabetes mellitus (T2DM) is a common metabolic disorder characterised by high 
plasma glucose levels (hyperglycaemia). It is the most common form of diabetes and affects 
millions of people, being estimated that about 450 million people will be affected by 2030. In 
modern medicine, the therapeutic strategy for T2DM management includes the inhibition of 
carbohydrate-hydrolysing enzymes, such as α-glucosidase and α-amylase, that results in the 
delay of carbohydrate digestion uptake, reduced postprandial blood glucose levels and 
therefore, in a reduction of hyperglycaemia linked to T2DM (Kumar et al. 2011; Patel et al. 
2012). Although no reports were found on the use of the halophytes included in this work as 
sources of traditional anti-diabetic remedies, related species have long been used in traditional 
herbal medicine to manage T2DM (Hung et al. 2012; Patel et al. 2012), as for example A. 
campestris and E. creticum (Dib et al. 2016; Yaniv et al. 1987). In this context, the halophytes’ 
extracts were assessed for their anti-diabetic potential by testing their capacity to inhibit α-
glucosidase (microbial and mammalian) and α-amylase enzymes, in comparison with a known 
inhibitor clinically used, acarbose. From the five plants under study, extracts from the 
everlasting, dune wormwood and sea holly showed inhibitory activity: all three halophytes were 
active towards the microbial α-glucosidase, the dune wormwood and sea holly inhibited both 
microbial and mammalian α-glucosidase, but only sea holly was able to inhibit α-amylase. 
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Following the classification previously used to describe the potency of antioxidant extracts 
under the cup-of-tea measure, the everlasting’s tisanes had a moderate to low inhibitory activity 
against microbial α-glucosidase (23 – 50%), as did those of sea holly (22 – 43%). Sea holly’s 
tinctures (except from roots), on the other hand, can be considered as potent inhibitors (> 50%) 
of the three enzymes. Nevertheless, samples from these two species did not match the standard 
inhibitor used (acarbose at 10 mg/mL) in comparison for the three digestive-enzymes (82 – 
96%). As for the dune wormwood, all of its extracts were more efficient at inhibiting the 
microbial α-glucosidase (IC50 values: 0.9 – 2.5 mg/mL) than acarbose, but only roots’ extracts 
were able to inhibit mammalian α-glucosidase, particularly roots’ tincture (IC50 = 2.90 mg/mL) 
that was more active than acarbose. Again, comparing these halophytes in terms of bioactivity 
potency is difficult considering the different approach between the everlasting and sea holly 
(activity in a cup-of-tea) and the dune wormwood (IC50 values). Still, sea holly was the only 
halophyte capable of inhibiting all three carbohydrate-hydrolysing enzymes while the dune 
wormwood scored higher efficiency at inhibiting α-glucosidase comparatively to the standard 
clinically used inhibitor acarbose.  
 It is recognized that polyphenolic phytochemicals, besides potent antioxidants (Ksouri et 
al. 2012; Shahidi and Ambigaipalan 2015), can modulate α-glucosidase and α-amylase activity 
therefore contributing to T2DM management by reducing post-prandial hyperglycaemia 
(Kumar et al. 2011; Hung et al. 2012). The stronger enzymatic inhibition of some extracts could 
be related to their constituents. For example, naringenin, catechin and carvacrol in sea holly’s 
tinctures, chlorogenic acid and kaempferol 3-O-glucoside in the everlasting, and chlorogenic, 
caffeic and ferulic acids in the dune wormwood, are all phenolic compounds with some sort of 
anti-diabetic properties like hypoglycaemic and / or digestive-enzymes inhibitory activity 
(Alam et al. 2016; Govindaraju and Arulselvi 2018; Meena et al. 2017; Meng et al. 2013; 
Nakajima et al. 2014; Patel et al. 2014; Pereira et al. 2011; Sutherland et al. 2006). Overall, 
results suggest that extracts from these three halophytes, particularly those from the dune 
wormwood and sea holly’s tinctures, could be beneficial in managing T2DM as they are capable 
of inhibiting dietary carbohydrate enzymes and consequently controlling glucose levels. 
Furthermore, oxidative stress has been implicated as a causative factor in the induction and 
progression of diabetes and diabetic complications by overproduction of ROS (Panigrahy et al. 
2017; Saeidnia and Abdollahi 2013). In this sense, the extracts’ combined antioxidant and anti-
diabetic potential could help reduce oxidative stress and control glucose levels, benefiting 
T2DM patients and those at risk of developing the condition. 
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8.1.4.3. Anti-hyperpigmentation properties 
 Skin hyperpigmentation conditions like melasma, freckles, or age spots, are a result of 
melanin over-production. The enzyme tyrosinase is essential in melanin biosynthesis and 
therefore its inhibition can help prevent and / or manage undesired skin darkening (Khan 2007; 
Ribeiro et al. 2015). Tyrosinase is also responsible for unwanted browning of fruits and 
vegetables, which decreases their market value (Chang 2009; Khan 2007). Hence, tyrosinase 
inhibitors are increasingly sought not only for cosmetic purposes but also for their potential in 
improving food quality (Chang 2009; Khan 2007; Ribeiro et al. 2015). In this context, the anti-
hyperpigmentation potential of the halophytes’ extracts was evaluated by assessing their 
capacity to inhibit tyrosinase, in comparison with a known inhibitor (arbutin, a substance 
commonly used to treat hyperpigmentary disorders; Gillbro and Olsson 2011). However, from 
the five plants under study, only the extracts from the dune wormwood showed inhibitory 
activity. All its extracts were active, particularly aerial-organs’ infusion (IC50 = 4.13 mg/mL), 
although less effective than the standard inhibitor arbutin (IC50 = 0.48 mg/mL). Some 
flavonoids were already identified as tyrosinase inhibitors, like quercetin, kaempferol and 
taxifolin (Chang 2009), all compounds detected in the dune wormwood’s extracts that possibly 
contributed to their tyrosinase inhibitory activity. With natural products currently in high 
demand particularly for substances with beauty-enhancement properties like skin whitening or 
hyperpigmentation-preventing, this halophyte is a prospective source of molecules / products 
with applicability in preventing or managing undesired skin and food darkening. 
 
8.1.4.4. Anti-protozoan properties 
 Little is known of halophytes potential use against neglected tropical diseases like Chagas 
disease (López et al. 2015; Oliveira et al. 2016), which is a potentially life-threatening zoonosis 
caused by the protozoan T. cruzi. The two aromatic halophytes, sea holly and the everlasting, 
have described anti-infective traditional uses and validated antimicrobial activities (Atia et al. 
2011; Viegas et al. 2014), especially aerial organs, including flowers. Hence, they were selected 
to be tested for in vitro anti-trypanosomal activity by evaluating their natural extracts 
(decoctions, tinctures and essential oils from everlasting’s flowers and sea fennel’s stems, 
leaves and flowers) against intracellular amastigotes of two T. cruzi strains. From these two 
halophytes, sea fennel was active, namely its’ flowers aqueous extract, with significant anti-
trypanosomal activity (EC50 = 17.7 µg/mL) against one of the T. cruzi strains and no toxicity 
towards the host cells. Major phenolic compounds identified in this extract were chlorogenic 
acid and its isomers neo- and crypto-chlorogenic acids, but that phenolic has reported weak in 
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vitro activity against T. cruzi (IC50 > 100 μg/mL; Clavin et al. 2016) and its isomers were not 
found described as anti-trypanosomal compounds. Further fractionation of the active extract 
afforded 5 fractions from which the hexane fraction was the most active and selective (EC50 = 
0.47 μg/mL); the clinically used positive control benznidazole had comparatively lower potency 
(EC50 = 0.92 µg/mL), although similar or higher selectivity. Tentative characterization of the 
active fraction was without success in identifying the major compound present, likely 
responsible for the anti-trypanosomal activity. To the best of our knowledge, this is the first 
report of sea fennel’s in vitro anti-trypanosomal activity, showing that this halophyte can 
provide effective anti-parasitic molecule(s) with potential pharmacological application in the 
treatment of Chagas disease.  
 
 
8.2. Synopsis / Conclusions 
 In this work, five halophyte plants with known ethnopharmacological value in the 
Mediterranean region were studied to unveil their potential as sources of bioactive compounds 
and /or bioactive extracts with therapeutic, cosmetic and / or nutritional applications. The 
greater scope was to expand our limited knowledge on the potential therapeutic and health-
promoting properties of medicinal halophytes species.  
 In summary: 
- Buckshorn plantain (P. coronopus; Chapter 2), traditionally 
used as analgesic, anti-inflammatory, antipyretic, anticancer, emollient 
and to treat disorders of the respiratory system (Ksouri et al. 2012; 
Redzic 2006), showed a high polyphenolic content, phenolic diversity 
and good antioxidant activity. Moreover, leaves can be considered as 
relevant sources of minerals. Altogether, results emphasize its potential 
as a source of bioactive molecules useful as antioxidants.  
- Dune wormwood (A. campestris subsp. maritima; Chapter 3) is 
traditionally used to treat gastric disorders, hypertension, rheumatics, as 
anthelmintic and abortifacient (Almargem 2018); the species, A. 
campestris, is also described as having anti-diabetic, anti-inflammatory 
and antipyretic uses (Dib et al. 2016). Results show that this halophyte’s 
extracts are a source of polyphenolic and mineral constituents, 
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antioxidants and α-glucosidase and tyrosinase inhibitors, pointing to a potential role in 
preventing oxidative-stress related diseases and managing T2DM and skin-hyperpigmentation 
conditions.  
- Sea fennel (C. maritimum; Chapters 4 and 7) is described in folk 
medicine as appetizer, tonic, purgative, carminative, anthelmintic, 
diuretic, to prevent scurvy, and to treat renal and urinary complaints, 
digestive disorders, colic and inflammation of the urinary tract and 
prostate (Atia et al. 2011; Cornara et al. 2009; Franke 1982). Extracts 
had a high polyphenolic content, a strong antioxidant potential, and an 
interesting mineral profile, thus, they could be a potential source of 
bioactive molecules and / or products for the food industry, as for example antioxidants and 
minerals. Additionally, this halophyte had significant anti-T. cruzi activity, showing it may 
provide a source of anti-parasitic molecule(s) in the treatment of Chagas disease. 
- Everlasting (H. italicum subsp. picardii; Chapters 5 and 7) is 
associated in folk therapeutics to analgesic properties and used in 
dermatologic, respiratory and digestive disorders with inflammatory, 
allergic or infectious components (Facino et al. 1990; Viegas et al. 
2014). Helichrysum plants are also used as diuretic and to treat urinary 
disorders, burns, venomous bites and hernias (Viegas et al. 2014). 
Extracts from this plant had a high and diverse polyphenolic content, 
with similar or even higher antioxidant potential than the commercial green and herbal red teas, 
showing moderate α-glucosidase inhibition, pointing to a potential role in preventing oxidative-
stress related diseases and managing T2DM. 
- Sea holly (E. maritimum; Chapter 6) is a folk remedy used as 
diuretic, kidney stone inhibitor, aphrodisiac, expectorant, anthelmintic, 
antitoxin against various infections, for oedema reabsorption and / or 
pain relief (Erdem et al. 2015; Isermann and Rooney 2014; Lisciani et 
al. 1984). Results highlight that this halophyte’s extracts could be a 
source of phenolic and mineral constituents, antioxidants and inhibitors 
of dietary carbohydrate digestive enzymes, pointing to their prospective 
role in managing T2DM and help preventing oxidative stress-related diseases. 
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 Comparatively, the everlasting had the highest total phenolic content, followed by the 
dune wormwood while sea holly had the lowest TPC. Sea fennel was the better mineral 
supplementary source of macro-elements while dune wormwood was best for micro-nutrients. 
The everlasting and dune wormwood scored the highest antioxidant capacity, closely followed 
by sea fennel, but sea holly had the only potent iron-chelating extracts. Sea holly was capable 
of inhibiting all three carbohydrate-hydrolysing enzymes, but the dune wormwood scored 
higher efficiency at α-glucosidase inhibition. Additionally, only the dune wormwood had 
tyrosinase inhibitory capacity while only sea fennel was active against T. cruzi. Overall, all 
halophytes can be sources of bioactive molecules that, by being potent antioxidants, can help 
prevent oxidative stress-related diseases. However, only the dune wormwood combines 
antioxidant, anti-diabetic and anti-hyperpigmentation potential. Still, sea fennel’s prospective 
anti-T. cruzi molecule(s) is of great pharmacological importance. 
  
 After these considerations, the biological questions posed in the objectives (section 1.5. 
Scope and Main Objectives of this Study) can be answered: 
 
- Can the traditional use of halophytes in folk medicine be supported by scientific 
evidence? In part, yes. For example, the species A. campestris and another Eryngium species, 
E. creticum, are used for anti-diabetic purposes; our extracts from the A. campestris subspecies, 
dune wormwood, and the Eryngium species studied, sea holly, proved to have anti-diabetic 
potential by inhibiting digestive-enzymes. Furthermore, the wide diversity of phenolic 
compounds found in the studied halophytes are known for a wide range of biological activities 
and that can help explain the main traditional uses given to them. For example, buckshorn 
plantain has anti-inflammatory, analgesic and anti-pyretic uses, and some of its main phenolics 
like verbascoside and salicylic acid are associated with those properties. Additionally, the 
strong antioxidant capacity that these halophytes display may act to prevent or reduce the 
severity of conditions / diseases in which oxidative stress is an underlying factor, such as 
neurodegeneration, inflammation, carcinogenesis, diabetes, cardiovascular disorders, etc. It is 
noteworthy, however, that molecules that could be responsible for the alleged medicinal 
properties may have not been present in the extracts due to the solvents chosen to prepare them. 
Moreover, it is difficult to test / prove many of the claimed folk therapeutics for lack of 
applicable assays or due to logistics and time constrains.  
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- Do these halophytes and / or their extracts have potential application as therapeutic, 
health-promoting or food-additive commodities? Yes. For all five halophytes under study, 
results summarized above emphasize their strong potential as new sources of health-promoting 
products for the food, cosmetic and / or pharmaceutical industries. The dune wormwood in 
particular could deliver raw material to explore as a source of antioxidant, anti-diabetes and 
anti-hyperpigmentation molecules and even minerals. Furthermore, the unconventional 
approach taken regarding the “cup-of-tea” measure showed the great potential of tisanes from 
sea fennel, the everlasting and sea holly to be further explored as potential health-promoting 
food products as, for example, innovative herbal beverages. 
 
- Can these plants be good candidates for identification and commercialization of 
bioactive compounds and / or nutraceuticals from natural sources? Yes. It is acknowledged 
that natural products are in high demand for positive outcomes particularly regarding anti-
ageing, improving cognitive functions, beauty-enhancement, or manage conditions such as 
diabetes and obesity. Considering the potential health benefits of medicinal plants, this work 
confirms that medicinal halophytes in particular can offer a wide range of bioactive 
components, such as polyphenols, and reveal new sources of compounds, products or raw 
material for different commercial segments. In fact, amidst the plant kingdom, halophytes are 
an unexplored source of a new generation of foods, drugs and /or health-promoting products 
awaiting imaginative exploration.  
  
 Overall and in conclusion, the outcome of this work shows that the five halophyte species 
studied are great prospective candidates to use as food (buckshorn plantain leaves, for example), 
in herbal beverages (e.g. sea fennel, sea holly and dune wormwood), as sources of relevant 
molecules (e.g.: anti-T. cruzi compounds in sea fennel), or as raw material for the cosmetic 
industry (like dune wormwood for anti-hyperpigmentation), the pharmaceutical industry (e.g.: 
the everlasting, dune wormwood and sea holly to manage diabetes) and the nutraceutical / 
functional foods commercial segment (all five halophytes as strong antioxidants to prevent 
oxidative stress-related conditions). Hopefully, this thesis will contribute to raise awareness of 
the importance of these renewable, useful and full of potential resources.  
 
 As future research, a number of ideas can be considered. This work can, in the near future, 
be used to promote halophyte species from the Algarve as food ingredients, for example, to use 
in beverages, salads and / or soups, or supplements for functional foods. Future studies may 
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also include combined extracts from the halophytes with best results aiming at the formulation 
of cosmetic / pharmaceutical ingredients with stronger bioactivities, as for example antioxidant, 
anti-diabetic or anti-hyperpigmentation. Additionally, it would be interesting to perform in vivo 
studies to test the properties found in these plants in animal models. Finally, the sustainable 
cultivation of selected species for commercial purposes, should be pursued. Halophyte crops 
can be irrigated with different salt-water resources like seawater, brackish water, or marine 
aquaculture effluents in aquaponics, and these approaches, if successful, could allow the use of 
uncultivable saline soils and also potentially integrate marine aquaculture systems to mitigate 
its wastes.  
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